Synthesis and Photophysical Studies of Nitrogen Heterocycles Containing Benzothiazines, Benzothiazoles, Indoles and Quinolines by Patel, Ealin N
The University of Maine 
DigitalCommons@UMaine 
Electronic Theses and Dissertations Fogler Library 
Summer 5-2021 
Synthesis and Photophysical Studies of Nitrogen Heterocycles 
Containing Benzothiazines, Benzothiazoles, Indoles and 
Quinolines 
Ealin N. Patel 
University of Maine, ealin.patel@maine.edu 
Follow this and additional works at: https://digitalcommons.library.umaine.edu/etd 
 Part of the Organic Chemistry Commons 
Recommended Citation 
Patel, Ealin N., "Synthesis and Photophysical Studies of Nitrogen Heterocycles Containing Benzothiazines, 
Benzothiazoles, Indoles and Quinolines" (2021). Electronic Theses and Dissertations. 3385. 
https://digitalcommons.library.umaine.edu/etd/3385 
This Open-Access Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been 
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of 
DigitalCommons@UMaine. For more information, please contact um.library.technical.services@maine.edu. 
 
 
  SYNTHESIS AND PHOTOPHYSICAL STUDIES OF NITROGEN HETEROCYCLES 




B.A. University at Buffalo, 2013 
B.S. University at Buffalo, 2013 
 
A DISSERTATION 
Submitted in Partial Fulfillment of the 
Requirements for the Degree of 
Doctor of Philosophy 
 (in Chemistry) 
 
The Graduate School 




Matthew Brichacek, Assistant Professor of Chemistry, Advisor 
Alice E Bruce, Professor of Chemistry  
Mitchell R. Bruce, Professor of Chemistry 
William M Gramlich, Associate Professor of Chemistry 














SYNTHESIS AND PHOTOPHYSICAL STUDIES OF NITROGEN HETEROCYCLES 
CONTAINING BENZOTHIAZINE, BENZOTHIAZOLE, INDOLE AND QUINOLINE  
By Ealin Patel 
Dissertation Advisor: Dr. Matthew Brichacek 
 
An Abstract of the Dissertation Presented 
in Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
(in Chemistry) 
May 2021 
Nitrogen heterocycles such as quinolines, benzothiazines, benzothiazoles, and indoles are widely 
found in nature and these compounds have significance in organic and medicinal chemistry, 
biochemistry as well as materials science. Monomeric units of eumelanin (brominated 5,6-
dimethoxyindolecarboxylate derivatives) were synthesized and regioselectively functionalized to 
form three monobrominated, three dibrominated, and a tribrominated variant using thermally 
induced nitrene insertions. After deprotection, three monobrominated 5,6-dihydroxyindole 
carboxylate (DHICA) derivatives were synthesized, and their UV-Vis absorbance was compared 
to DHICA. Bominated DHICA derivatives showed similar λmax as DHICA (~330 nm) but did not 
show aerial oxidation as evident by absence of chromophore absorbance at 550 nm. Monomeric 
synthetic analogues of pheomelanin subunit benzothiazole (six variants) and benzothiazine (four 
variants) were synthesized with CO2Et and CH2CN sidechain via Sandmeyer reaction, and Cu (II)-
catalyzed thiolation-Ullmann coupling, respectively. This monomeric pheomelanoid synthesis 
was the first successful unified strategy to access this class of molecules.  Utilizing these melanin 
building blocks, synthesis of mixed melanoids was done using Miyaura borylation and Suzuki-
coupling. Preliminary photophysical studies of synthesized mixed melanoids showed red shifted 
UV absorbance (from ~280 nm to 360 nm) due to extended conjugation and these compounds 
exhibited fluorescence properties as organic chromophores. With a goal of developing material for 
optical memory, gold-heli viologen was synthesized and characterized successfully via Pd (0)-
catalyzed Stille coupling route, or Hiyama-Heck coupling from 3-bromoquionoline as the key step. 
Temperature variable photoluminescence and quenching experiments were performed to study the 
photophysical behavior which showed quenching of gold luminescence by heli-viologen involving 
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1.1 Nitrogen heterocycles 
Nitrogen heterocycles (N-heterocycles) are one of the most significant chemical class of organic 
molecules, as they are widely found in natural products and active pharmaceuticals.1 N-
heteocycles are present in building blocks of life- DNA, RNA, ribosomes and conenzymes.2 
Over 75% of pharmaceuticals approved by the FDA contain nitrogen-heterocycles.3 Most 
common structural classes of five and six membered nitrogen heterocycles present in 
pharmaceuticals have been shown in Figure 1-1.4 
 
Figure 1-1- Pharmaceuticals containing nitrogen Heterocycles4 (Adapted with permission from 
Njardson et al.). 
Four membered β-lactams are of importance due to their activity in antibiotics (e.g. Penicillin) 
among other bioactive heterocycles.3 Five membered N-heterocycles-indole, thiazole, and 
imidazole, and six membered N-heterocycles-quinoline, pyridine, and thiazine have been of 
interest in organic, medicinal and materials chemistry. N-heterocycles exhibit hydrogen bonding, 
dipole-dipoe interactions, π-π stacking interactions in addition to electron acceptor and donor 
properties, which are important in biological functions as well as materials development.1,3,4 N-
heterocycles can be synthesized via biosynthesis and chemoenzymatic synthesis, or chemical 
synthesis methods such as transition metal catalysis, cycloaddition, photocatalysis, nitrene 
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insertion and other radical reactions. Subclasses of N-heterocycles such as indole, thiazole, 
thiazine and quinoline (Figure 1-2) are of interest to the research discussed in this work. Indole 
compounds are most commonly synthesized by intramolecular reaction of two ortho-substituents 
on an aromatic ring or by internal cyclization of a single substituent onto the aromatic ring. 
Thiazoles are synthesized by metal catalyzed thiocyanation. Quinolines are generally synthesized 
by Skraup synthesis or Michael type reactions.5 Our interest in these particular heterocycles stem 
from their presence and role in biological systems as well as potential material applications of 
these conjugated systems. 
 
Figure 1-2 N-heterocycles of interest. 
Indoles, thiazoles and thiazines are widely present in melanin which are natural biopolymers 
found in skin, hair pigments and brain of humans and other animals. They exhibit interesting 
photoprotective and phototoxic behavior due to their unique photophysical properties.  Pyridines 
and quinolones are present in viologens (diquaternary salts of Bipyridine), which have 
applications in optical memory storage and electrochromic devices. Detailed background on 
melanins and viologens is discussed in the following sections. 
1.2 Melanin  
Melanin pigments are one of the most widely present biological molecules in the animal kingdom 
as well as fungi, plants and bacteria.6,7 These compounds are involved in multiple biological 
functions such as thermoregulation, virulence factor where it protects organism from host immune 
response.8 They also possess interesting material, photophysical and chemical properties such as 
broadband radiation absorption (UV-Vis and Infrared), metal chelation, and free radical 
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scavenging.9 There are a few different types of melanin: eumelanin, pheomelanin, neuromelanin 
and allomelanin. Allomelanin is the only type of melanin which does not contain nitrogen or sulfur 
in the heterocycle as they are derived by polymerization of catechol and dihydroxynapthalene type 
monomers.9 Two of the most commonly found melanin in nature are Eumelanin and Pheomelanin. 
Eumelanin is an insoluble brown to black pigment, whereas pheomelanin is a red to yellow 
pigment as shown in Figure 1-3.10 The arrows in the chemical structure indicate branching points 
or chain proliferation sites of these bio-polymers. 
 
Figure 1-3 Melanin pigments responsible for hair color. 
Both of these melanins are derived from dopaquinone which is formed from oxidation of amino 
acid L-tyrosine by the enzyme tyrosinase.11 The structural difference between the two is the 
presence of sulfur it in pheomelanin due to the role of cysteine in formation of pheomelanin.9,12 
Neuromelanin is a dark polymer pigment present in substantia nigra and locus coereleus of the 
brain, and it is composed of mixed melanins (conjugated eumelanins and pheomelanins), metals, 
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and proteins.13 In order to understand the structure and the function of these biomolecules, 
discussion of melanogenesis is crucial. 
1.2.1 Melanogenesis 
1.2.1.1 Rapor-Mason-Prota pathway of Melanogenesis: 
Basic understanding of melanogenesis (Figure 1-4) was derived by Ito in 2003 from the works of 
Raper14 who isolated dopa, 5,6-dihydroxyindole (DHI), 5,6-dihydroxyindole carboxylic acid 
(DHICA) from tyrosine oxidation by tyrosinase; Mason15, who spectroscopically characterized 
dopachrome; and Prota16 who proved cysteinyldopa as a pheomelanin precursor leading to the 
understanding of late stage melanogenesis.17 As mentioned above both types of melanins found in 
animals, eumelanin and pheomelanin are formed from dopaquinone, which is highly reactive. It 
was believed previously that DOPA (3,4-dihydroxyphenylalanine) is formed from L-tyrosine 
which then oxidizes to dopaquinone. However, it was proved by Cooksey et al.18 using N,N-
dimethyldopamine as a substrate for tyrosinase enzyme that dopaquinone is formed directly from 
tyrosine during the initial stage of melanogenesis.18–20 In the absence of cysteine (sulfuryl 
compound), dopaquinone, due to its high reactivity undergoes intramolecular amine addition by 
the L-dopa sidechain amine group forming cyclodopa (leucodopachrome). Redox exchange 
between dopaquinone and cyclodopa results in formation of dopachrome and dopa. As described 




Figure 1-4 Rapor-Mason-Prota pathway of Mixed melanogenesis.17 
Dopachrome is a red-orange intermediate undergoes intramolecular rearrangement to form natural 
eumelanoid monomers, 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole 
(DHI) if it decarboxylates during rearrangement.14,17,20 These eumelanoid monomers further 
oxidize and polymerize to form the brown-black insoluble polymer pigment, eumelanin.  When 
sulfuryl compounds such as cysteine are present, it converts dopaquinone to one of the two 
isomers: 5-S-cysteinyldopa (5-S-CD) and 2-S-cysteinyldopa (2-S-CD), among which 5-S-CD is 
the major isomer.21 Redox exchange between dopaquinone and cysteinyldopa leads to formation 
of cysteinyldopaquinones (CD-quinones) and DOPA. CD-quinones further oxidize to form 
benzothiazine intermediates, which can convert to benzothiazoles via rearrangement. 
Benzothiazines and benzothiazoles are the natural pheomelanoid monomers. These small 
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molecules further oxidize and polymerize to form pheomelanin pigment.17,20,21 Several enzymes 
are involved in melanogenesis regulation. Tyrosinase, a class of proteins containing copper with 
ability to bind dioxygen, regulates formation of dopaquinones.22 Dopachrome tautaomerase (Dct), 
a melanogenic Tyrosinase-related protein-2 (Tyrp-2) catalyzes the tautomerization of dopachrome 
to DHICA.19,23,24 This isomerization involving hydrogen shift is also facilitated by divalent metal 
ions.25 DHI oxidative polymerization was previously attributed to tyrosinase activity, but it was 
proved through pulse radiolysis study that this process can be facilitated by oxidation of 
dopaquinone to DOPA.26,27 DHICA oxidative polymerization is catalyzed by Tyrosinase-related 
protein-1 (Tyrp-1).17 
1.2.1.2 Kinetics of melanogenesis 
Dopaquinone is a type of orthoquinone, which are very reactive and unstable compounds. Due to 
their low stability, to study kinetics of orthoquinone, pulse radiolysis is used. In this technique, 
pulsed ionized radiation (through a linear accelerator) is used to irradiate the sample and an 
analyzing beam (UV-Vis) is delivered perpendicularly (to the electron beam).28 Induced 
absorbance change is measured through this fast spectrophotometer and analyzed.22 Hydoxyl 
radicals produced from water initially and upon addition of halide such as bromine under saturated 
N2O, dibromide radicals are produced in buffer with KBr.
20,22 Dibromide radicals oxidize DOPA 
to form dopaquinone upon addition of catechol under pulse radiolysis conditions. Rate constants 
can be measured and quantified by observing subsequent changes in absorption wavelengths for 
different reactions.22 Figure 1-5 details the rate constants of reactions leading to formation of 




Figure 1-5 Kinetics of melanogenesis.22,29 
In the presence of cysteine dopaquinone is rapidly (k3=3 x 10
7 M-1s-1) conjugated to cysteinyldopa 
with the major isomer being 5-S-CD.22 Redox exchange step to form 5-S-cysteinyldopaquinone 
however is the rate determining step with the rate constant of 8.8 x 105 M-1s-1. It also produces 
DOPA, which is dearmoatized to dopaquinone. The rate of 5-S-CD formation depends on the rate 
of formation of dopaquinone.30 Through stages of pheomelanogenesis, Cysteinyldopaquinone 
produces pheomelanin biopolymer. In the absence of the sulphydryl (SH) compound cysteine, 
dopaquinone cyclizes to form cyclodopa. This step is very slow (k1=3.8 s
-1) and is possible due to 
the process being intramolecular at pH 8.6. This cyclization is also pH dependent as the rate is 100 
fold slower when pH is reduced to 5.6.29,30 Through redox exchange, (dopaquinone to DOPA) 
cyclodopa converts to dopachrome. This reaction is faster compared to the cyclization step with a 
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rate constant of 5.3 x 106 M-1s-1. Dopachrome through stages of eumelanogenesis produces 
eumelanin biopolymer. 
1.2.1.3 Eumelanogenesis 
In the absence of cysteine, dopaquinone (DQ) cyclizes to form cyclodopa (CD). Figure 1-6 
describes formation of DHI and DHICA quinones from cyclodopa, which with further oxidation 
and polymerization form eumelanin. Through redox exchange with dopaquinone, Cyclodopa 
converts to dopachrome, which has a half-life of ~30 minutes.  
 
Figure 1-6 Kinetics of Eumelanogenesis: formation of DHI and DHICA quinones. 
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Dopachrome undergoes spontaneous decomposition under physiological conditions resulting in 
formation of DHICA and as it decarboxylates it forms DHI. This process is non-enzymatic and it 
forms decarboxylated DHI as the major product with DHI:DHICA being 70:1.31 Through redox 
exchange with dopaquinone, DHI oxidizes to form DHI quinone with a slow reaction rate with 
rate constant of 1.4 x 106 M-1s-1 as this reaction does not go to completion.20,27 In the presence of 
dopaquinone tautomerase (Dct or Tyrp2), dopachrome is converted to DHICA through this 
enzymatic tautomerization where Cu(II) plays a key role.25,31,32 DHICA, through redox exchange 
with dopaquinone oxidizes to form DHICA quinone, which has a much slower rate of 1.6 x 105 
M-1s-1. As this process will not go to completion, involvement of enzymes such as tyrosinase 
speeds up oxidation of DHICA to DHICA quinone.27,33 Chemical or enzymatic oxidation of DHI 
and DHICA quinones leads to oligomerization and polymerization as rapid deposition of a black 
solid is observed leading to formation of eumelanin polymer.34,35 Oxidation of these quinones was 
studied by pulse radiolysis, which showed that it tautomerizes to imine and methide form. These 
tautomers undergo nucleophilic addition in order to make dimers, trimers and oligomers.29 
1.2.1.3.1 Eumelanin structure elucidation: 
The structure of eumelanin was elucidated by chemical degradation of this natural polymeric 
pigment.36 Through degradation studies using chemical oxidizing agents such as potassium 
permanganate, hydrogen peroxide or via reductive hydrolysis using hydroiodic acid. HPLC 
methods have been developed to detect the degradation products and the quantification of these 




Figure 1-7 Oxidative degradation of eumelanin by Alkaline H2O2. (Arrows indicate 
conjugation/chain proliferation sites of the polymer) 
As shown in Figure 1-7, degradation of different types of melanin using hydrogen peroxide 
under alkaline conditions results in simple degradation products, which can be detected and 
quantified by HPLC. Eumelanin containing dihydroxyindole (DHI) subunit results in pyrrole-
2,3,5-tricarboxylic acid (PTCA) and pyrrole-2,3-dicarboxylic acid (PDCA) upon oxidative 
degradation. Eumelanin containing dihydroxyindole carboxylic acid (DHICA) results in PTCA 
upon oxidative degradation whereas cross-linked eumelanin results in pyrrole-2,3,4,5-
tetracarboxylic acid (PTeCA). These degradation products are used as bio-markers for analysis 




In presence of cysteine formation of cysteinyldopas (5-S-CD and 2-S-CD) and 
cysteinyldopaquinones (5-S-CysQ and 2-S-CysQ) from dopaquinone is favored. 
 
Figure 1-8 Nucleophilic addition of cysteine. 
Ito and Prota showed (Figure 1-8) that through enzymatic reaction catalyzed by mushroom 
tyrosinase producing 5-S-cysteinyldopa as a major (74%) product, and 2,S-cysteinyldopa (14%), 
2,5-S,S’-dicysteinyldopa (5%), 6-S-cysteinyldopa (1%) as minor products.21 Due to this reaction 
major pheomelanoids observed in nature, in pheomelanin or neuromelanin are functinalized with 
Sulphur at 5’ position. As 5-S-CD is the major product it leads to the formation of the key 
intermediate 1,4-benzothiazine and other benzothiazine derivatives as described in Figure 1-9.  
During the late stage of pheomelanogenesis, 5-S-CD is converted to 5-S-cysteinyldopaquinone (5-
S-CysQ) with redox exchange with DOPA as it converts to dopaquinone. Cysteinyldopaquinone 
cyclizes to form 2H-1,4-benzothiazine-o-quinonimine(QI) as amine nucleophile attacks the 
neighboring carbonyl carbon. The rate of this reaction was measured with pulse radiolysis and was 
found to be fast with a value of 10 s-1.27  The competing reaction in presence of higher cysteine 
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content is addition of an extra cysteine to the 5-S-CD-Q which forms, 2,5-S,S’-dicysteinyldopa 
(2,5-S,S’-diCD). The rate of this reaction is much lower, 1 x 104 M-1s-1 and it only becomes a 
competitive process when cysteine concentration is higher than 1 mM in-vivo.17,30  
 
Figure 1-9 Pheomelanogenesis: formation of 1,4-benzothiazines.38 
Oxidation of cysteinyldopa and 1,4-benzothiazines was studied by enzymatic and other catalytic 
reaction using reagents such as peroxidase/H2O2, tyrosinase, periodate and ferricyanide under 
physiological pH.38 2H-1,4-benzothiazine-o-quinonimine (QI) is the key benzothiazine 
intermediate which leads to the formation of pheomelanoid monomers. QI undergoes 
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rearrangement with the reaction rate (measured by pulse radiolysis) of 6.0 s-1 in order to form 1,4-
benzothiazine carboxylic acid (BTZCA) as a major product (85%) and part of it decarboxylates to 
form 1,4-benzothiaine (BTZ).20,38–40 QI undergoes redox exchange with 5-S-cysteinyldopa as it is 
converted to 5-S-cysteinyldopaquinone resulting in formation of dihydro-1,4-benzothiazine 
carboxylic acid (DHBCA).20,41 Reduction of benzothiazine intermediate (BTZ) forms dihydro-1,4-
benzothiazine (DHB), and hydrolysis of this unstable DHB leads to the formation of dihydroxy-
dihydro-1,4-benzothiazine (DHDHB).38  
Cysteinyldopa and its 1,4-BTZ derivatives have shown to chelate strongly with metal ions such as 
Zn2+, Fe3+, Cu2+, Al3+, Co2+, and Cd2+. Zinc catalyzes oxidation of BTZCA and forms BTZCA-
dimers and further oxidation leads to formation of trichochrome C.38 Iron and copper ions chelate 
with BTZ and form a complex which assists in decarboxylation and ring contraction resulting in 
formation of 1,3-benzothiazole (BTZL) as described in Figure 1-10.38 
 
Figure 1-10 Oxidation of benzothiazine to benzothiazole.38 
Cysteinyldopa and its 1,4-BTZ derivatives under enzymatic and metal oxidative conditions  form 
pheomelanin polymer through oxidative polymerization. Through biomimietic conditions using 
enzymatic systems (peroxidase, tyrosinase), chemical agents (H2O2) and aerial oxidation, 
oxidative polymerization of cysteinyldopa and its derviatives have been studied.38,42 Different 
oligomers were made under different conditions and concentrations of different pheomelanoids, 
which implied that the make up of the final pheomelanin polymer is highly dependent on oxidative 
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conditions and the nature of polymerization. Degradation studies of natural pheomelanin polymers 
discussed below sheds light on the nature of polymerization and conditions in-vivo. 
1.2.1.4.1 Pheomelanin structre elucidation: 
Structure of Pheomelanin in natural melanin pigment is also determined by degradation 
experiments. Oxidative degradation using hydrogen peroxide or reductive hydrolysis by 
hydroiodic acid is used. Products are analyzed and quantified by HPLC to study the composition 
of pheomelanins.  Benzothiazine and its oxidation product benzothiazole are the most commonly 
found subunits in natural pheomelanin.36,37,43 
 
Figure 1-11 Pheomelanin degradation by oxidation and reductive hydrolysis. 
As shown in Figure 1-11, reductive hydrolysis of pheomelanin with benzothiazine unit using 
hydroiodic acid resuls in generation of 4-amino-3-hydroxyphenylalanine (4-AHP). Its isomer, 3-
AHP is also used as a biomarker for pheomelanin. Oxidative degradation of benzothiazine-
pheomelanin with alkaline hydrogen peroxide results in Pheomelanin containing benzothiazole 
unit results in benzothiazole carboxylic acid (BTCA isomers- BTCA-5 and BTCA-2), which can 
further degrade to yield thiazole-4,5-dicarboxylic acid (TDCA) and thiazole -2,4,5-tricarboxylic 
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acid (TTCA). Pheomelanin containing  benzothiazole subunit also oxidizes to yield TDCA and 
TTCA. These degradation prodcts can be analysed and quantified by HPLC and are used as 
biomarkers to understand pheomelanin strcture.36,37,43 
1.2.1.5 Mixed melanogenesis 
Three step pathway (Figure 1-12) proposed by Ito shows that melnogenesis has three stages of 
production, which depend on presence and concentration of cysteine. Initially when tyrosinase 
activity is low, dopaquinone is being produced at a low rate. When tyrosinase activity goes up 
resulting in increased dopaquinone production, the first stage of melanogenesis occurs as 
cysteinyldopas are being produced with presence of cysteine. This production occurs until cysteine 
concentration falls below 0.13 μM, after which the second stage begins where cysteinyldopas 
oxidize to produced 1,4-benzothiazine intermediates, which further oxidize to produce 
pheomelanin polymer. The second stage continues as long as cysteinyldopa concentration is above 
9 μM.12,17,19,20 Once cysteine is depleted and cysteinyldopa concentration has lowered, 
dopaquinone produces cyclodopa as the third stage begins. At this stage, cyclodopa produces DHI 
and DHICA via dopachrome, which further oxidize to form eumelanin polymer. 
 




This phenomenon of pheomelanin formation followed by eumelanin leads to casing model, which 
suggests that pheomelanin polymer forms the core, as its production is favored in the initial stage 
when cysteine concentration is high. Once cysteine is depleted, eumelanin production occurs and 
eumelanin forms the shell. This model supports structure and formation of neuromelanin, a mixed 
melanin polymer.11,44,45 As shown in Figure 1-12 melanogenesis depends on tyrosinase activity, 
which dictates dopamine production, as well as presence and concentration of cysteine. When 
cysteine levels are low, cysteinyldopaquinone production is low and as a result, 
pheomelanogenesis stage is short. In this case, eumelaninogenesis predominates. When cysteine 
concentration is high, cysteinyldopa-quinone production is high resulting in longer 
pheomelanogenesis and increased pheomelanin production.12,17,19,20  
1.2.1.5.1 Neuromelanin structure elucidation: 
Neuromelanin is a biopolymer structure consisting of pheomelanin and eumelanin as its major 
components. Degradative studies have suggested the benzothiazine and indole structures as 
subunits of this biopolymer. However, in contrast to pheomelanin and eumelanin found in skin 
and hair pigments, neuromelanin is derived from dopamine. In order to study the structure of 
neuromelanin, Ito and coworkers synthesized dopamine-derived eumelanin and cysteinyl 
dopamine derived pheomelanin via chemo enzymatic synthesis using mushroom tyrosinase 
enzyme.17 Degradation products of synthetic melanin and neuromelanin extracted from 
substantia nigra were generated from oxidative degradation and reductive hydrolysis as shown 




Figure 1-13 Degradation products of dopamine and cys-dopamine derived melanin. 
Upon oxidation with alkaline hydrogen peroxide, DHI melanin resulted in PDCA and PTCA 
Cysteinyl dopamine derived melanin (benzothiazole and benzothiazine subunit) upon oxidative 
degradation generated TDCA and TTCA and upon reductive hydrolysis generated 4-amino-3-
hydroxyphenylethylamine (4-AHPEA). Comparison of the neuromelanin reductive degradation 
products to synthetic melanin degradation products showed that neuromelanin contains nearly 
6% of DOPA sidechain compared to dopamine sidechain indicating that neuromelanin is mostly 
composed of dopamine derived melanins. Comparison of oxidative degradation products of 
neuromelanin with that of synthetic melanin showed that ~25% of melanin content in 
neuromelanin is cysteinyl dopamine derived in form of benzothiazine structure.36,46,47  
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1.2.2 Sources and synthesis of Melanins: 
1.2.2.1 Extraction: 
Natural melanin can be extracted from bacterial, fungal, animals or humans (hair, brain tissue). 
Method of extraction and purification depend on the source, but the commonality between the 
methods is use of alkaline solutions (1 M NaOH or KOH) followed by autoclavation.7 Fungal 
melanin can be extracted by incubation with 1 M NaOH at 60 °C followed by  precipitation using 
HCl. Precipitate is freeze-dried and resolubilized in alkaline solution where the above steps are 
repeated several times to purify the melanin.48–51 Extraction of human hair melanin involves 
washing with phosphate buffer and DTT (dithiothreitol), followed by incubation with proteinase 
K enzyme which is used for keratin digestion as it breaks the peptide bond  at carboxyl group 
adjacent to alpha amino groups. Repeated treatment with proteinase K and successive washing 




Figure 1-14 (A-D)SEM images (scale bar-200 nm) of neuromelanin from A) putamen B) 
premotor cortex C) cerebellum and D) substantia nigra. E) AFM of neuromelanin pigment from 
premotor cortex (scale bar-100 nm). F) Wavelength dependent photoelectron emission 
microscopy data. (Adapted from Zecca et al., 2008)53 
However acid/base extraction changes the molecular structure of melanin by changing 
concentration and distribution of metals coordinated to melanoids, as observed by morphology and 
spectroscopy.13,51,54 Human neuromelanin is extracted from one of the following organelles: 
substantia nigra, putamen, premotor cortex, and cerebellum. The process involves multiple steps 
of gradient centrifugation. Figure 1-14 (A-D) shows morphology of the extracted melanins 
visualized through electron microscope. Morphology and particle size of neuromelanin differ 
based on the source. However, as seen in the plot F in Figure 1-14; of wavelength dependent UV 
free electron laser photoelectron emission microscopy, all these melanins have common surface 
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oxidation potential.53 This observation provides additional evidence indicating that the process of 
melanogenesis involves synthesis of pheomelanins until cysteine is depleted, which forms the core. 
Once cysteine is depleted, eumelanins form creating the outer shell of the neuromelanin resulting 
in common surface oxidation potential among natural melanin samples. 
1.2.2.2 Chemoenzymatic synthesis: 
Synthetic melanins are obtained using tyrosinase enzyme to oxidize dopamine in order to get 
eumelanin and dopamine in presence of cysteine in order to get pheomelanin as shown in Figure 
1-15. Tyrosinase is extracted from plants (e.g. campanulatus) or mushrooms (e.g. Agaricus 
Bisporus).10,52,55,56 For pheomelanin synthesis, DOPA or dopamine and cysteine are oxidized using 
tyrosinase in sodium phosphate buffer as pheomelanin is precipitated by lowering the pH to 3-4 
using acetic acid or hydrochloric acid.13,57  
 
Figure 1-15 Chemoenzymatic synthesis of melanins. 
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Eumelanin can be synthesized by following similar procedure without the presence of cysteine, 
using DOPA, dopamine, DHI or DHICA, where enzymatic oxidation results in rapid deposition 
of black-brown pigment: Eumelanin.34 Enzymes such as peroxidase with H2O2 can also be used 
for controlled oligomerization of DHI and DHICA as studied by d’Ischia to synthesize dimers and 
tetramers of DHI to study the mechanism behind oxidative polymerization.10,55,58 Horseradish 
peroxidase can also be used to yield synthetic melanin from 5,6-dihydroxyindole substrate.59 
1.2.2.3 Oxidative polymerization: 
Oxidative polymerization or autooxidation of dopamine, DOPA, DHI or DHICA results in 
formation of pheomelanin, eumelanin or neuromelanin.60–64 e.g. Melanin can be synthesized via 
oxidative polymerization of dopamine hydrochloride in alkaline solution. Nanoparticles of 
melanin were synthesized using dopamine hydrochloride through oxidation and self-
polymerization of dopamine in aqueous ammonia in ethanol at room temperature.65  
 
Figure 1-16 Melanin (polydopamine) synthesis via oxidative polymerization (Adapted with 
permission from Ju et al., 2011)88 
Water-dispersible eumelanin nanoparticles were synthesized (Figure 1-16) by reaction of 
dopamine hydrochloride in deionized water with sodium hydroxide, which produced a pale yellow 
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basic solution at 50 °C and through spontaneous oxidation nanoparticles of melanin formed as the 
color change to dark-brown was observed.66 
1.2.2.4 Chemical synthesis of melanin subunits: 
1.2.2.4.1 Synthesis of 5,6-dihydroxyindole carboxylate compounds: 
Indoles are one of the most commonly studied nitrogen heterocycles, and several synthetic 
pathways are available in literature. However, methods to synthesize 5,6-dihydroxyindole (DHI) 
and 5,6-dihydroxyindole carboxylate (DHICA) are limited. Figure 1-17 shows commonly used 
methods to synthesize 5,6-dimethoxyindole carboxylate (DMIC). Methyl/ethyl azidoacetate 
sidechain condensation on aldehyde followed by thermal cyclization following Hemetsberger 
indole synthesis is one of the first methods used to synthesize DMIC (Figure 1-17a).67,68  
 
Figure 1-17 Methods to synthesize 5,6-dimethoxyindole carboxylate:(a) Hemetsberger indole 
synthesis67 (b) Copper catalyzed domino coupling-cyclization69 (c) Horner-Wadsworth-Emmons 
synthesis-Cadogan type cyclization.70 
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Copper-catalyzed domino coupling followed by cyclization of aldehyde with isocyanoacetate 
(Figure 1-17b) was used by Fang and coworkers to synthesize DMIC and its bromo derivatives in 
order to investigate their agonist activity for GRP35 (a G protein coupled receptor involved in 
pain, inflammation, cardiovascular diseases).69 Another method to synthesize DMICA was 
proposed by Chai, Huleatt and co-workers, where Horner-Wadsworth-Emmons method was used 
to more efficiently synthesize cinnamate sidechain from the corresponding nitroveratraldehyde 
followed by Cadogen type cyclization. This method used excess of triphenylphosphine in toluene 
under microwave conditions to achieve the DMICA product.70 
1.2.2.4.2 Synthesis of Eumelanoid oligomers 
Chemical synthesis of oligomeric dihydroxyindole (DHI), dihydroxyindole carboxylate 
(DHICA), and benzothiazine have been pursued by melanin chemists in last 20 years.35,59,64,71,72 
Chemical synthesis of these molecules would help understand complex biosynthesis of 
melangenesis. In addition, these oligomers and polymers have shown to be significant in 
developing bio-materials with applications in light-harvesting, bio-adhesion, and drug delivery. 
One of the synthetic strategy to access 5,6-DHI dimers and trimers is shown in Figure 1-18 using 
which dimers and trimers were synthesized from o-ethynylaniline derivatives.71,72 2,3’-biindolyl 
and 2,7’-biindolyl were synthesized from 3-iodoindole derivative and 7-iodoindole derivatives 
respectively using Pd catalysed Sonogashira coupling with o-ethynylaniline compound followed 
by intramolecular cyclization. 2,2-biindolyl compound was synthesized from oxidative 





Figure 1-18 Strategy to synthesize biindolyls.71,72 
This work was further extended by synthesizing trimers of 5,6-dihydroxyindoles using the same 
strategy. After deprotection, the dimers and trimers compound matched minor intermediates 
recovered during 5,6-dihydroxyindole polymerization to eumelanin.72  
 
Figure 1-19 Suzuki coupling to conjugate indole to a 5,6-Dimethoxyindole carboxylate 
(DMICA) compound73 
Palladium catalyzed couplings are commonly used for indole compounds, however only a few 
studies using Pd catalyzed couplings were found for 5,6-dihydroxyindole compounds.68,71,72,74,75 
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Recently, palladium catalyzed Suzuki coupling was used to conjugate DMIC to simple indole 
compounds in order to synthesize dimers and trimers of eumelanoid type small molecules. 
Commercially available DMIC ethyl ester derivatives were mono and dibrominated, and 
conjugated with borylated simple aromatic compounds in order to synthsize these derivatives.73 
1.2.2.4.3 Synthesis of aminobenzothiazole and 1,4-benzothiazine: 
Methods to synthesize benzothiazole include Hoffman method, Jacobson cyclization or oxidation 
by bromine under acidic condition or copper/palladium catalyst.76 One of the first methods 
utilized to synthesize aminobenzothiazole was to thiocyanate o-aminothiol followed by 
cyclization.77 Thiocyanation using potassium thiocyanate or ammonium thiocyanate with 
bromine followed by oxidative cyclization are common conditions in order to synthesize 
benzothiazoles.76,78 A method to synthesize aminobenzothiazoles from arylthiourea under mild 
conditions is by using benzyltrimethylammonium tribromide as bromine source.79  
 
Figure 1-20 Methods for aminobenzothiazole and 1,4-benzothiazine synthesis.  
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Most commonly used method to synthesize benzothiazine compound is alkylate condensation of 
dihalogenated alkylating reagent to ortho-aminothiol. ortho-halogenated thiol can also be used as 
a substrate with halogenated primary amine alkylating reagent.80–82 Similar to alkylate 
condensation, benzothiazine synthesis has also been doen by intramolecular cyclization with 
ethylamine tethered to the ring with thioether linkage.83,84 This method is similar to the 
conventional method to synthesize 1,4-benzothiazine from 5-S-cysteinyldopa using potassium 
ferricyanide as catalyst.40 Cho and coworkers developed a ring expansion reaction of cyclic 
ketones and ketoximes using DIBAL-H in order to access five to eight membered heterocycles 
one of which was benzothiazine. Reaction proceeds through a reductive rearrangement of oximes 
which provide cyclic secondary amines.85,86  
1.2.2.4.4 Synthesis of pheomelanoid oligomers: 
 
Figure 1-21 Synthesis of ∆2,2’-bibenzothiazine via oxidative coupling of 2-phenyl-1,4-
benzothiazine. 87 
Trichochromes-present in red hair pigment are consisted of dimeric units of benzothiazines. A 
strategy to synthesize ∆2,2’-bibenzothiazine from 3-phenyl-1,4-benzothiazine was done as shown 
in Figure 1-21. Oxidative coupling of 3-pheyl-1,4-benothiazine was performed using hydrogen 
peroxide in presence of oxygen under strong acidic condition (methanol:36%HCl-3:1). The 




1.2.3 Properties of Melanins: 
1.2.3.1 Physiochemical properties 
Melanin pigments exhibit low solubility in water, most common organic solvents such as ethanol, 
methanol, chloroform, acetone, benzene, hexane, diethyl ether. Synthetic and natural melanins are 
soluble in alkaline solutions such as 1 M sodium or potassium hydroxide and can be precipitated 
from alkaline solution at pH below 3 (commonly with 3 M HCl).7,49,61,88 Some common qualitative 
chemical tests and extraction protocols are used to identify, extract and analyze melanins. 
Precipitated melanin pigment can be decolorized/bleached by oxidizing agents such as KMnO4, 
K2Cr2O7, H2O2 and NaClO or by reducing agents such as H2S and Na2S2O4.
45,48,49,61,88–90 Melanins 
give positive reaction to the polyphenol test as it produces colloidal brown precipitate with FeCl3, 
and it produces gray precipitate with ammoniacal silver nitrate solution.7,48,61 Melanin pigment 
exhibits high resistance to thermal degradation as observed in the thermogravimetric (TGA) and 
derivative thermogravimetricanalysis (DTG). 
 
Figure 1-22 DTG (dashed line) and TGA (solid line) of sepia ink melanin. (Adapted from 
Praleaet al., 2019)7 
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This analysis was done with synthetic (DOPA-melanin) and natural melanin (from fungal and 
bacterial organisms) samples, of which data of melanin extracted from sepia ink has been shown 
in Figure 1-22. The first endothermal peak around 71 °C is attributed to evaporation of bound 
water. The exothermal peak at 306 °C is attributed to loss of carbon dioxide. Major thermal 
decomposition of melanin occurs at a much higher temperature around 998 °C, due to 
decarboxylation. It was observed that synthetic melanin are more resistant to decomposition than 
natural melanin. Morphology and melanin particle size has been studied with Scanning Electron 
Microscopy (SEM)91–100, Transmission Electron Microscopy (TEM)101–103, and Atomic Force 
Microscopy (AFM)54,104–107 of synthetic and natural melanins. Elemental analysis is used to 
identify and classify the subtype of melanins as the C:N:S, C:N, and S:N ratios differ between 
pheomelanin, eumelanin and allomelanin. 
1.2.3.2 Spectral and Photophysical properties 
Structure of melanin contains highly conjugated network of phenol, benzothiazole, 
benzothiazine, indole functionalities, and as a result, they exhibit high UV absorption. The UV 
absorption range of melanin in alkaline solution is 196-300 nm and varies between synthetic and 
natural melanins. Light absorption in visible region decreases as the wavelength increases. Plot 
of logarithmic absorption of melanin with wavelength gives straight line with negative slope, and 
is unique to the type of melanin.48,49 This method can be used to characterize and differentiate 
between the types of melanins. An example of UV-Vis absorption spectra of synthetic (DOPA) 
melanin and sepia melanin along with their logarithmic plots has been shown in Figure 1-23. 
Both samples were dissolved in 0.1 M NaOH and sonicated, followed by spectral scan of 220-
800 nm wavelength range. Both the samples have absorption maxima at 220 nm and show strong 
absorption in UV region (plot a). However they product unique absorption pattern as observed in 




Figure 1-23 A) UV-vis absorption spectra of sepia ink melanin (blue) and synthetic melanin 
(green), B) Linear plot of logarithmic absorbance vs wavelength. (Adapted from Pralea et al., 
2019)7 
Spectral analysis of human melanin has been done through in-vitro (400-720 nm) and in-vivo 
measurements (620-720 nm).108,109 Melanin quantity can be approximated by slope of the 
absorption spectra from the in-vivo experiment results (Figure 1-23).109 Epidermal melanin and 
neuromelanin exhibit similar broadband spectrum showing increasing absorbance at higher 
energies.53,108–110 Spectral analysis is also useful in differentiating the types of melanin as they 
exhibit different behaviors in-vitro and in-vivo. UVA induced absorption of pheomelanin and 
eumelanin was studied in-vivo and in-vitro, which showed difference in spectra and dose 




Figure 1-24 IR absorption spectra of synthetic melanin and sepia ink melanin. (Adapted from 
Pralea et al., 2019)7 
Fourier-transform infrared spectroscopy is also used to identify melanin pigment. IR of melanin is 
dependent on the source of the melanin and extraction process. An example spectrum of synthetic 
melanin and melanin from sepia officinalis has been shown in Figure 1-24.The scan was done on 
sample powder (synthetic or sepia) with KBR discs in the range of 400-4000 cm-1. The broad 
absorption between 3000 and 3600 cm-1 is characteristic of -OH and -NH stretching vibrations as 
melanin contains amine, amide, phenol, carboxylate and aromatic functionalities in indoles, 
benzothiazole, benzothiazine core structures as well as different sidechains. C=C and C=O 
stretches are observed between 1600-1750 cm-1. Characteristic melanin stretches however are 
observed between 1400-1500 cm-1 that are attributed to bending of N-H and stretching modes of 
secondary amine (C-N) of indoles, in addition to phenolic stretching between 1100-1150 cm-1. 
49,112–114 In addition to UV-Vis and FTIR, NMR (1H and 13C) is also used to characterize melanin 
pigments. Proton NMR showed peaks for aromatic hydrogens of phenyl, indole and pyrrole rings, 
methylene groups (sidechain), and N-H of indoles, and carbon NMR showed characteristic peaks 
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for carbonyl carbons in carboxyl, amide, and carbon atoms linked to heteroatoms such as nitrogen 
and sulfur.115–117 Mass spectrometry techniques such as (electrospray ionization) ESI-MS, matrix 
assisted laser desoption/ionization (MALDI), secondary ion mass spectrometry (SIMS), electron 
impact (EI) have been used to characterize structures of synthetic and natural melanins.50,118,119 
1.2.4 Significance and applications: 
1.2.4.1 Biological significance:  
Melanin has a protective role due to its ability to scatter photons, scavenge free-radicals, and 
dissipation of absorbed photons in non-radiative manner.120 It is present in hair and skin in different 
forms in humans, and is responsible for the color. Neuromelanin is a dark pigment, which 
accumulates in brain primarily in substantia nigra and locus coerleus. Formation of neuromelanin 
prevents accumulation of reactive quinones, which are generated from oxidation of catecholamine 
neurotransmitters. In addition, it has ability to sequester and bind metal ions, which reduces the 
metal toxicity. However, due to its affinity towards iron, it accumulates high level of iron (III) in 
form of high-spin, pseudo-octahedral centers with oxo and hydroxo bridges at the binding sites 




Figure 1-25 MRI images of substantia nigra and locus coeruleus of healthy individual. (NM 
present-white) and patient with PD (depleted NM). (Adapted from Isaias et al., 2016)123 
This high accumulation of metals may be related to role of neuromelanin in neurodegenerative 
diseases such as Parkinson’s Disease (PD). Substantia nigra and locus coeruleus are the most 
affected areas in this disorder as shown in MRI of PD patient brain vs healthy brain in Figure 
1-25.123 In the affected areas, accumulation and presence of neuromelnain has reduced 
significantly in patients with PD whereas significant presence of neuromelanin can be seen in 
healthy individual brain. Structural and redox properties of mixed melanin need to be studied in 
order to further understand the structure and function of neuromelanin and its role in Parkinson’s 
disease.  
1.2.4.2 Materials applications: 
Despite issues such as insolubility in organic solvents and certain material properties (amorphous 
polymer), melanins have been of interest to material chemists due to its desired physiochemical 
and photophysical properties.62 Melanins have photoconductivity (UV-Vis) and electrical 
conductivity (AC and DC), and have confirmed to be a natural amorphous semiconductor due to 
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its ability to do bistable electrical switching.124,125 These properties can be utilized in organic 
electronics. Figure 1-26 describes applications (current and potential) of dopamine and 
polydopamine derived melanins.62 
 
Figure 1-26 Applications of DOPA and dopamine derived melanins. (Adapted with permission 
from d’Ischia et al., 2014)62 
Metal and drug binding properties of melanin can be utilized for water purification, and free radical 
scavenging property of melanin has applications in polymer stabilization.126,127 UV and 
photoprotective properties of melanin has applications in materials for UV screens, and its 
adhesion properties can be used in surface coating and bio-adhesion.62,128 Recent applications of 
polydopamine type melanin materials include biosensing, nano particle and nanocapsule 





Viologens are redox active, strong electron accepting diquaternary salts of 4,4’-bipyridine 
(MV2+). Their photoreduction properties have been known for several years and their common 
applications are as herbicides, photocleaving agents, electronic and electrochromic devices.136 
Viologens (MV2+) can abstract an electron to generate radical cation (MV+), and if it two 
electrons are abstracted it generates neutral species (MV). These species exhibit unique 
electronic and photophysical properties.  
1.3.1 Viologen Applications: 
 
Figure 1-27 Viologen as (a) electron acceptor (b) electron donor (c) Donor-acceptor tandem. 
(Adapted with permission from Kiriya et al., 2014 and Xu et al., 2014)137,138 
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Viologens are good electron acceptors in their dicationic (MV2+) state. e.g. Paraquat is a widely 
used herbicide which is a dichloride salt of 4,4-bipyridine. During photosynthesis, it abstracts an 
electron from mitochondria generated by oxidation of NADH to NAD+. As a result, it oxidizes to 
radical cation of paraquat (Figure 1-27a).139 This unstable species abstracts and electron from 
oxygen (O2) generating reactive oxygen species (ROS) which leads to degradation of 
mitochondria and other organelles. Electron donating property of viologens can be utilized in 
conductors as shown in Figure 1-27b. Benzyl viologen (BV) can be used as dopant MoS2 
transition metal dichalcogenide semiconductor to form air stable electron transfer complex. It 
can also be used as surface dopant at metal junctions in electronic devices which reduces contact 
resistance.137  As indicated in Figure 1-27c, triethanolamine (TEOA) donates an electron to the 
Ir(III) complex. Photoexcitation of this electron leads to electron transfer to an electron relay 
viologen-1,1-ethylene-2,2-bipyridyldiylium (DQ2+). Generated radical cation of this viologen 
reduces the acceptor viologen-propyl viologen sulfonate (PVS) by electron transfer through 
zeolite solution interface resulting in charge separation. This system works as an artificial 
photosynthesis system.138 
 
Figure 1-28 Electochromic switching in tri-cat viologen system. (Adapted with permission from 
Sun et al., 2015-  https://pubs.acs.org/doi/10.1021/jacs.5b09274, further permissions related to 
the material excerpted should be directed to the ACS)140 
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Viologens can be used in electrochromic molecular switches. e.g. Cyclobis(paraquatp-
phenylene) (CBPQT4+) ring can be switched among different units reversibly as shown in Figure 
1-28.140 Each unit responds differently to external redox potentials, donating the electrons to the 
viologen ring. Each of these oxidation states and bound-unbound states exhibit different colors. 
These electrochromic properties can be utilized in electronic and optical devices.  
1.3.2 Ion-Pair Charge Transfer (IPCT) complex: 
Ion-Pair Charge Transfer (IPCT) metal-viologen complexes are made of dianionic transition 
metals and dicationic methyl viologen. These structures exhibit photoinduced electron transfer 
between the donor and the acceptor. IPCT complexes with metals such as Au, Ag, Sm, Eu, Fe 
have been studied.137,141–145 With donors such as dicyanoaurate, transfer properties of IPCT can 
be applied in photochromic and electrochromic devices. Phenyl-viologens such as DNP2+ have 
shown desirable optical and electronic properties due to extended π conjugation.146 Their π-π 
stacking interactions are being explored in chemistry and biology due to its effect on 
photophysical properties of supramolecular complexes.  
1.3.2.1 Au(CN)2-DNP viologen complex: 
Dicyanoaurate (I) complexes are of interest as they form one of the most stable two-coordinate 
complexes due to their high stability constant as well as potential applications in semiconductor 
materials and photonic devices147,148. Dicyanoaurate(I) has unique geometric and charge-transfer 
properties as d10 Au(I) metal center favors aurophilic interactions and aggregation of [Au(CN)2
-
]n, which would allow tuning of the optical properties
149,150 Due to their strong electron accepting 
potential, viologens are fluorescence quenchers as they can quench triplet MLCT luminescence 
in a complex with metals such as gold (I). {DNP-[Au(CN)2]2}.4H2O exhibit dual luminescence in 





Figure 1-29 Temperature dependent luminescence of DNP2+-[Au(CN)2]2
2-. (Adapted with 
permission from Abouelwafa et al., 2012)150 
Excitation at 355 nm results in gold-dimer broad emission at 580 nm.As the temperature 
increases, the gold dicyanoaurate dimer luminescence (ex-355 nm) is quenched by DNP2+ 
cations. Oxidative electron transfer results in quenching of the excited state gold-dimer 
luminescence at higher temperatures. Viologen luminescence (ex-410 nm) is not quenched at 
higher temperatures as oxidation of ground state [Au(CN)2]
- is not observed. These observations 




Figure 1-30 Energy diagram of the {DNP-[Au(CN)2]2} complex. (Adapted with permission 
from Abouelwafa et al., 2012)150 
At lower temperatures (10 K) fluorescence and phosphorenscence of excited state, ground state 
gold-dicyanide, and phosphorescence of excited state DNP2+ are observed as confirmed by the 
lifetimes measurements. At higher temperatures (>50 K), after intersystem crossing (ISC) from 
singlet to excited state triplet state, luminescence of gold-dicyanide is quenched by the DNP-
viologen via electron transfer quenching. Findings of the photophysical study of this metal-
viologen complex indicated that low energy phosphorescence of [Au(CN)2]
- and DNP despite 
DNP being non-luminescent in its free state. This observation was attributed to heavy atom 
effect due to gold resulting in gold-viologen orbital overlap.150 
1.3.2.2 Ag(CN)2-DNP viologen complex:  
It was observed that DNP, which is non-luminescent in its free state, exhibits phosphorescence 
when coupled with dimeric gold-dicyanoaurate, the DNP viologen was complexed with 
dicyanoargentate which is known form [Ag(CN)2
-]n.
146 As shown in Figure 1-31, excitation spectra 
at 10 K and 78 K are similar(285 nm and 298 nm respectively). Emission of 412 nm was observed 
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at 78 K with excitation at 265 K. Low energy excitation of DNP results in excited singlet state(S1) 
of DNP2+ with radiationless decay to triplet excited state (T1) followed by intersystem crossing to 
Ag(CN)2
- lowest triplet excited state (T1). Phosphorescence is observed due to Ag(CN)2
- emission 
from T1 to S0. This emission band is high energy due to direct excitation of Ag(CN)2
- resulting in 
T1 to S0 emission via charge transfer transition.
146  
 
Figure 1-31 Luminescence of DNP2+-[Ag(CN)2]2
2-. (Adapted with permission from Ahern et al., 
2014)146 
Luminescence of Ag-DNP complex is different from Au-DNP complex not only due to metal 
identity, but due to lack of argentophilic interaction (Ag-Ag) as compared to aurophilic 
interactions (Au-Au) observed in Au-DNP complex. Crystallographic analysis along with optical 
data suggest that there is little to no interaction between DNP2+ cation and dicyanoargentate as 




1.3.3 Helicene viologen 
Helicene compounds are nitrogen heterocycles which possess extended armoaticity, chirality, 
solid state structures, and ability to form transition metal complexes which can be applied to 
development of chemosensers, photovoltaics, and electrochromic devices.151 5,10-
diaza[5]helicene is one of the helicene compounds which exhbit helical chirality and partially 
electron rich and poor molecular regions as indicated by electrostatic potential energy surface in 
Figure 1-32.  
 
Figure 1-32 Electrostatic potential energy surface and crystal motif of 5,10-diaza[5]helicene. 
(Adapted with permission from Zhang et al., 2016)141 
5,10-diaza[5]helicene viologen has C2 symmetry and shows π-π stacking due to extended 
aromaticity in the crystal structure, however stacking is not sandwich like due to non-planar 
topography as shown in Figure 1-32.141 It shows fluorescence at 504 nm and phosphorescence at 
623 nm in its free state. DFT calculations indicate that it exhibits charge transfer character ( S0 to 
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S1 electronic transition). This molecule when coupled with anionic metal donors could have 
potential applications in electrochromic switches, molecular electronics and sensors.141 
1.4 Thesis overview: 
Enzymatic and chemical synthesis of melanin from dopamine, DOPA, cysteine, DHI and DHICA 
has been widely studied. However, the nature and mechanism of oligomerization and 
polymerization have been challenging. Eumelanin has been widely studied ranging from 
dimerization, oligomerization (through enzymatic process) to oxidative polymerization involving 
development of materials for applications, pheomelanin and its oligomerization mechanisms still 
need to be explored. Access to monomeric units of pheomelanin would help bridge this gap. In 
addition, it will provide an opportunity for controlled oligomerization using different types of 
monomeric units including synthesis of mixed melanoids. 
Melanin-based materials have been developed through empirical approaches rather than structure-
activity relationships.94 These developments are based on simple eumelanin monomers such as 
polydopamine. Due to difficulties in synthesis and properties of pheomelanin, such as 
benzothiazine and benzothiazole there is a lack of knowledge in bottom-up synthesis of these 
compounds. In addition, materials research related to melanin other than eumelanin is limited. This 
research work discusses regioselective synthesis and modification of eumelanoids (eumelanin 
monomeric units). Chemical synthesis of pheomelanoids (pheomelanin monomeric units) 
benzothiazole and benzothiazine was accomplished from ortho-methoxyaniline (via 
thiocyanation) and o-aminothiol (via alkylate condensation) respectively. Following the synthesis 
of monomeric melanoids, mixed melanoids (conjugates of eumelanoid and pheomelanoid) were 
synthesized via Miyaura borylation and Suzuki coupling. These melanoids may have applications 
in biomaterials, organic electronics, nanomedicine, bioadhesion, and photoprotection. In addition, 
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preliminary UV-Vis and Fluorescence spectroscopy analysis of the mixed melanoids material were 
performed in order to understand its photophysical properties. 
 
Figure 1-33 Overview of the thesis. 
DNP-viologen does not exhibit luminescence in its free state, however when complexed with 
gold-dicyanoarate it exhbits phosphorescence due to orbital overlap with dicyanoaurate dimer. 
Helicine viologen exhibits luminescence in its free state. In addition it is able to form 2D solid-
state architectures due to π-π stacking interactions. These propeties can be harvested by coupling 
this ligand with an anionic metal salt. It would be interesting to study the photophysical 
properties of a helicene viologen when coupled with dicyanoaurate. As shown in Figure 1-33, 
helicene viologen was synthesized from bromoquinoline starting material. This was 
accomplished by Pd catalyzed stille coupling or Hiyama-Heck coupling of bromoquinoline, 
followed by photocyclization of the resulting stillbene. Product of photocyclization was 
methylated and coupled with gold-dicyanoaurate in order to yield the Gold-heli viologen. Crystal 




2 SYNTHESIS, AND PHOTOPHYSICAL STUDIES OF REGIOSELECTIVELY 
FUNCTIONALIZED EUMELANOIDS 
2.1 Introduction 
Eumelanin is an insoluble black-brown polymeric pigment which is derived from DHI (5,6-
dihydroxyindole) and DHICA (5,6-dihydroxyindolecarboxylic acid). These polymers possess UV 
and photoprotective properties, free radical scavenging, and adhesion; and have applications in 
polymer stabilization, photoprotection, organic electronics, biosensing, nanomaterial drug 
delivery, and bioadhesion.62,124,133–135,152–154,125–132 In addition, eumelanin has biological 
significance due to its presence in human skin, hair and brain. Eumelanin can be synthesized 
chemoenzymatically, via oxidative polymerization from monomeric DHI or DHICA units. 
Intermediates of DHI and DHICA polymerization are an area of interest due to their structure and 
properties. Chemical synthesis of subunits of eumelanin biopolymer has been explored in 
literature.67–70,73 5,6-dimethoxyindole carboxylate (DMIC) and its 3’-bromo derivative were 
synthesized using Hemetsberger-Knittel indole synthesis.67  Huleatt et al. described synthetic 
strategies to access a small library functionalized DHI and DHICA derivatives via expedient routes 
using similar methods.68 A more efficient assembly of these functionalized derivatives was done 
which involved Cadogen indole synthesis using ortho-nitroveratraldehyde derivatives.70 DHICA 
derivatives were synthesized using copper catalyzed domino four component coupling and 
cyclization in order to study their GPR35 agonist activity (GPR35- A G-protein coupled receptor 
involved in inflammation, pain, metabolic disorders).69 
The focus of this research was chemical synthesis of small DMIC eumelanoids and their 
regioselective functionalization to utilize these functionalized derivatives for mixed melanoid 
synthesis via Miyaura-Suzuki coupling with pheomelanoid subunits (Chapter-3). Figure 2-1 shows 
the desired DMIC derivatives functionalized with bromine. Despite Cadogen type indole synthesis 
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considered more efficient, Hemetsberger indole synthesis was utilized for this work, as the 
Cadogen synthesis requires access to nitroveratraldehydes involving an extra synthetic step, and it 
uses a molybdenum catalyst for cyclization, which is not easily accessible. In addition, variety of 
reaction conditions are required for cyclization step for different substrates.70 
 
Figure 2-1 Targeted 5,6-dimethoxyindole carboxylate (DMIC) derivatives. 
Research goal of this project included synthesis of monomeric 5,6-dimethoxyindole carboxylate 
(DMIC) from simple starting material like vanillin or isovanillin. Targeted DMIC derivatives were 
a) mono-brominated derivatives-3’-bromo, 4’-bromo and 7’-bromo DMIC; b) dibrminated 3,4’-
dibromo, 3,7’-dibromo and 4,7’-dibromo DMIC; and c) 3,4,7’-tribromo DMIC. Synthesis of 
brominated variants have been explored, however synthesis of multibrominated eumelanoids and 
synthesis and stability of brominated DHICA has not been studied. Following the synthesis of the 
desired regioselectrively brominated DMIC derivatives, deprotection was done on mono-
brominated compounds to establish deprotection procedures and synthesize deprotected natural 
analogues of DHICA (5,6-dihydroxyindole carboxylic acid). 
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2.2 Results and discussion 
Expedient pathway suggested by Huleatt et al. was followed for this work for synthesis of mono-
brominated eumelanoids.18 Regioselective bromination was done at different steps in the 
sequence to get brominated indole products at 3’, 4’ and 7’ positions. These bromo DMIC 
eumelanoids were synthesized from simple starting material like vanillin or isovanillin.  
Experiment procedures were altered and optimized in order to fill the gap in experimental 
methods, results and characterization data. 
 
Scheme 2-1 Synthesis of 4’-bromo DMIC (2-8) from isovanillin. 
Synthesis of 4’-bromo DHICA has been shown in Scheme 2-1. Isovanillin was brominated using 
N-bromosuccinimide (NBS) to get the bromination at the 4’-position of the final indole 
compound. Recrystallized product was methylated using methyl iodide and purified with silica 
gel flash chromatography. In the following step, methyl azidoacetate was condensed on the 




Figure 2-2 Mechanism of methyl azidoacetate condensation over sidechain aldehyde. 
This reaction follows Knoevenagel condensation type mechanism as shown in Figure 2-2. Sodium 
methoxide activates α-carbon of methylazioacetate, which attacks the electrophilic carbonyl 
carbon. Mechanism proceeds via several proton transfer steps, and deprotonation and dehydration 
of the final intermediate results in formation of α-azido β-arylacrylate as the condensation 
product.155 Condensation product was purified by silica gel flash chromatography and 
characterized by NMR as well as IR. As observed in Figure 2-3, the condensation product’s 
infrared spectrum shows a strong asymmetric stretch at 2124 cm-1 and symmetric stretch around 




Figure 2-3 Infrared spectrum of azidoacetate condensation product. 
The final step to synthesize the 4’-bromo DMICA was cyclization via nitrene insertion. Azide 
activation is required to create highly electrophilic nitrene intermediate, which would insert into 
the aromatic ring resulting in cyclization and indole formation, which could be a light or heat 
induced process. Cyclization via Hemetsberger indole synthesis was utilized as heat was used to 
generate nitrene.156–158 A tentative reaction mechanism is described in Figure 2-4. Due to heat 
nitrogen is evolved as nitrene is generated. Nitrene forms an unstable tricyclic intermediate with 
the neighboring unsaturated carbons. Due to low ring stability electrons of the aromatic phenyl 
ring opens the tricyclic intermediate as the phenyl ring is dearomatized and nitrogen attaches to 






Figure 2-4 Mechanism of cyclization via nitrene insertion. 
In alternate mechanism, 1,3-dipolar cycloaddition occurs creating the same intermediate.157 This 
final intermediate undergoes [1,5]-H shift to generate the desired indole product. Overall yield of 
4’-bromo DMIC (2-8) was 54% over four steps. As described in Scheme 2-2, 7’-bromo DMIC (2-
12) and 3’-bromo DMIC (2-4) can be synthesized from vanillin. Similar reaction conditions, 




Scheme 2-2 Synthesis of 3’-bromo DMIC and 7’-bromo DMIC. Bromination- NBS, DCM, RT, 
8 hrs; Methylation-MeI, K2CO3, Acetone, 60 °C, 12 hrs; Sidechain condensation- Methyl 
azidoacetate, NaOMe, MeOH, -15 °C-RT, 18 hrs; Nitrene insertion-Toluene, 110 °C, 24 hrs 
3’-bromo DMIC (2-4) was synthesized in four steps by the following reaction sequence- 
methylation (compound 2-1), sidechain condensation (compound 2-2), nitrene insertion 
(compound 2-3) and bromination of vanillin. The overall yield of 3’-bromo DHICA (2-4) from 
vanillin was 48% in four steps. Bromination of vanillin results in selective bromination at ortho-
position to the phenolic OH.  
 
Figure 2-5 7’-bromo DMIC (2-12) synthesis via Hemetsberger-Knittel indole cyclization. 
 7’-bromo DMIC (2-12) was synthesized from bromination product (2-9) by methylation 
(compound 2-10), sidechain condensation (compound 2-11) and nitrene insertion. The overall 
yield for 7’-bromo DMIC (2-12) with the above synthetic sequence from vanillin was ~31%. 
Overall yield was lower due to the nitrene insertion step, where significant amount of side product 





Figure 2-6 Synthesis of 3,4’-dibromo DMIC (2-14) and 3,7’-dibromo DMIC (2-15). 
Once monobrominated compounds were accessed, different combinations of bromination-
selective debromination were utilized to synthesize di and tri-brominated DMIC derivatives. 
Figure 2-6 describes synthetic methods to synthesize 3,4’-dibromo (2-14) and 3,7’-dibromo DMIC 
(2-15) from 4’-bromo DMIC (2-8) and DMIC (2-3) respectively.  Using stoichiometric amount of 
N-bromosuccinimide (NBS) to brominate 4’-bromo DMIC (2-8) results in selective bromination 
at 3’-position resulting in 3,4’-dibromo DMIC (2-14). 3,7’-dibromo DMIC was synthesized by 
controlled double bromination of DMIC with NBS(4 eq.) by heating it at 65 °C for 3 hours. Limited 
generation of tribromo DMIC was observed.  However, if this reaction is ran for 24 hours at 65 
°C, it generates 3,4,7’-tribromo DMIC (2-16), which was recovered in 80% yield as shown in 
Figure 2-7. 
 
Figure 2-7 Synthesis of 4,7’-dibromo DMIC (2-17) and 3,4,7’-tribromo DMIC (2-16). 
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This tribromo derivative (2-16) undergoes regioselective debromination of 3’-bromo under acidic 
conditions in presence of lithium bromide and m-dimethoxybenzene (used as a trapping agent) to 
generate 4’, 7’-dibromo eumelanoid compound (methyl 4,7-dibromo-5,6-dimethoxy-1H-indole-2-
carboxylate).9,10 Reaction was monitored with HPLC and TLC.  
 
Figure 2-8 Analytical HPLC chromatogram of regioselective debromination reaction.  
Figure 2-8 shows analytical HPLC (C-18) chromatogram of reaction mixture at 75 minutes into 
the reaction where most of the SM has been consumed (retention time-6.08 minutes) and m-
dimethoxybenzene is present at 3.21 minutes. Products were purified with prep-reverse phase 
chromatography and fractions were analyzed with NMR. Desired 4’-7’-dibromo product is the 





Figure 2-9 Mechanism of regioselective debromination of tribromo eumelanoid. 
Mechanism of regioselective 3’-debromination is shown in Figure 2-9. Protonation occurs at C3 
position resulting in the carbocation intermediate, which is attacked by bromide resulting in 
bromine and the desired 4’,7’-dibromo DMIC (2-17). However, this compound can re-brominate 
in presence of bromine resulting in the tribromo starting material, which is thermodynamically 
more stable.73,159 In order to prevent this, o-methoxybenzene was added as a trapping agent, which 
is more nucleophilic than the indole. It reacts with bromine and brominates resulting in bromine 
trapping, and as a result 4’,7’-bromo DMIC is recovered as the major product after purification.  
Monobrominated DMIC synthetic eumelanoids were deprotected in order to get the natural 
analogues of DHICA eumelanoids. Deprotection was done by saponification of respective 
monobrominated DMICA by lithium or sodium hydroxide followed by demethylation of methoxy 




Figure 2-10 Synthesis of mono-brominated 5,6-dihydroxyindole carboxylic acid (DHICA)- A) 
NaOH (5 eq.), ethanol:water(1:1), RT, B) BBr3, DCM, -78 °C-RT, C) LiOH, ethanol:water (1:1), 
RT 
As shown in Figure 2-10, DHICA and its three-monobrominated derivatives were synthesized by 
deprotection of respective DMIC derivatives. DHICA (2-19) was synthesized by saponification 
of DMIC with sodium hydroxide followed by demethylation. Following similar conditions, 3’-
bromo, 4’-bromo and 7’-bromo DMIC were deprotected by saponification with lithium 
hydroxide and demethylation with boron tribromide. Final products were purified by prep-
HPLC. These deprotections were done in order to access DHICA and mono-brominated 




Figure 2-11 UV-Vis spectra of 4’-bromo DMIC (2-8) and 4’-bromo DHICA (2-21). 
UV-Vis absorption properties of protected (DMIC) and deprotected (DHICA) monomeric 
eumelanoids were studied. As shown in Figure 2-11 λmax of the protected derivative 4’-bromo 
DMIC (2-8) and the deprotected derivative 4’-bromo DHICA (2-21) are 320 nm and 325 nm 
respectively. Despite this similar UV-absorption behavior, 2-21 exhibits broad absorption (with 
exponential fit) compared to 2-8 from ~400-650 nm in the visible region. This behavior is due to 
aggregation of 4’-bromo DHICA molecules and is similar to broad band absorption observed in 
synthetic eumelanin (derived from non-enzymatic oxidation of DOPA) UV-Vis spectrum where 




Figure 2-12 UV-Vis absorption spectra of 5,6-dihydroxyindole (DHICA) and its bromo 
derivatives. 
After deprotection of Methyl-5,6-dimethoxyindole carboxylate (DMIC) and its monobrominated 
derivatives, UV-Vis spectra of DHICA (2-19), 3’-bromo DHICA (2-23), 4’-bromo DHICA (2-
21), and 7'-bromo DHICA (2-25) were recorded. In literature DHICA has been shown to absorb 
in UV region at ~330 nm and it generates violet chromophore as a result of non-enzymatic 
oxidation in which shows a broad absorption band in visible 500-550 nm.162 Similar to the 
literature, Figure 2-12 shows absorption at 330 nm followed by a broad absorption band around 
550 nm indicating aggregation of DHICA molecules. Interestingly, the mono-brominated 
DHICA derivatives show absorption at 320 nm in UV region with low intensity broad 
absorbance in the visible region. However, the absence of absorption band at 550 nm indicates 




Figure 2-13 UV-Vis spectra of DHICA (2-19) and 4’-bromo DHICA (2-21) at t=5 mins, 1 hr, 
and 24 hrs. 
As shown in Figure 2-13,  at 5 mins and 1 hour, the absorbance of 5,6-DHICA does not show 
significant change with ~330 nm λmax and absorption ~550 nm due to chromophore generation 
due to oxidation of DHICA. UV-Vis of 2-19 at 24 hours show the broaderning of the 
chromophore absorbance and scattering due to precipitation which could also be visibly observed 
by darkening solution with precipitates present. 4’-bromo DHICA showed similar absorbance 
behaviour at 5 minutes, 1 hour and 24 hours with maximum absorbance at 320 nm and weak 
broad absorbance attributed to slow aggregation of 4’-bromo DHICA molecules. This solution 
was observed to darken very little over the course of 24 hours and showed no precipitation. This 
indicates that chromophore generation resulting from DHICA oxidation is may be slow as seen 




Methyl-5,6-dimethoxyindole carboxylate (DMIC) and its regioselectively functionalized 
derivatives were synthesized using Hemetsberger-Knittel indole synthesis. Indole synthesis was 
done from vanillin or isovanillin by using bromination, methylation, sidechain condensation of 
azidoacetate, and nitrene insertion in different orders to access DMIC, 3’-bromo DMIC, 4’-
bromo DMIC, and 7’-bromo DMIC. These DMIC derivatives were further brominated to access 
di and tribromo DMIC derivatives. 4’-bromo DMIC was further brominated to access 3,4’-
dibromo DMIC. Controlled bromination of DMIC resulted in formation of 3,7’-dibromo DMIC. 
Bromination of DMIC with excess NBS was done to synthesize 3,4,7’-tribromo DMIC. 
Regioselective debromiation of tribromo DMIC resulted in selective 3’-debromination forming 
4,7’-dibromo DMIC. DHICA and Mono-brominated DHICA were synthesized from respective 
DMIC derivatives. Deprotection of DMIC, 3’-bromo DMIC, 4’-bromo DMIC, and 7’-bromo 
DMIC resulted in formation of DHICA, 3’-bromo-DHICA, 4-bromo DHICA, and 7’-bromo 
DHICA respectively. UV-Vis spectra of DHICA and its mono-brominated derivatives indicated 
that bromination slows down aggregation and chromophore generation via oxidation of DHICA 
molecules as indicated by absence of broad absorption band at 550 nm. 
2.4 Synthesis  
2.4.1 General information  
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly without 
further purification. Solvents were dried with activated 4 Å molecular sieves or anhydrous solvents 
were dispensed from Solvent system.  Reactions were monitored by TLC or analytical HPLC. TLC 
analysis was performed with silica gel 60 and visualized with UV light (254 nm and 365 nm). All 
products were purified with silica-gel flash chromatography or preparative HPLC. Silica gel flash 
chromatography was performed with SiliaFlash® F60 (Silicycle, 40-60 μm). HPLC was 
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performed on a Gilson® and Agilent® analytical and Gilson® semi-preparative system with UV-
Vis spectrophotometer, using Kinetex 5 µm EVO C18 100Å 4.6 x 150 mm for analytical and 
Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for preparative purpose. Products were characterized 
by 1H and 13C NMR and mass spectrometry. NMR characterization results and J values were 
compared with published results. 1H and 13C NMR spectra were recorded on Agilent/Varian 400 
MHz or Bruker Neo 500 MHz and 101 MHz NMR spectrometer respectively. 1H NMR 
multiplicities are defined as ‘s’-singlet, ‘d’-doublet, ‘t’-triplet, ‘dd’-doublet of doublets, and ‘m’-
multiplet.  ~1 mg of dried sample was sent out to University of Illinois Mass Spectrometry lab 
where Mass spectra were recorded using a Synapt G2 Q-TOF ESI mass spectrometer. UV-Vis 
absorption spectra were recorded on the SpectraMax i3x multi-mode detection device.  
Abbreviations: TLC-Thin layer chromatography, HPLC-High Performance Liquid 
Chromatography, NMR-Nuclear Magnetic Resonance, Q-TOF-Quadrupole time of flight, ESI-
Electrospray ionization 
2.4.2 Synthesis of  DMIC(2-3) and 3’-bromo DMIC (2-4) 
3,4-dimethoxybenzaldehyde (2-1) 
 
To a stirred solution of vanillin (600 mg, 3.94 mmol) in acetone (15 mL) in a scintillation vial was 
added potassium carbonate (1.089 g, 7.88 mmol, 2.0 eq.) followed by addition of methyl iodide 
(1.399 g, 9.85 mmol, 2.5 eq.) at RT. The mixture was heated at 60 °C for 12 hrs. The mixture was 
cooled to RT and solvent was evaporated under reduced pressure. The crude product was dissolved 
in ethyl acetate (100 mL) and washed with water, brine and dried over sodium sulfate. The crude 
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product was purified with silica gel flash chromatography (30%:70% EtOAc:Hexanes). Product 
was confirmed with 1H NMR. Yield: 583 mg, 89% 1H NMR (400 MHz, CDCl3) δ 9.85 (s, 1H), 
7.46 (dd, 1H, J = 2.0 Hz, 8.0 Hz), 7.41 (d, 1H, J = 1.6 Hz), 6.98 (d, 1H, J = 8.0 Hz), 3.97 (s, 3H), 
3.95 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 191.05, 154.66, 149.80, 130.31, 127.02, 110.54, 
109.11, 56.33, 56.17 ppm. Spectral data matched with those in literature.163  
Methyl (Z)-2-azido-3-(3,4-dimethoxyphenyl)acrylate (2-2) 
 
To a solution of 3,4-dimethoxybenzaldehyde (250 mg, 1.5 mmol), and methyl 2-azidoacetate (693 
mg, 6 mmol, 4 eq.) in methanol (0.5 mL) was added sodium Methoxide (1M in methanol, 4.25 
mL, 2.5 eq.) at -15 °C. The mixture was stirred at -15 °C for 2 hours and RT for 18 hrs. TLC 
confirmed the consumption of benzaldehyde and formation of the product. The mixture was 
washed with water (25 mL) and extracted with diethyl ether (3x25 mL). Combined organic layers 
were washed with brine and dried over sodium sulfate. Solvent was evaporated and crude was 
purified with silica gel (10:90 EtOAc:Hex). 328 mg, 83% Yield 1H NMR (400 MHz, CDCl3) δ 
7.51 (d, 1H, J = 2.0 Hz), 7.34 (dd, 1H, J = 2.0 Hz, 8.8 Hz), 6.88 (s, 1H), 6.87 (d, 1H, J = 8.8 Hz), 
3.92 (s, 3H), 3.91 (s, 3H), 3.90 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 164.37, `150.42, 
148.75, 126.37, 126.03, 125.06, 123.36, 113.13, 110.90, 56.08, 56.06, 52.94 ppm. Spectral data 






Methyl 5,6-dimethoxy-1H-indole-2-carboxylate (DMIC) (2-3) 
 
3,4-dimethoxy7-ene azidoacetate (150 mg, 0.57 mmol) was dissolved in toluene (5 mL). The vial 
was capped with teflon heat resistant cap and tape, and refluxed for 24 hours. Crude was purified 
with p rep-HPLC. Solvent was evaporated under reduced pressure yielding the desired product. 
Yield-94 mg, 71% 1H NMR (400 MHz, CDCl3) δ 8.88 (N-H), 7.11 (d, 1H, J=2.4 Hz), 7.04 (s, 
1H), 6.85 (s, 1H), 3.93 (s, 3H), 3.92 (s, 6H), ppm. 13C NMR (125 MHz, CDCl3) δ 162.22, 150.17, 
146.25, 132.00, 125.63, 120.47, 108.84, 102.59, 93.74, 56.16, 51.78 ppm.  Spectral data matched 
with those in literature.165 
Methyl 3-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (2-4) 
 
To a scintillation vial equipped with a stir bar was added Methyl 5,6-dimethoxy-1H-indole-2-
carboxylate (86 mg, 0.37 mmol), followed by addition of methylene chloride (1.5 mL), N-
bromosuccinimide (66 mg, 0.37 mmol, 1 eq.) at RT. The mixture was stirred at RT for 3 hrs. 
Yellow precipitate were filtered and dried to get Methyl 3-bromo-5,6-dimethoxy-1H-indole-2-
carboxylate. Yield- 106 mg, 92%. 1H NMR (400 MHz, CDCl3) δ 8.91 (N-H), 6.97 (s, 1H), 6.81 
(s, 1H), 3.97 (s, 3H), 3.97 (s, 3H), 3.94 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 161.43, 
151.30, 147.15, 130.50, 122.48, 121.34, 101.05, 98.27, 93.79, 56.35, 56.34, 52.11 ppm. Spectral 
data matched with those in literature.70 
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2.4.3 Synthesis of 4’-bromo DMIC (2-8) 
2-bromo-3-hydroxy-4-methoxybenzaldehyde (2-5) 
   
To a scintillation vial equipped with a stir bar was added 3-hydroxy 4-methoxybenzaldehyde/ 
isovanillin (500 mg, 3.29 mmol), followed by addition of methylene chloride (8 mL), N-
bromosuccinimide (585 mg, 3.29 mmol, 1 eq.) at RT. The mixture was stirred at RT for 8 hrs. 
Solvent was evaporated under reduced pressure and product was recrystallized with hot ethanol 
(15 mL). Solid product was filtered. Yield- 688 mg, 91%. Product was confirmed with 1H NMR. 
1H NMR (400 MHz, CDCl3) δ 10.25 (s, 1H), 7.56 (d, 1H, J = 8.4 Hz), 6.91 (d, 1H, J = 8.4 Hz), 
6.11 (s, 1H), 4.00 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 191.02, 151.85, 143.38, 127.44, 
122.91, 113.03, 109.44, 56.75 ppm. Spectral data matched with those in literature.166 
2-bromo-3,4-dimethoxybenzaldehyde (2-6) 
 
To a stirred solution of 2-bromo 3-hydroxy 4-methoxybenzaldehyde (200 mg, 0.87 mmol) in 
acetone (5 mL) in a scintillation vial was added potassium carbonate (240 mg, 1.74 mmol, 2.0 eq.) 
followed by addition of methyl iodide (492 mg, 3.46 mmol, 4.0 eq.) at RT. The mixture was heated 
at 60 °C for 16 hrs. The mixture was cooled to RT and solvent was evaporated under reduced 
pressure. The crude product was dissolved in ethyl acetate (40 mL), washed with water, brine, and 
dried over sodium sulfate. The crude product was purified with silica gel flash chromatography 
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(30%:70% EtOAc:Hexanes). Product was confirmed with 1H NMR. Yield: 178 mg, 84% 1H NMR 
(400 MHz, CDCl3) δ 10.24 (s, 1H), 7.73 (d, 1H, J = 8.8 Hz), 6.95 (d, 1H, J = 8.4 Hz), 3.95 (s, 
3H), 3.87 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 191.12, 158.81, 146.54, 127.54, 126.65, 
123.29, 111.08, 60.82, 56.46 ppm. Spectral data matched with those in literature.167 
Methyl (Z)-2-azido-3-(2-bromo-3,4-dimethoxyphenyl)acrylate (2-7) 
 
To a solution of 2-bromo 3,4-dimethoxy benzaldehyde (100 mg, 0.41 mmol), and methyl 2-
azidoacetate (188 mg, 1.63 mmol, 4 eq.) in methanol (0.5 mL) was added sodium Methoxide (1M 
in methanol, 1 mL, 2.5 eq.) at -15 °C. The mixture was stirred at -15 °C for 2 hours and RT for 18 
hrs. TLC confirmed the consumption of benzaldehyde and formation of the product. The mixture 
was washed with water (20 mL) and extracted with diethyl ether (3x20 mL). The combined organic 
layers were washed with brine and dried over sodium sulfate. Solvent was evaporated and crude 
was purified with silica gel (10:90 EtOAc:Hex). Yield-106 mg, 76% Yield 1H NMR (400 MHz, 
CDCl3) δ 7.96 (d, 1H, J = 8.8 Hz), 7.28 (s, 1H), 6.90 (d, 1H, J = 8.8 Hz), 3.93 (s, 3H), 3.92 (s, 
3H), 3.85 (s, 3H) ppm.  13C NMR (125 MHz, CDCl3) δ 164.13, 154.29, 146.79, 127.16, 126.27, 








Methyl 4-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (2-8) 
 
5-bromo 3,4-dimethoxy7-ene azidoacetate (116 mg, 0.34 mmol) was dissolved in toluene (3 mL). 
The vial was capped with teflon heat resistant cap and tape, and refluxed for 24 hours. Solvent was 
evaporated under reduced pressure yielding the desired product. Yield-98 mg, 93% 1H NMR (400 
MHz, CDCl3) δ 8.89 (N-H), 7.19 (s, 1H), 6.82 (s, 1H), 3.94 (s, 3H), 3.92 (s, 3H), 3.87 (s, 3H) 
ppm. 13C NMR (125 MHz, CDCl3) δ 162.22, 153.65, 143.35, 133.45, 126.48, 122.52, 110.44, 
109.65, 93.72, 61.15, 56.38, 52.13 ppm. Spectral data matched with those in literature.70 
2.4.4 Synthesis of 7’-bromo DMIC (2-12) 
3-bromo-4-hydroxy-5-methoxybenzaldehyde (2-9) 
 
In a scintillation vial equipped with a stir bar to a solution of 4-hydroxy 3-methoxybenzaldehyde/ 
vanillin (500 mg, 3.29 mmol) in acetic acid (11 mL), was added bromine (578 mg, 3.61 mmol, 1.1 
eq.) dropwise at RT. The mixture was stirred at RT for 5 hrs. The mixture was poured into ice-
water resulting in product precipitation. Solid product was filtered and dried under vacuum. Yield-
677 mg, 89%. 1H NMR (400 MHz, CDCl3) δ 9.79 (s, 1H), 7.64 (d, 1H, J = 2.0Hz), 7.36 (d, 1H, 
J = 1.6 Hz), 6.49 (s, 1H), 3.99 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 189.79, 149.03, 






To a stirred solution of 3-bromo-4-hydroxy-5-methoxybenzaldehyde (523 mg, 2.26 mmol) in 
acetone (15 mL) in a scintillation vial was added potassium carbonate (626 mg, 4.53 mmol, 2.0 
eq.) followed by addition of methyl iodide (1.287 g, 9.06 mmol, 4.0 eq.) at RT. The reaction 
mixture was heated at 60 °C for 16 hrs. The mixture was cooled to RT and solvent was evaporated 
under reduced pressure. The crude product was dissolved in ethyl acetate (120 mL) and washed 
with water, brine and dried over sodium sulfate. The crude product was purified with silica gel 
flash chromatography (30%:70% EtOAc:Hexanes)and confirmed with 1H NMR. Yield:439 mg, 
79% 1H NMR (400 MHz, CDCl3) δ 9.85 (s, 1H), 7.65 (d, 1H, J = 1.6 Hz), 7.39 (d, 1H, J = 1.6 
Hz), 3.95 (s, 3H), 3.94 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 190.03, 154.35, 151.97, 
133.20, 128.95, 118.09, 110.22, 60.99, 56.40 ppm. Spectral data matched with those in 
literature.169 
Methyl (Z)-2-azido-3-(3-bromo-4,5-dimethoxyphenyl)acrylate (2-11) 
 
To a solution of 3-bromo-4,5-dimethoxybenzaldehyde (150 mg, 0.61 mmol), and methyl 2-
azidoacetate (282 mg, 2.45 mmol, 4 eq.) in methanol (0.5 mL) was added sodium methoxide (1M 
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in methanol, 1.5 mL, 2.5 eq.) at -15 °C. The mixture was stirred at -15 °C for 2 hours and RT for 
18 hrs. TLC confirmed the consumption of benzaldehyde and formation of the product. The 
mixture was washed with water (25 mL) and extracted with diethyl ether (3x25 mL). The combined 
organic layers were washed with brine and dried over sodium sulfate. Solvent was evaporated and 
crude was purified with silica gel (10:90 EtOAc:Hex). Yield- 154 mg, 74% Yield 1H NMR (400 
MHz, CDCl3) δ 7.58 (d, 1H, J = 2.0 Hz), 7.39 (d, 1H, J = 1.6 Hz), 6.76 (s, 1H), 3.91 (s, 3H), 3.90 
(s, 3H), 3.89 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 163.93, 153.40, 147.53, 127.65, 125.67, 
123.81, 117.68, 113.71, 60.88, 56.33, 53.15 ppm. Spectral data matched with those in literature.70 
Methyl 7-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (2-12) 
 
Methyl(Z)-2-azido-3-(3-bromo-4,5-dimethoxyphenyl)acrylate(116 mg, 0.34 mmol) was dissolved 
in toluene (3 mL). The vial was capped with teflon heat resistant cap and tape, and refluxed for 24 
hours. Solvent was evaporated under reduced pressure. The crude product was purified with silica 
gel flash chromatography (30:70 EtOAc:Hex) to get the desired product. Desired product: Methyl 
7-bromo-5,6-dimethoxy-1H-indole-2-carboxylate.Yield- 63 mg, 60%1H NMR (500 MHz, 
CDCl3) δ 8.82 (N-H), 7.18 (d, 1H, J=2.5 Hz), 7.06 (s, 1H), 3.94 (s, 3H), 3.92 (s, 3H), 3.91 (s, 3H) 
ppm. 13C NMR (125 MHz, CDCl3) δ 162.05, 145.92, 139.32, 131.17, 128.17, 125.87, 120.83, 
111.93, 108.46, 61.47, 61.21, 52.26 ppm. Side-product: Methyl 5-bromo-6,7-dimethoxy-1H-
indole-2-carboxylate. Yield- 31 mg, 30% 1H NMR (500 MHz, CDCl3) δ 9.01 (N-H), 7.61 (s, 1H), 
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7.09 (d, 1H, J=2.5 Hz), 3.94 (s, 3H), 3.92 (s, 3H), 3.92 (s, 3H) ppm. Spectral data matched with 
those in literature.70 
2.4.5 Synthesis of di and tri-brominated DMIC (2-14 to 2-17) 
Synthesis of 3’4’-dibromo DMICA (2-14) 
 
To a scintillation vial equipped with a stir bar was added methyl 4-bromo-5,6-dimethoxy-1H-
indole-2-carboxylate (40 mg, 0.12 mmol), followed by addition of acetonitrile (1.2 mL), N-
bromosuccinimide (66 mg, 0.12 mmol, 1 eq.) at RT. The mixture was stirred at 65 °C for 5 hrs. 
Solvent was evaporated and crude was purified by silica gel flash chromatography. Yield-41 mg, 
88%. 1H NMR (500 MHz, CDCl3) δ 8.98 (N-H), 6.78 (s, 1H), 3.97 (s, 3H), 3.91 (s, 3H), 3.86 (s, 
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 161.23, 154.05, 144.16, 133.33, 124.21, 118.10, 
111.06, 98.31, 93.49, 60.90, 56.33, 52.31 ppm. HRMS (TOF MS ES+) m/z calculated for 
C12H12NO4Br2 ([M+H]
+) 391.9126 Da, found 391.9133 Da. 
Synthesis of 3’-7’-dibromo DMICA (2-15) 
 
To a scintillation vial equipped with a stir bar was added methyl 5,6-dimethoxy-1H-indole-2-
carboxylate (39 mg, 0.16 mmol), followed by addition of acetonitrile (1.5 mL), N-
bromosuccinimide (116 mg, 0.64 mmol, 4 eq.) at RT. The mixture was stirred at 65 °C for 3 hrs. 
Solvent was evaporated and crude was purified by silica gel flash chromatography. Yield-50 mg, 
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81%. 1H NMR (500 MHz, CDCl3) δ 8.91 (N-H), 7.00 (s, 1H), 3.99 (s, 3H), 3.96 (s, 3H), 3.92 (s, 
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 160.91, 150.64, 147.84, 129.49, 124.44, 123.83, 
101.37, 100.28, 100.28, 98.55, 661.39, 56.57, 52.38 ppm. HRMS (TOF MS ES+) m/z 
calculated for C12H12NO4Br2 ([M+H]
+) 391.9132 Da, found 391.9133 Da. 
Synthesis of 3’-4’-7’-tribromo DMICA (2-16) 
 
To a scintillation vial equipped with a stir bar was added methyl 5,6-dimethoxy-1H-indole-2-
carboxylate (100 mg, 0.42 mmol), followed by addition of acetonitrile (4 mL), N-
bromosuccinimide (303 mg, 1.70 mmol, 4 eq.) at RT. The mixture was stirred at RT for 20 hrs. 
Solvent was evaporated under reduced pressure. Crude was purified with silica gel flash 
chromatography (30:70-EtOAc:Hex). Yield-158 mg, 80%. Product was confirmed with 1H 
NMR. 1H NMR (500 MHz, CDCl3) δ 9.05 (N-H), 4.01 (s, 3H), 3.98 (s, 3H), 3.90 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3) δ 160.54, 150.87, 147.79, 131.86, 125.93, 120.43, 110.27, 98.99, 
98.70, 61.60, 61.15, 52.44 ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 
([M+H]+) 469.9295 Da, found 469.9272 Da. 




In a scintillation vial methyl 3,4,7-tribromo-5,6-dimethoxy-1H-indole-2-carboxylate (46 mg, 
0.098 mmol) was dissolved in acetic acid (1 mL) followed by addition of lithium bromide (18 
mg, 0.21 mmol, 2.1 eq.), m-dimethoxybenzene (29 mg, 0.21 mmol, 2.1 eq.), and sulfuric acid 
(20.5 mg, 0.21mmol, 2.1 eq.). The mixture was heated at 65 °C for 1.5 hrs. After cooling, the 
solution mixture was added to ice water and resulting precipitate were filtered out. The crude 
product was purified with silica gel flash chromatography (30:70-EtOAc:Hex). Yield-26 mg, 
68% 1H NMR (500 MHz, CDCl3) δ 8.96 (N-H), 7.27 (d, 1H, J=2.0 Hz), 3.97 (s, 6H), 3.92 (s, 
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 161.80, 151.23, 143.67, 134.00, 131.51, 127.17, 
123.15, 122.56, 60.53, 56.65, 51.28 ppm. HRMS (TOF MS ES+) m/z calculated for 
C12H12NO4Br2 ([M+H]
+) 391.9133 Da, found 391.9123 Da. 
2.4.6 Synthesis of DHICA (2-19) and its mono-brominated derivatives (2-21, 2-23, 2-25) 
5,6-dimethoxy-1H-indole-2-carboxylic acid (2-18) 
 
To a solution of 5,6-dimethoxyindole carboxylate (20 mg, 0.085 mmol) was added sodium 
hydroxide (5 eq.) and water:ethanol (1:1, 10 mL). The reaction mixture was stirred at RT for 8 
hrs. Solvent was evaporated and pH was adjusted to ~2-3 with 1 N HCl. The crude product was 
extracted with ethyl acetate (3 x 10 mL). Organic layer was dried with sodium sulfate and 
solvent was evaporated. Yield: 18 mg, 95% 1H NMR (500 MHz, CD3CN) δ 9.70(s, N-H), 7.08 
(s, 1H), 7.05(s, 1H), 6.95 (s, 1H), 3.85 (s, 3H), 3.81 (s, 3H) ppm. 13C NMR (125 MHz, CD3OD) 
δ 164.92, 151.16, 147.16, 134.25, 127.56, 121.82, 109.59, 104.07, 95.41, 56.71, 56.71 ppm. 
HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 ([M+H]




5,6-dihydroxy-1H-indole-2-carboxylic acid (DHICA) (2-19) 
 
To the solution of 5,6-dimethoxyindole carboxylic acid (22 mg, 0.099 mmol) in DCM (0.2  mL) 
was added BBr3 (0.29 mL, 0.29 mmol, 3 eq) dropwise at -78 
oC. The mixture was stirred for 18 
hours at RT. The mixture was quenched with water and precipitate were filtered. The crude 
product was purified with prep-HPLC. Yield-12 mg, 62% 1H NMR (500 MHz, CD3CN) δ 9.77 
(s, N-H), 7.02 (s, 1H), 6.97 (s, 1H), 6.95 (s, 1H) ppm. 13C NMR (125 MHz, CD3CN) δ 163.44, 
146.55, 142.16, 133.72, 126.46, 121.50, 109.04, 105.92, 97.51 ppm. Spectral data matched with 
those in literature.70 
4-bromo-5,6-dimethoxy-1H-indole-2-carboxylic acid (2-20) 
 
To a solution of 4’-bromo 5,6-dimethoxyindole carboxylate (25 mg,  0.079 mmol) was added 
Lithium Hydroxide (9.5 mg, 0.39 mmol, 5 eq.) and water:ethanol (1:1, 8 mL). The reaction 
mixture was stirred at 50 oC for 8 hours. Solvent was evaporated and pH was adjusted to ~2-3 
with 1N HCl. Product was extracted with ethyl acetate (3 x 10 mL). The combined organic layer 
was dried with sodium sulfate and solvent was evaporated. Yield-21 mg, 90% 1H NMR (500 
MHz, CD3CN) δ 9.95 (s, N-H), 7.05 (s, 1H), 7.00 (s, 1H), 3.89 (s, 3H), 3.79 (s, 3H) ppm. 13C 
NMR (125 MHz, CD3CN) δ 162.26, 154.27, 143.90, 134.78, 127.81, 122.72, 109.90, 109.24, 
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95.20, 61.16, 56.79 ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 ([M+H]
+) 
299.9867 Da, found 299.9871 Da. 
4-bromo-5,6-dihydroxy-1H-indole-2-carboxylic acid (2-21) 
 
To the solution of 4’-bromo-5,6-dimethoxyindole carboxylic acid (14 mg,  0.046  mmol) in 
DCM (0.2  mL) was added BBr3 (0.14 mL, 0.14 mmol, 3 eq) dropwise at -78 
oC. The mixture 
was stirred for 20 hours at RT. The mixture was quenched with water followed by filtration of 
the precipitate. The product crude was purified with prep-HPLC. Yield-10 mg, 80% 1H NMR 
(500 MHz, CD3CN) δ 9.74 (s, N-H), 6.98 (s, 1H), 6.94 (s, 1H) ppm. 13C NMR (125 MHz, 
CD3CN) δ 161.92, 146.17, 139.75, 132.50, 126.77, 126.70, 122.41, 108.20, 96.93 ppm. HRMS 
(TOF MS ES-) m/z calculated for C12H12NO4Br2 ([M-H]
-) 269.9397 Da, found 269.9402 Da. 
3-bromo-5,6-dimethoxy-1H-indole-2-carboxylic acid (2-22) 
 
To a solution of 3’-bromo 5,6-dimethoxyindole carboxylate (25 mg,  0.079 mmol) was added 
Lithium Hydroxide (9.5 mg, 0.39 mmol, 5 eq.) and water:ethanol (1:1, 8 mL). The reaction 
mixture was stirred at 50 oC for 5 hours. Solvent was evaporated and pH was adjusted to ~2-3 
with 1N HCl. The crude product was extracted with ethyl acetate (3 x 10 mL). The combined 
organic layer was dried with sodium sulfate and solvent was evaporated. Yield-22 mg, 93% 1H 
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NMR (500 MHz, CD3CN) δ 9.94 (s, 1H), 6.95 (s, 2H), 3.86 (s, 6H) ppm. 13C NMR (125 MHz, 
CD3CN) δ 161.52, 152.11, 148.13, 131.83, 123.14, 121.63, 101.28, 97.80, 95.20, 56.52, 56.48 
ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 ([M+H]
+) 299.9866 Da, found 
299.9871 Da. 
3-bromo-5,6-dihydroxy-1H-indole-2-carboxylic acid (2-23) 
 
To the solution of 3’-bromo-5,6-dimethoxyindole carboxylic acid (18 mg, 0.06 mmol) in DCM 
(0.25 mL) was added BBr3 (0.18 mL, 0.18 mmol, 3 eq) dropwise at -78 
oC. The mixture was 
stirred for 20 hours at RT. The mixture was quenched with water and precipitate were filtered. 
The crude product was purified with prep-HPLC. Yield-11 mg, 68% 1H NMR (500 MHz, 
CD3CN) δ 10.13 (s, N-H), 7.01 (s, 1H), 6.96 (s, 1H) ppm. 13C NMR (125 MHz, CD3CN) δ 
163.27, 146.35, 141.96, 133.47, 132.39, 126.31, 121.27, 108.75, 105.66 ppm. HRMS (TOF MS 
ES-) m/z calculated for C12H12NO4Br2 ([M-H]
-) 269.9401 Da, found 269.9399 Da. 
7-bromo-5,6-dimethoxy-1H-indole-2-carboxylic acid (2-24) 
 
To a solution of 7’-bromo 5,6-dimethoxyindole carboxylate (25 mg,  0.079 mmol) was added 
Lithium Hydroxide (9.5 mg, 0.39 mmol, 5 eq.) and water:ethanol (1:1, 8 mL). The reaction 
mixture was stirred at 50 oC for 6 hours. Solvent was evaporated and pH was adjusted to ~2-3 
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with 1N HCl. The crude product was extracted with ethyl acetate (3 x 10 mL). The combined 
organic layer was dried with sodium sulfate and solvent was evaporated. Yield-22 mg, 90% 1H 
NMR (500 MHz, CD3CN) δ 9.91(s, N-H), 6.99 (s, 1H), 6.96 (s, 1H), 3.85 (s, 3H), 3.82 (s, 3H) 
ppm. 13C NMR (125 MHz, CD3CN) δ 160.25, 153.27, 142.80, 133.75, 127.5, 121.62, 109.50, 
108.84, 94.70, 60.86, 56.29 ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 
([M+H]+) 299.9867 Da, found 299.9871 Da. 
7-bromo-5,6-dihydroxy-1H-indole-2-carboxylic acid (2-25) 
 
To the solution of 7’-bromo-5,6-dimethoxyindole carboxylic acid (20 mg,  0.066  mmol) in 
DCM (0.3  mL) was added BBr3 (0.2 mL, 0.20 mmol, 3 eq) dropwise at -78 
oC. The mixture was 
stirred for 20 hours at RT. The mixture was quenched with water and product precipitate were 
filtered. The crude product was purified with prep-HPLC. Yield-13 mg, 74% 1H NMR (500 
MHz, CD3CN) δ 9.70 (s, N-H), 6.94 (s, 1H), 6.92 (s, 1H) ppm. 13C NMR (125 MHz, CD3CN) δ 
160.55, 145.20, 138.25, 131.86, 126.18, 125.50, 121.47, 108.00, 97.56 ppm. HRMS (TOF MS 
ES-) m/z calculated for C12H12NO4Br2 ([M-H]







3 SYNTHESIS OF PHEOMELANOID MONOMERS- BENZOTHIAZOLES AND 
BENZOTHIAZINES 
3.1 Introduction 
Pheomelanin is red-yellow pigment, commonly found in hair and skin. It is derived from DOPA 
or dopamine in presence of cysteine, and as a result, it possesses nitrogen as well as sulfur in its 
polymeric structure.10,17,20,55,170 Monomeric eumelanin units (DHI and DHICA) (Chpater-2) have 
been widely studied due to scope and applications of eumelanin and polydopamine. Synthesis 
and study of pheomelanin has gained significance due to its role in skin cancer and 
melanoma.171–174 Pheomelanin is prone to photogdegradation in presence of oxygen and is 
potentially phototoxic. Intermediates of pheomelaninogenesis from cyteinyldopa to pheomelanin 
need to be further studied in order to understand their biological function and their phototoxic 
role in diseases.38  
 
Figure 3-1 Pheomelanin monomeric units. 
Pheomelanin found in skin and hair contains DOPA sidechain, whereas pheomelanin found in 
brain as part of neuromelanin structure contains dopamine sidechain. Pheomelanin consists of 
benzothiazine and its metabolite benzothiazole as shown in Figure 3-1. Synthesis of 
benzothiazine with DOPA sidechain was done by Donato and Napolitano from 5,S-
cysteinyldopa by potassium ferricyanide catalyzed cyclization.38 A unified strategy to synthesize 
benzothiazole and benzothiazine with potential access to DOPA and dopamine sidechain still 
needs to be explored. In this chapter, synthetic equivalent of natural analogues of pheomelanin 
monomeric units benzothiazole and benzothiazine were synthesized with two different 
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sidechains-ethyl ester (CO2Et) and methylene nitrile (CH2CN). Ethyl ester sidechain can 
potentially be converted to DOPA sidechain by reduction of ester followed by condensation-
hydroamination.175 Methylene nitrile sidechain can be converted to dopamine sidechain by 
hydrogenation with borane-tetrahydrofuran or transition metal catalyzed hydrogenation. This 
strategy is advantageous as both types of monomeric units of phenomelanin, benzothiazole and 
benzothiazine can be accessed from a simple starting material like ortho-methoxyaniline. 
 
Figure 3-2 Unified strategy to access monomeric pheomelanin subunits. 
Benzothiazole were synthesized by thiocyanation of o-methoxyaniline compounds which results 
in aminobenzothiazole (X=NH2). Aminobenzothiazole was modified via Sandmeyer reaction to 
access benzothiazole (X=H) and bromobenzothiazole (X=Br). Benzothiazine were synthesized 
by halogenation followed by Ullman type thiolation at ortho position to amine, followed by 
alkylate condensation using different alkylating reagents such as dichloroethane, 
bromoacetaldehyde and ethyl bromopyruvate.  
3.2  Results and Discussion: 
Monomeric pheomelanoids such as benzothiazole (BTZL) and benzothiazine (BTZ) derivatives 
were synthesized using commercially available starting material like 3-methoxyphenyl acetonitrile 
and 3-methoxy 4-amino benzoic acid. The key intermediate was ortho-methoxyaniline 
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(compounds 3-6 and 3-8), which were used to synthesize benzothiazole in one-step. In addition, 
ortho-methoxyaniline was also used for synthesis of ortho-aminothiol compounds via 
halogenation followed by Ullman coupling. 
3.2.1 ortho-methoxyaniline synthesis 
One-pot conversion methods to synthesize anilines from phenols via smiles rearrangement are 
widely known.176–178 These methods utilize harsher conditions such as use of sodium hydride 
base and dimethylacetamide solvent, which produces exothermic reaction. As shown by Xie et 
al. anilines can be synthesized from phenols in one-step using smiles rearrangement using milder 
conditions.179 Homovanillonitrile was synthesized using vanillin by modifying the sidechain 
using TosMIC in 66% yield after purification.  
 
Scheme 3-1 Synthesis of ortho-methoxyaniline (CH2CN sidechain) 
Smiles reaction was attempted using two different smiles reagents, 2-chloropropionamide and 
bromoacetamide at a few different temperatures (Table 3-1) and reactions were monitored by 
TLC. As shown in Scheme 3-2, the mechanism of the reaction involves formation of 3-3 as the 
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nucleophilic oxygen attacks the halogenated carbon of the smiles reagent resulting in 
nucleophilic substitution.  
 
Scheme 3-2 Smiles rearrangement of homovanillonitrile. 
Nitrogen of the terminal amide is activated by deprotonation by base and it attacks the aromatic 
carbon. The rearrangement proceeds through an unstable cyclic intermediate, and as a result of 
this ring-opening, 3-4 is formed. Upon hydrolysis, 3-4 would be converted to the desired aniline 
product. Table 3-1 shows the results of the smiles rearrangement experiments. 3-3 was observed 
on TLC and NMR initially when the reaction was being run at higher temperatures (148 or 165 
°C) for 5 hours with both the smiles reagents. When the temperature and time were optimized to 





Table 3-1 Smiles rearrangement-reaction conditions and results 










90 oC- 2 hrs 
148 oC- 5 hrs 




100 oC- 2 hrs 
165 oC- 5 hrs 




100 oC- 2 hrs 







100 oC- 2 hrs 




Due to poor conversion after multiple synthesis attempts and difficulty in purification due to 
isolation of multiple intermediates, alternate route, which also involved a two-step synthesis of 
desired ortho-methoxyaniline compound starting from a simple starting material like 3-
methoxyphenyl acetonitrile, was used as shown in Scheme 3-1. Nitration was done using 
tetrabutylammonium nitrate which gave the desired 2(3-methoxy-4-nitrophenyl)acetonitrile 
product (3-5) in 47% yield. Reaction also produced 2,6 dinitro compound as side products. As 
described in previous literature, desired product was purified using silica gel flash 
chromatography.180,181 This nitro compound undergoes palladium on carbon mediated 
hydrogenation in presence of hydrogen gas to yield the desired o-methoxyaniline product (3-6). 
Ortho-methoxyaniline variant of CO2Et sidechain (3-8) was synthesized by ethylating 4-amino-3-
methoxybenzoic acid in ethanol by using sulfuric acid as a catalyst.  
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3.2.2 Benzothiazole(BTZL) synthesis 
Once ortho-methoxyaniline compounds (3-6 and 3-8) were accessed, the next step was to 
synthesize benzothiazole (synthetic analogues of natural phenomelanin subunit BTZL), which 
include aminobenzothiazole, benzothiazole, and bromobenzothiazole. 
 
Scheme 3-3 Synthesis of benzothiazoles 
Scheme 3-3 was followed in order to access these pheomelanoids. Thiocyanation-cyclization is a 
commonly used protocol to synthesize aminobenzothiazole in one-step.7-10 Thiocyanation occurs 
at the ortho position to amine, and in presence of bromine in acetic acid nucleophilic nitrogen of 
amine cyclizes to form aminobenzothiazole, which is a stable compound. This reaction worked 
well for ethyl ester sidechain (3-9, Yield-92%), and methylene nitrile sidechain (3-12, Yield-95%) 
and did not require extensive purification steps. Aminobenzothiazole undergoes deamination in 
presence of isoamyl nitrite in THF resulting in benzothiazole derivative. Deamination were done 
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successfully to synthesize 3-10 (86%) and 3-13 (89%) from 3-9 and 3-12 respectively. 
Benzothiazole (3-10 and 3-13) can be brominated using carbon tetrabromide with potassium tert-
butoxide to synthesize bromobenzothiazole resulting in 3-11 (83%) and 3-14 (78%). Alternatively, 
bromobenzothiazole (3-11 and 3-14) were synthesized directly from aminobenzothiazole via 
copper catalyzed sandemeyer reaction in 75% and 67% yield respectively. Deamination to 
synthesize benzothiazole and deamination-bromination to synthesize bromobenzothiazole in one-
step from aminobenzothiazole follow Sandmeyer mechanism as discussed in Figure 3-3. 
 
Figure 3-3 Sandmeyer reaction mechanism 
Sodium nitrite, tert-butyl ammonium nitrite and isoamyl nitrite are used for diazotization of 
aromatic amines as they generate nitrosonium, which goes under nucleophilic attack, and generate 
diazonium salts.182 In Sandmeyer mechanism, nucleophile can be altered in order to substitute the 
aromatic amine with different nucleophilic functional groups. In the case above, when bromination 
is done on diazonium salt, nitrogen leaves and bromobenzothiazole is recovered as the product 
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whereas if hydrogen adds to the electrophilic carbon of the thiazole, benzothiazole is generated 
(Figure 3-3).  
3.2.3 Synthesis of key intermediate: ortho-aminothiophenol 
The key intermediate to access 1,4-benzothiazine subunits of pheomelanin was ortho-
aminothiophenol which could later be alkylated to make benzothiazines. Aminobenzothiazole (3-
7, 3-9 and 3-12) could be synthesized from ortho-methoxyaniline compound in one-step. 
Aminobenzothiazole could be reduced in alkaline condition at high temperature in order to get 
ortho-aminothiophenol. Aminobenzothiazole compound with methyl ester sidechain (3-7) was 
used as a model to assess the reaction conditions. Upon reduction with sodium or potassium 
hydroxide, the starting material reduced to the dimer of the desired ortho-aminothiophenol 
(Scheme 3-4). In addition to challenges in purification, demethylation occurred at the sidechain as 
acid product was observed in 1H NMR. Several reaction conditions were attempted by varying 
base concentration, temperature, and time, in order to optimize reaction conditions. However, the 
same product was observed in each case. The dimer was reduced to the thiol monomer by breaking 
the disulfide bond using lithium aluminum hydride, which gave the ortho-aminothiophenol 
compound with sidechain acid reduced to primary alcohol. Reduction of ethyl ester (3-9) and 
methylene nitrile (3-12) benzothiazole under similar condition did not yield in formation of desired 




Scheme 3-4 Reduction of aminobenzothiazole. 
Due to undesired modification of sidechain while using harsh reducing conditions with 
aminobenzothiazole and challenges in purification, an alternate pathway was explored in order to 
get the ortho-aminothiophenol. This pathway involved protection of amine followed by 
thiocyanation at the ortho position, and reduction and deprotection to get the nucleophilic 
functionalities as shown in Scheme 3-5. Three different protecting groups were used in these 
experiments- Boc (di-tert-butyl dicarbonate), Azide (N3), and trityl (triphenylmethyl). 
 






Table 3-2 Thiocyanation of protected ortho-methoxyaniline. 
 
Aromatic amine was protected with the protecting groups mentioned above and the formation of 
these products was confirmed with NMR and Infrared spectroscopy. Thiocyanation conditions 
were similar to benzothiazole synthesis conditions, except in this case ammonium thiocyanate was 
used instead of potassium thiocyanate. Reactions were ran under ice-bath to control thiocyanation 
and to prevent cyclization. Table 3-2 shows the results of thiocyanation reactions. With no 
protecting group present, under these reaction conditions, benzothiazole formed. With Boc-
protected amine, thiocyanation was incomplete and major product recovered was the deprotected 
o-methoxyaniline compound. With azide protected amine, thiocyanation did not work as the 
starting material was recovered. With trityl protected amine, thiocyanation resulted in deprotection 
and thiocyanation at the desired ortho position of amine. However, cyclization occurred resulting 
in benzothiazole formation, as it was recovered as the major product.  
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Since the pathway discussed above to protect, thiocyanate, and reduce the aniline failed to give the 
expected outcomes, thiolation via Ullman type coupling was pursued.  
 
Scheme 3-6 Halogenation-Ullman type thiolation.  
ortho-methoxyaniline compound with ethyl ester sidechain (3-8) was iodinated using iodine 
monochloride at the ortho position to amine selectively. Following iodination, desired thiol 
functionality was installed using copper (II) catalyzed single step aryl thiol synthesis via C-S cross 
coupling using 1,2-ethanedithiol as explored by Liu et al.183 The mechanism of this reaction 
involves two steps. First step is the catalysis step where halogenated compound undergoes C-S 




Figure 3-4 Mechanism of thiolation via Ullman type C-S coupling. 
As shown in Figure 3-4, thiol nucleophile coordinates to the metal, followed by oxidative addition 
of aryl halide to the metal complex. Aryl is attached to sulfur of 1,2-ethanedithiol as it reductively 
eliminates following C-S coupling, as the intermediate shown in Figure 3-4 is generated. The 
second step of this mechanism is intramolecular sulfide cleavage, as the terminal nucleophilic 
sulfur of 1,2-dithioethane moiety attacks the neighboring carbon of the aryl attached sulfur forming 
tricyclic thioether. This thioether is eliminated, and aromatic thiol is generated upon acid workup. 
Ullman type thiol installation was done on iodinated and brominated ortho-methoxy aniline 
compounds. Iodination was successfully done to synthesize 3-21 (78%), 3-22 (75%), and 3-23 
(60%). Bromination was done with NBS at ortho-position of amine to synthesize 3-24 (84%), 3-
25 (79%), and 3-26 (81%). Thiolation reactions were carried out on methyl ester (CO2Me) 3-21 
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and 3-24 to assess conditions. However, Ethyl-ester sidechain was later used to optimize the 
reaction condition due to deesterification observed in compounds with methyl-ester sidechain. 
Triphenylphosphine and tributylphosphine were used to reduce the dimer to get the o-aminothiol 
compound. However, these protocols required an extra purification step and as a result, TCEP was 
used to reduce the dimer.  Ullman type thiolation was done successfully to synthesize 3-27 in 
overall yield of 54% from ortho-methoxyaniline compound (3-8), and 3-29 was synthesized with 
overall 47% yield from. 3-6. 
3.2.4 Alkylate condensation: 
The key intermediate ortho-aminothiophenol was synthesized using Ullman type coupling, which 
was followed by alkylate condensation of different alkylating agents to synthesize monomeric 
benzothiazines. Synthesis scheme of 1,4-benzothiazine ethyl ester derivatives is shown in Scheme 
3-7. Dihydrobenzothiazine (3-30, Yield-71%) was synthesized by condensing dichloroethane on 
o-aminothiophenol compound (3-27) in DMF. The aliphatic protons of benzothiazine (CH2-CH2) 
and their splitting were characteristic of the desired dihydrobenzothiazine product. Benzothiazine 
(3-31, Yield-59%) was synthesized by condensing bromoacetaldehyde on ortho-aminothiophenol 
compound (3-27). In the first step, thiophenolate is generated by reaction with sodium hydride. 
After addition of bromoacetaldehyde, amino aldehyde is condensed in situ to yield the desired 




Scheme 3-7 Synthesis of benzothiazines by alkylate condensation. 
When this reaction was performed with ortho-aminothiophenol compounds with methylene nitrile 
sidechain (3-29), isomer of benzothiazine (3-33) was observed in 46% yield. Following similar 
reaction mechanism, benzothiazine carboxylate (3-32, Yield-66%) was synthesized by condensing 
ethylbromopyruvate on ortho-aminothiophenol (3-27). Crude was purified with prep-HPLC and 
products were characterized using NMR. Presence of aliphatic CH2 and proton of ethyl ester 
sidechain with relevant chemical shift and integration confirmed the formation of benzothiazine 
carboxylate products. Condensation reactions of 3-29 with dibromoethane and ethyl 
bromopyruvate were attempted using similar conditions, but product could not be confirmed with 
1H or 13C NMR. These reactions could be optimized and scaled to yield these benzothiazine 
products in a future work. Thus, pheomelanin subunits-benzothiazines (BTZ) and benzothiazloles 
(BTZL) were synthesized. Benzothiazoles were synthesized using thiocyanation-cyclization and 
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sandmeyer reaction. Benzothiazines were synthesized using Ullman type thiolation and alkylate 
condensation reactions. These synthetic pheomelanin subunits could be deprotected to better 
represent their natural analogues to extend this work. 
3.3 Conclusion and future direction 
Synthetic analogues of benzothiazole and benzothiazine (pheomelanin subunits) derivatives were 
synthesized from ortho-methoxyaniline derivatives with two different sidechains (CO2Et and 
CH2CN) for the first time. Synthesized analogues included aminobenzothiazole compounds with 
CO2Et and CH2CN sidechain in 92% and 95% yield, benzothiazole compounds with CO2Et and 
CH2CN sidechain in 86% and 89% yield. Bromobenzothiazole compounds with CO2Et and 
CH2CN sidechain were synthesized via bromination of benzothiazole with 83% and 78% yield 
respectively and via Sandmeyer reaction of aminobenzothiazole compounds with 75% and 67% 
yield, respectively. To synthesize benzothiazine compounds, which are synthetic analogues of 
1,4-benzothiazine subunit of pheomelanin, ortho-aminothiol compounds with CO2Et and CH2CN 
sidechain were synthesized as key intermediates via Ullman type thiolation of ortho-brominated 
or ortho-iodinated aniline compounds in 69% and 58% yield. Synthetic analogues of 1,4-
benzothiazine- dihydrobenzothiazine (71% yield) was synthesized via alkylative condensation of 
dichloroethane, benzothiazine with CO2Et and CH2CN sidechain were synthesized via alkylate 
condensation of bromo-acetaldehyde in 59% yield 41% respectively; and benzothiazine 
dicarboxylate (66% yield) via alkylate condensation of ethyl bromopyruvate.  
Ullman type thiolation reaction conditions could be optimized further in future to increase the 
yield and efficiency. In addition, it may include modifying sidechains of pheomelanin to access 
DOPA sidechain to access natural analogues of 1,4-benzothiazine and benzothiazole which are 
key intermediates of pheomelanogenesis. Degradation experiments followed by HPLC analysis 
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via reductive hydrolysis or oxidative degradation using HI or H2O2 could be performed on 
synthesized natural analogues to analyze degradation products of melanogenesis. 
3.4 Synthesis  
3.4.1 General synthesis procedure 
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly without 
further purification. Solvents were dried with activated 4 Å molecular sieves or anhydrous solvents 
were dispensed from Solvent system. Reactions were monitored by TLC or analytical HPLC. All 
products were purified with silica-gel flash chromatography or preparative HPLC. HPLC was 
performed on a Gilson analytical to semi-preparative system using Kinetex 5 µm EVO C18 100Å 
4.6 x 150 mm for analytical and Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for preparative 
purpose. Products were characterized by 1H and 13C NMR and mass spectrometry. NMR 
characterization results and J values were compared with published results. 1H and 13C NMR 
spectra were recorded on Agilent/Varian 400 MHz or Bruker Neo 500 MHz and 101 MHz NMR 
spectrometer, respectively. 1H NMR multiplicities are defined as ‘s’-singlet, ‘d’-doublet, ‘t’-
triplet, ‘dd’-doublet of doublets, and ‘m’-multiplet. Mass spectra were recorded using a Synapt G2 
Q-TOF ESI mass spectrometer at the Mass Spectrometry Lab at the University of Illinois Urbana 
Champagne. Abbreviations: TLC-Thin layer chromatography, HPLC-High Performance Liquid 
Chromatography, NMR-Nuclear Magnetic Resonance, Q-TOF-Quadrupole time of flight, ESI-
Electrospray ionization 
3.4.2 Synthesis of ortho-methoxy aniline compound 




To the mixture of potassium tert-butoxide (2.24 g, 10 mmol) in THF (15 mL), solution of 
toluenesulfonylmethyl isocyanide-TosMIC (1.95 g, 10 mmol) in THF (5 mL) was added at -78 
°C. Mixture was stirred for 15 minutes followed by addition of vanillin (761 mg, 5 mmol) in 
THF (5 mL) dropwise at -78 °C. The mixture was stirred at -78 °C for 2 hours and warmed to rt. 
Methanol (5 mL) was added and the mixture was heated at 66 °C for 1.5 hours. Solvent was 
evaporated under reduced pressure. Water (20 mL) was added to the crude and the crude product 
was extracted with ethyl acetate (3x20 mL). The combined organic layer was dried with sodium 
sulfate and evaporated under reduced pressure. The crude product was purified with silica gel 
flash chromatography (40:60 EtoAc: Hex). 567 mg, 66%. 1H NMR (400 MHz, CDCl3) δ 6.84 
(d, 1H, J=2.0 Hz), 6.82 (d, 1H, J=8.4 Hz), 6.79 (dd, 1H, J=2.0 Hz, 8.4 Hz), 3.85 (s, 3H), 3.62 (s, 
2H). 13C NMR (101 MHz, CDCl3) δ 146.63, 146.26, 123.03, 119.76, 118.45, 114.51, 111.29, 
56.26, 23.18 ppm. Spectral data matched with those in literature. 185 
2-(4-amino-3-methoxyphenyl) acetonitrile synthesis via Smiles rearrangement 
 
General procedure: Cyanovanillin (55 mg, 0.32 mmol) was dissolved in DMF (1.5 mL). Smiles 
reagent (1.2 eq.) was added to the solution followed by addition of potassium carbonate (2.5 eq.) 
and potassium iodide (0.2 eq.). The mixture was stirred at variable temperature and time (refer to 
the Table 3-1-results and discussion).  Solvent was evaporated under reduced pressure and crude 





2-(3-methoxy-4-nitrophenyl) acetonitrile (3-5) 
 
To a solution of tetra-n-butyl ammonium nitrate (1.97 g, 6.45 mmol) and 18-crown-6 (27 mg, 
0.102 mmol) in dry DCM (40 mL) cooled in ice-bath was added trifluoroacetic anhydride (2.2 mL) 
dropwise at 0°C. The solution was stirred in ice bath for 30 minutes and slowly syringed to a 
solution of 3-methoxyphenyl acetonitrile (1 g, 6.79 mmol) in DCM (70 mL). The mixture was 
stirred at rt overnight. The crude product solution was washed with sodium bicarbonate (100 mL) 
and extracted with DCM (3 x 100 mL). The combined organic extracts were dried over sodium 
sulfate and solvent was evaporated under reduced pressure. Crude was purified with silica-gel flash 
chromatography (30:70 ethyl acetate:hexanes). 613 mg, 47%.1H NMR (500 MHz, CDCl3) δ 7.86 
(d, 1H,8 Hz), 7.07 (s,1H), 6.99 (d, 1H, J=8.5 Hz), 3.99 (s, 3H), 3.83 (s, 2H) ppm. 13C NMR (125 
MHz, CDCl3) δ 153.62, 136.72, 132.23, 126.74, 120.80, 119.86, 113.13, 56.86, 23.99 ppm. 
Spectral data matched with those in literature.180 
2-(3-methoxy-4-aminophenyl) acetonitrile (3-6) 
 
To a 20 mL scintillation vial with a septum were added 2-(3-methoxy-4-nitrophenyl) acetonitrile 
(150 mg, 0.78 mmol) and palladium on carbon (75 mg). The vial was evacuated and purged with 
hydrogen, followed by addition of methanol (3.5 mL). Reaction was stirred under hydrogen for 12 
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hours. The catalyst was filtered and solvent was evaporated under reduced pressure to recover 124 
mg (98%) 2-(3-methoxy-4-aminophenyl) acetonitrile. 122 mg, 98%. 1H NMR (500 MHz, CDCl3) 
δ 6.65 (s,1H), 6.64 (d, 1H,8 Hz), 6.60 (d, 1H, J=7.5 Hz), 3.79 (s, 3H), 3.57 (s, 2H) ppm. 13C NMR 
(125 MHz, CDCl3) δ 147.71, 136.13, 121.46, 120.75, 115.07, 110.29, 110.15, 55.72, 23.39 ppm. 
Spectral data matched with those in literature.186 
3.4.3 Benzothiazole synthesis 
Methyl 2-amino-4-methoxybenzo[d]thiazole-6-carboxylate (3-7) 
 
In a 7 mL scintillation vial, potassium thiocyanate (322 mg, 3.31 mmol) and acetic acid (0.5 mL) 
were added, followed by addition of methyl 4-amino-3-methooxybenzoate (150 mg, 0.83 mmol) 
in acetic acid (1 mL) dropwise at 0 °C. To this mixture was added bromine (146 mg, 0.91 mmol) 
in acetic acid (0.5 mL) dropwise at 0 °C. The reaction mixture was stirred at rt for 12 h. The crude 
product mixture was diluted with water and potassium carbonate was added to adjust the pH ~8. 
Solid precipitate were filtered and dried under vacuum overnight. 177 mg, 89%.  1H NMR (400 
MHz, d6-DMSO) δ 7.94 (d, 1H, J=1.2 Hz), 7.84 (s, N-H, 2H), 7.34 (d, 1H, J=1.6 Hz), 3.87 
(s, 3H), 3.83 (s, 3H). 13C NMR (101 MHz, d6-DMSO) δ 169.32, 166.91, 149.68, 146.85, 








To a 7 mL scintillation vial with a stir bar was added, 4-amino 3-methoxybenzoic acid (200 mg, 
1.20 mmol) followed by addition of ethanol (2.4 mL) and sulfuric acid (0.10 mL). The reaction 
mixture was stirred at 81 °C for 10 h. After cooling to room temperature, the solvent was 
evaporated under reduced pressure. Saturated sodium bicarbonate (20 mL) was added to the crude 
and product was extracted with ethyl acetate (2*20 mL). The organic layer was washed with brine 
and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure. 220 
mg, 94%. 1H NMR (500 MHz, CDCl3) δ 7.56 (dd, 1H, J=1.6, 6.4 Hz), 7.46 (d, 1H, J=1.2 
Hz), 6.66 (d, 1H, J=6.4 Hz), 4.33 (q, 2H, J=6 Hz), 3.90 (s, 3H), 1.37 (t, 3H, J=6 Hz) ppm. 
13C NMR (125 MHz, CDCl3) δ 166.96, 146.20, 141.10, 124.05, 119.90, 113.18, 111.20, 
60.48, 55.63, 14.51 ppm. Spectral data matched with those in literature.188 
Ethyl 2-amino 4-methoxybenzothiazole 6-carboxylate (3-9) 
 
In a 7 mL scintillation vial, potassium thiocyanate (364 mg, 3.75 mmol) and acetic acid (0.6 mL) 
were added, followed by addition of ethyl 4-amino-3-methooxybenzoate (183 mg, 0.94 mmol) in 
acetic acid (1 mL) dropwise at 0 °C. To this mixture was added bromine (165 mg, 1.03 mmol) in 
acetic acid (0.5 mL) dropwise at 0 °C. The reaction mixture was stirred at rt for 12 h. The crude 
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product mixture was diluted with water and potassium carbonate was added to adjust the pH ~8. 
Solid precipitate were filtered and dried under vacuum overnight. 220 mg, 92%. 1H NMR (500 
MHz, CDCl3) δ 7.97 (d, 1H, J=1.0 Hz), 7.51 (d, 1H, J=1.5 Hz), 5.34 (s, N-H, 2H), 4.40 
(q, 2H, J=7.5 Hz), 4.03 (s, 3H), 1.41 (t, 3H, J=7.0 Hz). 13C NMR (125 MHz, CDCl3) δ 
165.94, 146.23, 139.17, 126.88, 119.73, 115.73, 109.73, 106.63, 60.81, 56.06, 14.42 ppm. 
Spectral data matched with those in literature.189 
Ethyl 4-methoxybenzothiazole 6-carboxylate (3-10) 
 
In a 7 mL scintillation vial, ethyl 2-amino 4-methoxybenzoate 6-carboxylate (25 mg, 0.098 mmol) 
and THF (0.5 mL) were added followed by slow addition of isoamyl nitrite (25 mg, 0.21 mmol). 
The mixture was stirred at 66 °C for 1 hour. The mixture was cooled and poured into ice-water (8 
mL). The aqueous mixture was extracted with ethyl acetate (3 x 8 mL). The organic extracted were 
combined and washed with brine, dried over sodium sulfate, and concentrated under reduced 
pressure. 20 mg, 86%.  1H NMR (500 MHz, CDCl3) δ 9.05 (s, 1H), 8.29 (d, 1H, J=1.0 Hz), 7.60 
(d, 1H, J=1.5 Hz), 4.44 (q, 2H, J=7.5 Hz), 4.12 (s, 3H), 1.43 (t, 3H, J=7.0 Hz). 13C NMR (125 
MHz, CDCl3) δ 165.85, 152.43, 145.25, 140.56, 138.59, 129.05, 114.97, 108.01, 61.61, 






Ethyl 2-bromo 4-methoxybenzothiazole 6-carboxylate (3-11) 
 
To a solution of ethyl4-methoxybenzothiazole 6-carboxylate (20 mg, 0.084 mmol) in DMF (0.2 
mL) were added carbon tetrabromide (30.5 mg, 0.092 mmol) and potassium tert-butoxide (38 mg, 
0.336 mmol). The mixture was stirred at rt for 1.5 hours. The reaction mixture was poured into 
water (5 mL), extracted with DCM (3 x 5 mL), and dried over sodium sulfate. Solvent was 
evaporated under reduced pressure to get crude product. The crude product was purified with 
silica-gel flash chromatography (40:60 ethyl acetate:hexanes). 22 mg, 83% 
Sandmeyer reaction 
 
In a 7 mL scintillation vial, to a stirred solution of 2-amino 4-methoxybenzothiazole 6-carboxylate 
(20 mg, 0.079 mmol) and copper (II) bromide (30 mg, 0.134 mmol) in acetonitrile (0.5 mL) was 
added isoamyl nitrite (11 mg, 0.095 mmol) dropwise at 0 °C. The mixture was stirred at rt for 3 
hours, after which water (4 mL) was added. The precipitate were filtered and dried under vacuum. 
19 mg, 75%.  1H NMR (500 MHz, CDCl3) δ 8.13 (d, 1H, J=1.2 Hz), 7.58 (d, 1H, J=1.2 Hz), 4.43 
(q, 2H, J=5.6 Hz), 4.09 (s, 3H), 1.43 (t, 3H, J=5.6 Hz). 13C NMR (125 MHz, CDCl3) δ 165.85, 
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152.43, 145.25, 140.55, 138.59, 129.05, 114.96, 108.00, 61.61, 56.34, 14.36 ppm. HRMS (TOF 
MS ES+) m/z calculated ([M+H]+) 315.9643 Da, found 315.9642 Da. 
2-(2-amino-4-methoxybenzothiazol-6-yl) acetonitrile (3-12) 
 
In a 7 mL scintillation vial, potassium thiocyanate (134 mg, 1.38 mmol) and acetic acid (0.2 mL) 
were added, followed by addition of 2-(3-methoxy-4-aminophenyl) acetonitrile (56 mg, 0.35 
mmol) in acetic acid (0.3 mL) dropwise at 0 °C. To this mixture was added bromine (62 mg, 0.38 
mmol) in acetic acid (0.5 mL) dropwise at 0 °C. The reaction mixture was stirred at rt for 12 hours. 
The crude product mixture was diluted with water and potassium carbonate was added to adjust 
the pH ~8. Solid precipitate were filtered and dried under vacuum overnight. 73 mg, 95%. 1H 
NMR (500 MHz, CDCl3) δ 7.01 (d, 1H,1.5 Hz), 6.58 (d, 1H, J=1.5 Hz), 3.76 (s, 2H), 3.61 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 166.16, 150.14, 141.96, 132.69, 124.74, 119.96, 113.29, 108.89, 
56.34, 22.86 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 220.0545 Da found 220.0542 
Da. 
2-(4-methoxybenzothiazol-6-yl) acetonitrile (3-13) 
 
In a 7 mL scintillation vial, 2-(2-amino-4-methoxybenzothiazol-6-yl) acetonitrile (40 mg, 0.18 
mmol) and THF (0.9 mL) were added followed by slow addition of isoamyl nitrite (47 mg, 0.40 
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mmol). The mixture was stirred at 66 °C for 1 hour. Mixture was cooled and poured into ice-water 
(15 mL). The aqueous mixture was extracted with ethyl acetate (3 x 15 mL). The organic extracted 
were combined and washed with brine, dried over sodium sulfate, and concentrated under reduced 
pressure. 33 mg , 89%.  1H NMR (500 MHz, CDCl3) δ 8.93 (s, 1H), 7.53 (d, 1H, J=1.5 Hz), 6.85 
(d, 1H, J=1.0 Hz), 4.08 (s, 3H), 3.90 (s, 2H). 13C NMR (125 MHz, CDCl3) δ 154.24, 153.27, 
143.52, 136.33, 128.84, 117.69, 113.20, 106.74, 56.37, 24.20 ppm. HRMS (TOF MS ES+) m/z 
calculated ([M+H]+) 205.0436 Da found 205.0433 Da. 
2-(2-bromo-4-methoxybenzothiazol-6-yl) acetonitrile (3-14) 
 
To a solution of 2-(4-methoxybenzothiazol-6-yl) acetonitrile (17 mg, 0.084 mmol) in DMF (0.2 
mL) were added carbon tetrabromide (30.5 mg, 0.092 mmol) and potassium tert-butoxide (38 mg, 
0.336 mmol). Mixture was stirred at rt for 1.5 hours. The reaction mixture was poured into water 
(5 mL), extracted with DCM (3 x 5 mL), and dried over sodium sulfate. Solvent was evaporated 
under reduced pressure to get crude product. The crude product was purified with silica-gel flash 
chromatography (40:60 ethyl acetate: hexanes). 19 mg, 78% 
 
In a 7 mL scintillation vial, to a stirred solution of 2-(2-amino-4-methoxybenzothiazol-6-yl) 
acetonitrile (46 mg, 0.208 mmol) and copper (II) bromide (79 mg, 0.35 mmol) in acetonitrile (1.5 
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mL) was added isoamyl nitrite (29 mg, 0.25 mmol) dropwise at 0 °C. The mixture was stirred at 
rt for 3 hours, after which water (4 mL) was added. The precipitate were filtered and dried under 
vacuum. 40 mg, 67%. 1H NMR (500 MHz, CDCl3) δ 7.38 (d, 1H, J=1.5 Hz), 6.83 (d, 1H, J=1.0 
Hz), 4.06 (s, 3H), 3.87 (s, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ 153.13, 142.36, 139.64, 
138.14, 129.12, 112.20, 109.10, 107.39, 56.43, 24.17 ppm. HRMS (TOF MS ES+) m/z calculated 
([M+H]+) ([M+H]+) 282.9542 Da found 282.9541 Da. 
3.4.4 Synthesis of ortho-aminothiophenol intermediate 
4-amino-3-mercapto-5-methoxybenzoic acid (3-17) 
 
Methyl 2-amino-4-methoxybenzo[d]thiazole-6-carboxylate (120 mg, 0.50 mmol) was added to a 
solution of sodium hydroxide (or potassium hydroxide) (10 mmol, 20 eq.) in water (1.5 mL). The 
mixture was heated and stirred at 110-140 °C for 2-4 days (Multiple trials). The mixture was 
poured into ice-water (12 mL), acidified with concentrated HCl to pH 4-5 and extracted with ethyl 
acetate. The organic layer was washed with water and dried over sodium sulfate. Solvent was 
evaporated under reduced pressure. 32 mg, 30%. 1H NMR (400 MHz, DMSO-d6) δ 12.22 (s, 1H), 
7.28 (d, 1H, J=1.6 Hz), 7.24 (d, 1H, J=1.6 Hz), 5.86 (s, 2H, N-H), 3.84 (s, 3H) ppm. 13C NMR 




To a solution of 5,5'-disulfanediylbis(4-amino-3-methoxybenzoic acid) (28 mg, 0.07 mmol) in 
water:acetonitrile (1:1, 5 mL) was added TCEP (tris(2-carboxyethyl)phosphine) (36 mg, 0.126 
mmol). Mixture was stirred at room temperature for 3 hours. Solvent was evaporated under 
reduced pressure to get the desired thiol. 26 mg, 88%. 1H NMR (400 MHz, CDCl3) δ 7.88 (d, 1H, 
J=1.6 Hz), 7.41 (d, 1H, J=1.6 Hz), 4.75 (s, 2H, N-H), 3.92 (s, 3H) ppm. 13C NMR (101 MHz, 
DMSO-d6) δ 167.40, 146.08, 144.50, 130.89, 117.41, 115.08, 112.33, 56.40 ppm. Spectral data 
matched with those in literature.190 
Methyl 4-amino-3-methoxy-5-thiocyanatobenzoate 
 
To a mixture of methyl 4-amino-3-methoxy benzoate (75 mg, 0.41 mmol) in methanol (2 mL) 
were added ammonium thiocyanate (76 mg, 0.99 mmol). The mixture was cooled to 5 °C and 
bromine (99 mg, 0.62 mmol) in methanol (1 mL) wad added dropwise. The mixture was stirred at 
5 °C for 3 hours and at room temperature for 12 hours. Solid was filtered and washed with water. 
Aminobenzothiazole product was observed.77 mg, 79%. 1H NMR (400 MHz, d6-DMSO) δ 
7.94 (d, 1H, J=1.2 Hz), 7.84 (s, N-H, 2H), 7.34 (d, 1H, J=1.6 Hz), 3.87 (s, 3H), 3.83 (s, 
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3H). 13C NMR (101 MHz, d6-DMSO) δ 169.32, 166.91, 149.68, 146.85, 132.25, 123.03, 
116.30, 108.83, 56.39, 52.69 ppm. Spectral data matched with those in literature. 187 
Methyl 4-((tert-butoxycarbonyl) amino)-3-methoxybenzoate (3-18) 
 
In a 7 mL scintillation vial, to a solution of methyl 4-amino 3-methoxy benzoate (196 mg, 0.82 
mmol) in THF (2 mL) was added Boc-anhydride (289 mg, 0.98 mmol, 1.2 eq.). The reaction 
mixture was heated and stirred at 66 °C for 24 hours. Reaction was monitored by TLC. The 
reaction mixture was cooled, and solvent was evaporated under reduced pressure. Water (10 mL) 
was added to the crude and product was extracted with diethyl ether (3x10 mL). The combined 
organic layer was washed with brine and dried over sodium sulfate. Solvent was evaporated under 
reduced pressure and the crude product was purified using silica gel flash chromatography (20:80 
EtOAc:Hex) to get the desired product. 171 mg, 74%. 1H NMR (400 MHz, CDCl3) δ 8.17 (d, 1H, 
J= 8.8 Hz), 7.68 (dd, 1H, J=2.0, 8.8 Hz), 7.51 (d, 1H, J=2.0 Hz), 7.28 (s, 1H, N-H), 3.93 (s, 3H), 
3.89 (s, 3H), 1.53 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 167.33, 166.90, 152.31, 146.83, 









Methyl 4-azido-3-methoxybenzoate (3-19) 
 
Methyl 4-amino 3-methoxy benzoate (100 mg, 0.55 mmol) and 2N HCl (1.65 mL) were added to 
a vial and the solution was cooled to 0 °C. Sodium nitrite (57 mg, 0.83mmol, 1.5 eq.) in water (1.3 
mL) was added dropwise to the above solution at 0 °C and the mixture was stirred for 30 minutes. 
Sodium azide (142 mg, 2.2 mmol, 4 eq.) in water (2.25 mL) was added to the mixture dropwise 
and the vial was stirred for 4 hours at room temperature. The reaction mixture was extracted with 
ethyl acetate (3x8 mL). The organic layers were combined and washed with water. Product 
solution was dried over sodium sulfate and solvent was evaporated under reduced pressure to get 
the desired product. 99 mg, 87%. 1H NMR (400 MHz, CDCl3) δ 7.63 (dd, 1H, J= 2.0, 8.4 Hz), 
7.55 (d, 1H, J=2.0 Hz), 7.02 (d, 1H, J=8.4 Hz), 3.93 (s, 3H), 3.91 (s, 3H) ppm. 13C NMR (101 
MHz, CDCl3) δ 166.57, 151.82, 133.36, 127.48, 123.27, 120.08, 112.96, 56.32, 52.47 ppm. 
Spectral data matched with those in literature.192 
Methyl 3-methoxy-4-(tritylamino) benzoate (3-20) 
 
Methyl 4-amino 3-methoxy benzoate (150 mg, 0.83 mmol) was dissolved in dichloromethane (3 
mL) in a vial. Triethylamine (168 mg, 1.66 mmol, 2.0 eq.) and trityl chloride (254 mg, 0.91 mmol, 
1.1 eq.) were added to the reaction mixture and the vial was stirred at room temperature for 16 
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hours. The reaction mixture was diluted with dichloromethane (25 mL) and washed with water 
(3x25 mL). The organic layer was dried over sodium sulfate and solvent was evaporated under 
reduced pressure to get the desired product. 281 mg, 80%. 1H NMR (400 MHz, CDCl3) δ 7.34-
7.26 (m, 15H), 7.04 (dd, 1H, J=2.0, 8.4 Hz), 6.16 (s, 1H), 5.92 (d, 1H, 8.4 Hz), 5.76 (s, 1H), 3.91(s, 
3H), 3.71 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.47, 146.25, 144.90, 140.42, 129.06, 128.08, 
127.95, 127.02, 123.02, 117.59, 113.53, 109.54, 71.10, 55.78, 51.56 ppm. Spectral data matched 
with those in literature.192 
Methyl 4-amino-3-iodo-5-methoxybenzoate (3-21) 
 
To a solution of 4-amino 3-methoxy benzene compound (1.65 mmol) and sodium bicarbonate 
(279 mg, 3.32 mmol) in DCM (4 mL) was added iodine monochloride (297 mg, 1.83 mmol) 
DCM (2.5 mL). Reaction mixture was stirred at room temperature for 24 hours. The mixture was 
washed with saturated sodium bicarbonate and extracted with DCM (4x15 mL). The combined 
organic fractions were dried over sodium sulfate and solvent was evaporated under reduced 
pressure. The crude product was purified with silica gel flash chromatography (30:70 
EtOAc:Hex). 395 mg, 78%. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 1H, J=1.6 Hz), 7.38 (d, 1H, 
J=1.6 Hz), 4.59 (s, 2H, N-H), 3.88 (s, 3H), 3.86 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 
166.10, 145.10, 141.82, 133.13, 120.34, 110.55, 80.56, 55.99, 51.95 ppm. Spectral data matched 





Ethyl 4-amino-3-iodo-5-methoxybenzoate (3-22) 
 
To a solution of 4-amino 3-methoxy benzene compound (0.80 mmol) and sodium bicarbonate 
(134 mg, 1.6 mmol) in DCM (2.5 mL) was added iodine monochloride (143 mg, 0.88 mmol) 
DCM (1.5 mL). The reaction mixture was stirred at room temperature for 24 hours. Mixture was 
washed with saturated sodium bicarbonate and extracted with DCM (4x10 mL). The combined 
organic fractions were dried over sodium sulfate and solvent was evaporated under reduced 
pressure. The crude product was purified with silica gel flash chromatography (30:70 
EtOAc:Hex). 193 mg, 75%. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 1H, J=1.6 Hz), 7.40 (d, 1H, 
J=1.6 Hz), 4.33 (q, 2H, J=7.2 Hz), 3.90 (s, 3H), 1.37 (t, 3H, J=7.2 Hz) ppm. 13C NMR (101 
MHz, CDCl3) δ 165.65, 145.13, 141.72, 133.01, 120.76, 110.58, 80.58, 60.78, 55.99, 14.44 
ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 321.9940 Da, found 321.9943 Da. 
2-(4-amino-3-iodo-5-methoxyphenyl)acetonitrile (3-23) 
 
To a solution of 4-amino 3-mthoxy benzene compound (0.5 mmol) and sodium bicarbonate (84 
mg, 1 mmol) in DCM (1 mL) was added iodine monochloride (89 mg, 0.55 mmol) DCM (1 mL). 
Reaction mixture was stirred at room temperature for 24 hours. The reaction mixture was washed 
with saturated sodium bicarbonate and extracted with DCM (4x5 mL). The combined organic 
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fractions were dried over sodium sulfate and solvent was evaporated under reduced pressure. 
Crude was purified with silica gel flash chromatography (30:70 EtOAc:Hex). 86 mg, 60%. 1H 
NMR (400 MHz, CDCl3) δ 7.11 (d, 1H, J=2.0 Hz), 6.62 (d, 1H, J=2.0 Hz), 4.22 (s, 2H, N-H), 
3.80 (s, 3H), 3.55 (s, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 146.50, 137.45, 129.60, 120.23, 
117.97, 109.59, 82.42, 55.94, 22.64 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 
288.9838 Da, found 288.9835 Da. 
Methyl 4-amino-3-bromo-5-methoxybenzoate (3-24) 
 
To a solution of 4-amino 3-mthoxy benzene compound (1.50 mmol) in DCM (5 mL) was added 
N-bromosuccinimide (1.50 mmol) at 0 °C. The mixture was stirred at room temperature for 10 
hours. The crude was washed with water (40 mL) and extracted with DCM (3x50 mL). The 
combined organic layers were dried over sodium sulfate and solvent was evaporated under 
reduced pressure. The crude product was purified with silica gel flash chromatography (30:70 
EtOAc:Hex). 328 mg, 84%. 1H NMR (400 MHz, CDCl3) δ 7.81 (d, 1H, J=2.0 Hz), 7.38 (d, 1H, 
J=2.0 Hz), 4.65 (s, 2H, N-H), 3.91 (s, 3H), 3.87 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 
161.98, 146.24, 139.26, 127.00, 110.56, 109.78, 106.65, 56.06, 51.96. Spectral data matched 









To a solution of 4-amino 3-mthoxy benzene compound (0.6 mmol) in DCM (2 mL) was added N-
bromosuccinimide (0.6mmol) at 0 °C. Mixture was stirred at room temperature for 12 hours. The 
crude was washed with water (15 mL) and extracted with DCM (3x15 mL). The combined organic 
layer was dried over sodium sulfate and solvent was evaporated under reduced pressure. The crude 
product was purified with silica gel flash chromatography (30:70 EtOAc:Hex).130 mg, 79%. 1H 
NMR (400 MHz, CDCl3) δ 6.99 (d, 1H, J=2.0 Hz), 6.67 (d, 1H, J=2.0 Hz), 3.88 (s, 3H), 3.64 (s, 
2H), 3.49 (s, 1H, S-H) ppm. 13C NMR (125 MHz, CDCl3) δ 147.74, 134.81, 123.80, 119.39, 
118.11, 108.80, 108.26, 56.14, 23.04 ppm. Spectral data matched with those in literature.195 
2-(4-amino-3-bromo-5-methoxyphenyl)acetonitrile (3-26) 
 
To a solution of 4-amino 3-mthoxy benzene compound (0.35 mmol) in DCM (1.5 mL) was 
added N-bromosuccinimide (0.35 mmol) at 0 °C. The mixture was stirred at room temperature 
for 10 hours. The crude product was washed with water (10 mL) and extracted with DCM (3x10 
mL). The combined organic layers were dried over sodium sulfate and solvent was evaporated 
under reduced pressure. The crude product was purified with silica gel flash chromatography 
(30:70 EtOAc:Hex). 68 mg, 81%. 1H NMR (400 MHz, CDCl3) δ 6.99 (1H, J=2.0 Hz), 6.66 
(1H, J=2.0 Hz), 4.25 (2H, N-H), 3.87 (3H), 3.63 (2H) ppm. 13C NMR (101 MHz, CDCl3) δ 
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147.74, 134.81, 123.80, 119.39, 119.12, 108.80, 108.26, 56.14, 23.04 ppm. HRMS (TOF MS 
ES+) m/z calculated ([M+H]+) 240.9977 Da, found 240.9976 Da. 
Methyl 4-amino-3-mercapto-5-methoxybenzoate 
 
To a 7 mL vial evacuated and purged with N2, methyl-4-amino-3-halo-5-methoxy benzoate (70 
mg, 0.27 mmol) was added followed by addition of copper sulfate (2.2 mg, 5 mol%), potassium 
hydroxide (76 mg, 1.35 mmol) in DMSO (0.6 mL), water (0.06 mL) were added. 1,2-
ethanedithiol (51 mg, 0.54 mmol) was added dropwise under N2 to the above mixture. Mixture 
was stirred at 90 °C for 36 hours. The reaction mixture was quenched with 5% HCl and extracted 
with ethyl acetate. The organic layer was washed with water, brine and dried over sodium 
sulfate. Solvent was evaporated under reduced pressure and crude was purified with silica gel 
flash chromatography (40:60 EtOAc:Hex). 32 mg, 59%. 1H NMR (400 MHz, CDCl3) δ 7.88 (d, 
1H, J=1.6 Hz), 7.41 (d, 1H, J=1.6 Hz), 4.75 (s, 2H, N-H), 3.92 (s, 3H) ppm. 13C NMR (101 
MHz, DMSO-d6) δ 167.40, 146.08, 144.50, 130.89, 117.41, 115.08, 112.33, 56.40 ppm. Spectral 








Diethyl 5,5'-disulfanediylbis(4-amino-3-methoxybenzoate) (3-28) 
 
To a 7 mL vial evacuated and purged with N2, ethyl-4-amino-3-halo-5-methoxy benzoate (223 
mg, 0.69 mmol) was added followed by addition of copper sulfate (11 mg, 10 mol%), cesium 
carbonate (1.1 g, 3.45 mmol) in DMSO (3 mL) were added. 1,2-ethanedithiol (98 mg, 1.04 mmol) 
was added dropwise under N2 to the above mixture. The mixture was stirred at 110 °C for 20 hours. 
The reaction mixture was quenched with 5% HCl and extracted with ethyl acetate. The organic 
layer was washed with water, brine and dried over sodium sulfate. Solvent was evaporated under 
reduced pressure and the crude product was purified with silica gel flash chromatography (40:60 
EtOAc:Hex). 116 mg, 74%. 1H NMR (400 MHz, CDCl3) δ 7.48 (d, 2H, J=1.6 Hz), 7.42 (d, 2H, 
J=1.6 Hz), 4.97 (s, 4H, N-H), 4.24 (q, 4H, J=7.2 Hz), 3.90 (s, 6H), 1.30 (t, 6H, J=7.2 Hz). 13C 










Ethyl 4-amino-3-mercapto-5-methoxybenzoate (3-27) 
 
To a solution of diethyl 5,5’-disulfanediylbis(4-amino-3-methoxybenzoate) (30 mg, 0.06 mmol) 
in water:acetonitrile (1:1, 5 mL) was added TCEP (tris(2-carboxyethyl)phosphine) (36 mg, 0.126 
mmol). The mixture was stirred at room temperature for 3 hours. Solvent was evaporated under 
reduced pressure to get the desired thiol. 28 mg, 93%. 1H NMR (400 MHz, CDCl3) δ 7.78 (d, 
1H, J=2.0 Hz), 7.39 (d, 1H, J=2.0 Hz), 4.33 (q, 2H, J=7.2 Hz), 3.90 (s, 3H), 2.96 (s, 1H, S-H), 
1.37 (t, 3H, J=7.2 Hz) ppm. 13C NMR (125 MHz, CDCl3) δ 166.17, 146.01, 143.48, 131.30, 
118.38, 112.11, 107.55, 60.74, 55.97, 14.30 ppm. HRMS (TOF MS ES+) m/z calculated 
([M+H]+) 228.1007 Da, found 228.1005 Da. 
2-(4-amino-3-mercapto-5-methoxyphenyl)acetonitrile (3-29) 
 
To a 7 mL vial evacuated and purged with N2, 2-(4-amino-3-halo-5-methoxyphenyl)acetonitrile 
(50 mg, 0.21 mmol) was added followed by addition of copper sulfate (4 mg, 10 mol%), cesium 
carbonate (367 mg, 1.15 mmol) in DMSO (1 mL) were added. 1,2-ethanedithiol (39 mg, 0.42 
mmol) was added dropwise under N2 to the above mixture. The mixture was stirred at 110 °C for 
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20 hours. The reaction mixture was quenched with 5% HCl and extracted with ethyl acetate. The 
organic layer was washed with water, brine and dried over sodium sulfate. Solvent was 
evaporated under reduced pressure and the crude product was purified with silica gel flash 
chromatography (40:60 EtOAc:Hex). 24 mg, 58%. 1H NMR (400 MHz, CDCl3) δ 6.94 (d, 1H, 
J=2.0 Hz), 6.62 (d, 1H, J=1.6 Hz), 4.26 (s, 2H, N-H), 3.98 (s, 2H), 3.86 (s, 3H), 1.58 (s, 1H, S-
H). 13C NMR (101 MHz, C3D6O) δ 146.50, 137.45, 129.60, 120.23, 117.97, 109.59, 82.42, 
55.94, 22.64 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 195.0592 Da, found 
195.0586 Da. 
Ethyl 5-methoxy-3,4-dihydro-2H-benzo[b][1,4]thiazine-7-carboxylate (3-30) 
  
To Ethyl 4-amino-3-mercapto-5-methoxybenzoate (9 mg, 0.04 mmol) and potassium carbonate 
(0.02 mmol) in DMF (0.4 mL) was added 1,2-dichloroethane or 1,2-dibromoethane (0.05 mmol). 
Mixture was stirred at 60 °C for 10 hours. DMF was evaporated under reduced pressure. The 
crude was washed with brine and extracted with ethyl acetate (3x 4 mL). The combined organic 
layer was dried over sodium sulfate and solvent was evaporated under reduced pressure. The 
crude product was purified with silica gel flash chromatography or HPLC. 7 mg, 71%. 1H NMR 
(400 MHz, CDCl3) δ 7.44 (d, 1H, J=2.0 Hz), 7.21 (d, 1H, J=1.6 Hz), 4.98 (s, 1H, N-H), 4.31 (q, 
2H), 3.88 (s, 3H), 3.75 (m, 2H), 3.02 (m, 2H), 1.36 (t, 3H). 13C NMR (125 MHz, CDCl3) δ 
163.19, 139.16, 130.93, 129.26, 116.91, 111.32, 109.32, 60.59, 55.68, 42.78, 36.90, 14.44 ppm. 




Ethyl 5-methoxy-2H-benzo[b][1,4]thiazine-7-carboxylate (3-31) 
  
To a solution of sodium hydride (9 mg, 0.04 mmol) in anhydrous THF (0.2 mL) was added 2-(4-
amino-3-mercapto-5-methoxyphenyl) (0.04 mmol) THF (0.2 mL) was added under N2 at 0 
oC. 
Reaction mixture was stirred at RT for 2 hours followed by addition of bromoacetaldehyde (0.05 
mmol) in THF (0.1 mL) and molecular sieves. The mixture was stirred at RT for 16 hours. The 
crude product was filtered through celite and purified with silica gel flash chromatography.6 mg, 
59%. 1H NMR (400 MHz, CDCl3) δ 9.06 (s, 1H), 8.30 (d, 1H, J=1.2 Hz), 7.61 (d, 1H, J=1.2 
Hz), 4.44-4.42 (m, 4H), 4.12 (s, 3H), 1.42 (t, 3H). 13C NMR (125 MHz, CDCl3) δ 167.95, 
143.92, 131.17, 126.02, 116.58, 111.20, 110.85 109.60, 58.47, 56.34, 24.54 ppm. HRMS (TOF 
MS ES+) m/z calculated for ([M+H]+) 252.0652, found 252.0654. 
2-(5-methoxy-4H-benzo[b][1,4] thiazine-7-yl)acetonitrile 
 
To a solution of sodium hydride (0.035 mmol) in anhydrous THF (0.2 mL) was added 2-(4-
amino-3-mercapto-5-methoxyphenyl) (0.04 mmol) THF (0.2 mL) was added under N2 at 0 
oC. 
Reaction mixture was stirred at RT for 2 hours followed by addition of bromoacetaldehyde (0.05 
mmol) in THF (0.1 mL) and molecular sieves. The mixture was stirred at RT for 16 hours. The 
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crude product was filtered through celite and purified with silica gel flash chromatography. 3 mg, 
41%. 1H NMR (400 MHz, CDCl3) δ 7.70 (d, 1H, J=3.2 Hz), 7.21 (d, 1H, J= 3.6 Hz), 7.01 (d, 
1H, J=1.6 Hz), 7.68 (d, 1H, J=1.6 Hz), 4.21 (s, 2H), 3.83 (s, 3H). 13C NMR (125 MHz, CDCl3) 
δ 143.50, 137.45, 135.91, 129.60, 128.70, 117.97, 113.25, 112.98, 106.59, 55.94, 24.64 ppm. 
HRMS (TOF MS ES+) m/z calculated for ([M+H]+) 219.0516, found 219.0512. 
Diethyl 5-methoxy-2H-benzo[b][1,4]thiazine-3,7-dicarboxylate (3-32) 
 
To a solution of sodium hydride (8 mg, .035 mmol) in anhydrous THF (0.2 mL) was added 2-(4-
amino-3-mercapto-5-methoxyphenyl) (0.035 mmol) THF (0.2 mL) was added under N2 at 0 
oC. 
Reaction mixture was stirred at RT for 2 hours followed by addition of ethyl bromopyruvate 
(0.05 mmol) in THF (0.1 mL) and molecular sieves. The mixture was stirred at RT for 16 hours. 
The crude product was filtered through celite and purified with silica gel flash chromatography.7 
mg, 66%. 1H NMR (400 MHz, CDCl3) δ 8.26 (d, 1H, J=1.2 Hz), 7.60 (d, 1H, J=1.2 Hz), 4.54 
(q, 2H), 4.44 (q, 2H), 4.11 (s, 3H), 3.90 (s, 2H), 1.46 (t, 3H), 1.43 (t, 3H). 13C NMR (125 MHz, 
CDCl3) δ 166.66, 143.75, 141.40, 139.41, 131.10, 125.70, 117.14, 112.35, 109.45, 60.82, 56.15, 





4 SYNTHESIS OF REGIOSELECTIVELY FUNCTIONALIZED EUMELANOIDS 
MIXED MELANOIDS AND THEIR PHOTOPHYSICAL STUDIES 
4.1 Introduction 
Mixed melanin such as neuromelanin are melanin biopolymer which contain conjugated 
pheomelanin and eumelanin units. Human neuromelanin is extracted from one of the following 
organelles: substantia nigra, putamen, premotor cortex, and cerebellum. The process involves 
multiple steps of gradient centrifugation.53 Access to these natural melanin have been limited to 
extraction and biosynthesis.53,121 Oligomerization of pheomelanin subunits in order to access 
intermediates to pheomelanogenesis has been done by D’Ischia.87,196 Similarly, oligomerization 
of eumelanin subunits, DHI and DHICA has been developed in order to access polydopamine 
based synthetic eumelanin for applications in polymer stabilization126,127, surface coating and 
bio-adhesion62,128, biosensing, nano particle and nanocapsule preparation for drug delivery, light 
harvesting and cell interfacing.62,66,125,129–135 Eumelanin and pheomelanin have unique 
photoprotective and material properties. Conjugation of eumelanin and pheomelanin subunits 
would form a synthetic subunit of mixed melanin. Oligomerization of this new type of melanin 
could have interesting photophysical and materials properties.  
Suzuki coupling has been used to couple brominated DHICA compounds to borylated aromatic 
species.73 However, brominated indoles have not been functionalized before in order to 
conjugate these species with halogenated aromatics via Suzuki coupling. One of the research 
goals of this project was to functionalize regioselectivity brominated eumelanin subunits- DMIC. 
This would be followed by coupling of these functionalized DHICA subunits with brominated 




Figure 4-1 Target synthetic mixed melanoid synthesized from synthetic monomeric subunits of 
pheomelanin and eumelanin. 
Functionalizing monomeric eumelanin units would be advantageous to couple them selectively 
with pheomelanin monomeric units such as benzothiazole and benzothiazine. In this work, 
monomeric eumelanin units of mono brominated DMIC were functionalized and coupled with 
benzothiazole. Benzothiazole with CO2Et sidechain was used as a model substrate to assess the 
coupling reactions which would yield a mixed melanoid. Once Suzuki coupling was shown to be 
successful to form the new C-C bond, benzothiazole with CH2CN sidechain was used, which 
would allow to access natural analogues of dopamine derived mixed melanin (potential 
monomeric subunit of neuromelanin) in future. 
4.2 Results and Discussion: 
Scheme 4-1 describes the two reaction pathways attempted to functionalize eumelanoid and 
conjugate it to benzothiazole. Initially aldehyde was installed at the 4’-position via lithiation of 
the 4’-bromo eumelanoid (3-8) using organolithium reagent followed by KI catalyzed coupling 





Scheme 4-1 Reaction pathways for mixed melanoid (4-4) synthesis. 
After several unsuccessful attempts of KI catalyzed coupling, Miyuara borylation of brominated 
DMIC compounds followed by Pd catalyzed Suzuki coupling was successfully used to access two 
different types of mixed melanin subunits.  
4.2.1 Eumelanoid functionalization  
Initial pathway to functionalize bromo-DMIC derivatives included installing aldehyde at the 
brominated position via lithiation. 4’-bromo DMIC was used as a model substrate. Using 
organolithium reagent n-BuLi followed by reaction with DMF (dimethylformamide) installed 
aldehyde at the 4’-position via electrophilic addition. The second step of this pathway was KI 
catalyzed coupling of aldehyde of 4’-eumelanoid and benzothiazole (ethyl ester sidechain in this 
case) in aqueous solution in presence of tert-butylhydroperoxide.11 I- or I2 would form tert-
butylperoxyl radical which would form the product via annulation. The mechanism of this reaction 
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was studied by controlled experiments by Gao et al and it has been shown in Figure 4-2 for 4’-
DMIC aldehyde and benzothiazole.11 Benzothiazole would react with water in presence of tert-
butyl hydroperoxide to give the dihydrobenzothiazole.  
 
Figure 4-2 Mechanism of KI catalysed coupling of benzothiazole with aromatic aldehyde.11 
Nitrogen of the benzothiazole reacts with benzaldehyde forming aminal (Figure 4-2) after 
nucleophilic addition and protonation. In the dehydration step, loss of water results in formation 
of Schiff’s base. Tert-butylperoxyl radicals promote formation of intermediate as they are being 
reduced. This unstable and reactive intermediate undergoes annulation resulting in formation of 
intermediate which after deprotonation results in desired product (Figure 4-2) with extended 
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conjugation. Lithiation step was done with 4’ and 7’ bromo DMIC (2-8 and 2-12) successfully, 
however the purification of the product was difficult and the yields of both these products were 
low (30%-55%). In addition, the 7’-aldehyde DMIC product (4-3) was observed to have butylester 
at indole ester position as compared to methylester sidechain in the starting material. The KI 
catalyzed coupling step was unsuccessful as significant amount of unreacted starting material was 
recovered after up to 24 to 48 hours into the reaction. Using a different organlithium reagent may 
have helped with increasing the yield of the first step. However, due to low yields in the lithiation 
step, failure to consume starting material in the coupling step and limited substrate scope (limited 
to BTZL) of KI-catalyzed coupling, a different reaction pathway was used.  
In this alternate pathway-Suzuki-Miyaura coupling was used to synthesize mixed melanoids. 
Bromo DMIC derivatives (2-8 ans 2-12) were borylated via Miyaura borylation followed by Pd 
catalyzed Suzuki coupling of the functionalized eumelanoid with bromobenzothiazole. 4’-bromo 
eumelanoid (2-8) was used as model substrate to assess and optimize the reaction conditions. 
Initially, borylation via lithiation was attempted but due to poor conversion of the starting material 
different Pd catalysts were utilized. Pd catalysts such as PdCl2(dppf), PdCl2(PPh3)2, Pd2(dba)3, and 
Pd(PPh3)4 were assessed to optimize borylation. Reactions were monitored with analytical-HPLC 
to observe consumption of starting material (2-8), formation of product (4-5), and formation of 
protodeboronated product (2-3) at different time points. Pd(PPh3)4 along with reaction conditions 
listed below were observed to be the optimized conditions to maximize conversion of 2-8 to 4-5 
and minimize the formation of 2-3. Reaction was monitored with analytical HPLC and mole 
fraction data were plotted for comparison.  Tetrakistriphenyl palladium- Pd(PPh3)4 in dioxane with 
potassium acetate base and bispinacolatodiboron as borylating agent yielded the best results. The 






Figure 4-3 Mole fractions of 4’-bromo DMIC (2-8) borylation reaction. (Calculated from HPLC 
data) 
As observed in Figure 4-3, in HPLC chromatograms, in addition to the starting material and 
product traces, a trace of Methyl 5,6-dimethoxyindole carboxylate (2-3) was observed. This could 
be due to protodeboronation of the starting material. However, this degradation was negligible for 

































Figure 4-4 Borylation and hydrolysis of pinacol ester monitored by HPLC. (C-18 stationary 
phase, Mobile phase gradient 50%:50% water:can to 100% AcN in 10 minutes) 
Crude of borylation reaction mixture was purified using C18 prep-HPLC. It was observed that 
after purification on C-18 with water:acetonitrile as mobile phase, the 4’-pinacol ester product(4-
5) had partially hydrolyzed into the 4’-boronic acid product(4-6). Figure 4-4 details HPLC 
chromatograms of reaction mixture at the beginning containing starting material (2-8) at 3.83 
minutes, crude at 36 hours shows pinacol ester product (4-5) at 4.28 minutes, and a mixed trace 
after purification which shows 4’-boronic acid product (4-6) at 1.81 minutes with 4’-pinacol ester 
product (4-5) at 4.28 minutes. For all of the HPLC traces in Figure 4-4, HPLC conditions including 
the C-18 column, temperature (30 ℃), and solvent gradient (50%:50% water AcN to 100% AcN 
in 10 minutes) were kept constant. Most of the prep-HPLC fractions contained 4’-boronic acid as 
the major product and non-hydrolyzed pincol ester as the minor product. Since boronic acid 
functionalized aromatics are known to be more reactive in Suzuki coupling, 4’-pinacol ester 
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product (4-5) was hydrolyzed to 4’-bronic acid (4-6) in 50:50 water:AcN at RT in 24 hours. 4-6 
was used for Suzuki coupling reactions. 
 
Figure 4-5 Borylation of 7’-bromo DMIC (2-11). 
Similar to 4’-bromo DMIC (2-8) borylation to syntheize 4’-boronic acid product (4-6), borylation 
of 7’-bromo DMIC (2-11) was performed using Pd catalyst to install pinacol ester (4-8). 7’-pinacol 
ester product (4-8) as shown in Figure 4-5, was hydrolyzed using 1:1 water:acetonitrile in 24 hours 
to yield 7’-boronic acid product (4-9) in 77% yield over 2 steps. These reactions were monitored 
with analytical HPLC (Figure D-1, Appendix D) and showed similar trend as 2-8 borylation, with 
starting material (2-11) retention at 4.25 minutes, 7’-pinacol ester product (4-8) retention at 5.01 
minutes, and 7’-boronic acid product (4-9) retention at 1.90 minutes. 7’-boronic acid product (4-
9) was used in Suzuki coupling. 
Borylation of 3’-bromo DMIC (2-4) was attempted using several reaction conditions as significant 
protodeborylation was observed in these reactions. Reactions were monitored with C-18 analytical 
HPLC. An example HPLC chromatogram (Figure D-2, Appendix D), which shows HPLC traces 
for 3’-bromo DMIC starting material (2-4) at 2.94 minutes, protodeboronated product (2-3) at 2.24 
minutes, and desired 3’-borylated product (4-7) at 3.33 minutes. For each reaction, small fractions 
were taken out every 4 hours and HPLC conditions including the C-18 column, temperature (30 
℃), and solvent gradient (50%:50% water AcN to 100% AcN in 10 minutes) were kept constant. 
Mole fractions of the optimization experiments with variable changes have been shown in Table 
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4-1. Temperature optimization was done with PdCl2(dppf) catalyst and dioxane as solvent. All 
three reactions were running at the same indole concentration (0.28 M) and for the same duration.  
 
Figure 4-6 3’-borylation reaction monitored by analytical HPLC. 
Table 4-1 3’-borylation reaction optimization and relevant mole fractions (from HPLC data). 













(dppf) Dioxane 24 0.048 0.012 0.94 
2 50 °C PdCl
2
(dppf) Dioxane 24 0.53 0.04 0.43 
3 50 °C Pd(PPh3)4 Dioxane 24 0.35 0.076 0.57 
4 100 °C PdCl
2
(dppf) Dioxane 24 0.93 0.029 0.041 
5 100 °C Pd2(dba)3 
X-phos 
Dioxane 24 0.28 0.03 0.69 
6 100 °C Pd(PPh3)4 Dioxane 24 0.76 0.03 0.21 




 THF 24 0.11 0.09 0.80 
8 65 
o
C Pd(PPh3)4 THF 36 0.30 0.12 0.58 
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As observed by the trend in mole fractions of each compound, the product formation increases as 
the temperature is increased initially as the SM conversion is observed to increase, however it 
lowers at high temperature (100 °C). Most importantly, the amount of protodeboronated product 
increases as the temperature is increased. This indicates that the rate of borylation is much slower 
than protodeboronation under the reaction conditions. Consistent catalytical loading (5 mol%) was 
done with other Pd catalysts used [Pd(PPh3)4 and Pd2(dba)3 with X-phos] while keeping the 
reaction conditions same. Both of these catalysts gave similar yield of the product, however, 
Pd(PPh3)4 resulted in higher conversion of SM compared to slower reaction of Pd2(dba)3. Despite 
generation of higher debrominated product, following higher conversion of SM and better 
borylation yields in previous indole borylation, Pd(PPh3)4 was utilized as the catalyst and 
conditions were further optimized. Solvent was changed to THF in order to increase solubility and 
reflux temperature (65 °C) was used for these optimizations. Entry 8 in Table 4-1 indicates the 
optimized conversion of SM to desired borylated product and recovered yield was ~10%. A 
parallel reaction was ran for 60 hours and monitored with HPLC, but it indicated degradation of 
product to deboronated compound. Borylation of 3’-bromo DMIC (2-4) needs to be further 
optimized in future possibly with different bases or catalysts, and the mechanism of 
protodeboronation could be studied. 
 
Figure 4-7 Borylation of bromobenzothiazole (3-14). 
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In order to circumvent the protodeboronation problem of 3’-borylation, and to access 3’-
conjugated mixed melanoid, borylation of bromobenzothiazole was attempted. Borylation of 
bromo-BTZL (3-14) was attempted using Pd(PPh3)4 and PdCl2(dppf) as catalyst with similar 
reaction conditions to bromo-DMIC borylation. Reactions were monitored with HPLC, and it was 
observed that pinacol ester of the BTZL is generated as a minor product (22%) with the major 
product (63%) being the protodeboronation product of BTZL (3-13). Pinacol ester could be 
converted to boronic acid BTZL (4-13) in 77% yield. Borylation reaction of bromo-BTZL (3-14) 
needs to be optimized in a future study to access 3’-DMIC conjugated mixed melanoid. 
4.2.2 Mixed melanoid synthesis via Suzuki Coupling: 
 
 
Figure 4-8 Mechanism of Suzuki coupling. 
Mixed melanoid synthesis was carried out with 4’-and 7’-boronic acid compounds as they were 
conjgated with pheomelanoids using Suzuki coupling. Bromobenzothiazole (3-11) was used as a 
model monomeric pheomelanin substrate due to ease of synthesis and scalability. Mechanism of 
Pd catalyzed Suzuki coupling is shown in Figure 4-8. Bromobenzothiazole (3-11) would 
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oxidatively add to Pd(0) as it oxidizes to Pd(II) during oxidative addition. In transmetallation step, 
in presence of base-potassium phosphate (tribasic) 4’-boronic acid DMIC (4-6) adds to the metal 
complex as the boronic acid halogenates resulting in both the aryl compounds complexed to the 
Pd(II) metal. In the reductive elimination step, the new C-C bond is formed between the aryl 
compounds (4-6 and 3-11) as the mixed melanoid compound (4-10) is generated resulting in 
restoration of Pd oxidation state Pd(0).  
 
Figure 4-9 Suzuki coupling to synthesize mixed melanoids. 
Suzuki coupling was done successfully on 4’-boronic acid DMIC, where it was coupled with 
bromobenzothiazole (R=CO2Et or CH2CN) in presence of Xphos Pd G2 catalyst with yields of 
96% (R=CO2Et) and 88% (R=CH2CN). Products were characterized using combination of NMR 
experiments including 1D NMR experiments such as 1H, 13C and 2D NMR experiments such as 
COSY, HSQC, and HMBC. 2D HMBC was key in characterizing and confirming the 
conjugation of the melanoids. A specific section of HMBC spectra of  ethyl 2-(5,6-dimethoxy-2-





Figure 4-10 2D HMBC (Indole proton-focused) of mixed melanoid [ethyl 2-(5,6-dimethoxy-2-
(methoxycarbonyl)-1H-indol-4-yl)-4-methoxybenzo[d]thiazole-6-carboxylate] (4-4). 
Correlation of indole proton(1H shift-7.61 ppm-highlighted red) to the neighboring carbons(13C) 
is observed. The correlation and as a result the signal becomes weaker as the bond distance 
between the proton and the carbon increases. HMBC does not show one bond correlation, however 
two (2JCH) to three bond correlation (
3JCH) are commonly observed. Two bond correlation (
2JCH) 
(highlighted green) were observed between the indole proton and the neighboring aromatic 
carbons. Three bond correlation (3JCH) (highlighted blue) were observed between indole proton 
and two aromatic carbons as well as the carbonyl carbon of the methyl ester. Four bond 
correlations(4JCH) are rare in HMBC, but it was observed (highlighted red) for the indole proton 
correlating to the benzothiazole carbon of the conjugated benzothiazole. This analysis along with 
the NMR analysis mentioned above confirmed the formation of mixed melanoids. 7’-boronic acid 
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DMIC (4-9) was coupled with bromo-BTZL (3-14) via Suzuki coupling resulting in 7’-conugated 
mixed melanoid (4-11) in 70% yield. Once the mixed melanoids (4-4, 4-10 and 4-11) were 
accessed, initial photophysical properties of these compounds were studied using spectramax i3 
spectrophotometer. 
4.2.3 UV-Vis and Fluroscence properties of mixed melanoids 
Overlayed UV-vis spectra of 5,6-DMIC (2-3), benzothiazole (3-13), and their mixed melanoid 
(4-10) has been shown in Figure 4-11. Broad absorption spectra are characteristic of melanin 
derivatives. Absorption at 260 nm and 280 nm were observed as λmax for BTZL (3-13) and 5,6-
DMIC (2-3) respectively. Mixed melanoid (4-10) is a conjugate of 3-13 and 2-3, and it shows 
absorbance 280 nm however, the λmax was observed at low energy UV wavelength 360 nm 
resulting from extended aromaticity of the conjugated system.  
 
Figure 4-11 UV-Vis absorbance of 5,6-DMIC (2-3), BTZL (3-13), and their mixed melanoid (4-
10)- 50 µM in ethanol. 
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Similar UV-Vis absorption spectra were observed for mixed melanoids 4-4 and 4-11. For 
compound 4-4 (Figure E-1, Appendix E) absorption peaks were observed at 280 nm and λmax at 
350 nm and another absorption peak (shoulder) at 390 nm. For compound 4-11 (Figure E-3, 
Appendix-E), which contains the same sidechain (CH2CN) in the pheomelanoid unit as 4-10, 
UV-Vis absorption spectrum showed peaks at 280 nm. λmax was observed at low energy UV 
wavelength 350 nm and an absorption band (shoulder) at 380 nm similar to 4-10. 
 
Figure 4-12 Fluorescence spectra of 4-10. 
Preliminary fluorescence properties of mixed melanoids (4-4, 4-10 and 4-11) were studied. All 
three of these mixed melanoid products visibly luminesce under 365 nm light source. As shown 
in excitation-emission spectra of compound 4-10 in Figure 4-12, excitation at 280 nm and 360 
nm results in emission at 425 nm. Similarly, as described in Figure E-2 (Appendix E), compound 
4-4 exhibits luminescence (emission) at 455 nm upon excitation at 280 nm and 354 nm; and 
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compound 4-11 (Figure E-4, Appendix E) exhibits luminescence (emission) at 450 nm upon 
excitation at 280 nm and 350 nm. These luminescence results of a synthetic mixed melanin 
dimer are comparable to those of synthetic eumelanin solution where excitation at 360-380 nm 
showed emission at 460-480 nm.160 However, synthetic eumelanin solution exhibited excitation 
wavelength dependent emission as it breaks Kasha’s rule, and emission spectra does not mirror 
the respective absorption spectra violating the mirror image rule.160,197 As shown in Figure 4-12, 
luminescence spectra of 4-10 follows Kasha’s rule where emission is independent of excitation 
wavelength as it stays constant (420 nm) for two different excitation wavelengths (280 nm and 
360 nm) resulting from photon transfer from lowest excitation state S1 to ground state S0.
197 In 
addition, it follows the mirror image rule for organic chromophores as the emission spectra (ex-
280 nm and 360 nm) mirror the absorbance wavelengths. This preliminary data indicates that 
these mixed melanoid compounds possess interesting photophysical properties which can be 
studied further for materials applications, and these compounds can be studied as organic 
chromophores.  
4.3 Conclusion and future direction: 
Eumelanin subunit (5,6-DMIC) functionalization and conjugation with pheomelanin subunit 
(benzothiazole) was attempted using KI catalyzed coupling and Suzuki-Miyaura coupling. 
Miyaura borylation was successful in functionalizing 4’-bromo DMIC as it was borylated to 
form 4’-boronic acid DMIC in 61% yield over 2 steps. 7’-bromo DMIC was borylated to form 
7’-boronic acid DMIC with 77% yield over 2 steps. Functionalized Eumelanin DMIC subunit 4-
6 was coupled with bromobenzothiazole via Pd catalyzed Suzuki coupling to synthesize mixed 
melanin subunit with CO2Et and CH2CN sidechain with 96% and 88% yields respectively. 7’-
boronic acid DMIC was coupled with in similar manner to synthesize 7’-functionalized mixed 
melanoid in 70% yield. Structures of these compounds were confirmed with 1D and 2D NMR as 
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well as HRMS. Preliminary photophysical data was collected to study UV absorbance and 
luminescence behavior. Mixed melanin subunits exhibit broad absorption bands in UV-Vis 
absorption spectra with λmax ~360 nm, and luminescence at 425 nm resulting from extended 
conjugation of the heteroaromatic system. 
This work can be extended further to resolve the limitations regarding the substrate scope by 
functionalizing 3’-bromo DMIC and bromobenzothiazole by borylation for it to be used in 
Suzuki coupling. In addition, synthesis and functionalization of 5,6-dimethoxyindole (5,6-DMI) 
would give access to the 5,6-dihydroxyindole (DHI) mixed melanins. These would give access to 
a variety of dimeric, trimeric, and tetrameric mixed melanin subunits. In addition, deprotection 
via sidechain hydrogenation of pheomelanin subunit, saponification of methyl ester, and 
demethylation of methoxy groups of mixed melanoids would result in formation of natural 
analogues of mixed melanin subunits which could be key intermediates in melanogenesis of 
neuromelanin. To further explore the applications of these N-heterocycles for as organic 
chromophores, the next step should be a detailed study of their photophysical properties. 
4.4 Synthesis 
4.4.1 General Synthetic procedure: 
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly without 
further purification. Solvents were dried with activated 4 Ao molecular sieves or anhydrous 
solvents were dispensed from Solvent system. Reactions were monitored by TLC or analytical 
HPLC. All products were purified with silica-gel flash chromatography or preparative HPLC. 
HPLC was performed on a Gilson analytical to semi-preparative system using Kinetex 5 µm EVO 
C18 100Å 4.6 x 150 mm for analytical and Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for 
preparative purpose. Products were characterized by 1H and 13C NMR and mass spectrometry. 
NMR characterization results and J values were compared with published results. 1H and 13C NMR 
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spectra were recorded on Agilent/Varian 400 MHz or Bruker Neo 500 MHz and 101 MHz NMR 
spectrometer, respectively. Mass spectra were recorded using a Synapt G2 Q-TOF ESI mass 
spectrometer at the Mass Spectrometry Lab at the University of Illinois Urbana Champagne.  
Abbreviations: TLC-Thin layer chromatography, HPLC-High Performance Liquid 
Chromatography, NMR-Nuclear Magnetic Resonance, Q-TOF-Quadrupole time of flight, ESI-
Electrospray ionization 
4.4.2 Conjugation via oxidation: 
Methyl 4-formyl-5,6-dimethoxy-1H-indole-2-carboxylate 
    
To a stirred solution of methyl 4-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (19 mg, 0.06 
mmol) in dry THF (0.6 mL) at -78 °C under N2 was added 2.5 mM n-BuLi (0.30 mmol, 5 eq.) 
dropwise. The reaction mixture was stirred at room temperature for 2 hours and 
dimethylformamide (0.30 mmol) was added at 0 °C. The reaction mixture was stirred at room 
temperature for 5 hours. Ice pieces were added to the reaction mixture followed by 1N HCl (~1 
mL) and extracted with ethyl acetate (3x10 mL). The combined organic layer was dried over 
sodium sulfate and solvent was evaporated under reduced pressure. The crude product was 
purified with silica gel flash chromatography (30:70 EtOAc:Hex). 9 mg, 55%. 1H NMR (400 
MHz, CDCl3) δ 10.64 (s, 1H), 8.13 (s, 1H, N-H), 7.22 (d, 1H, 2.0 Hz), 7.15 (s, 1H), 3.97 (s, 3H), 







To a stirred solution of To a stirred solution of To a stirred solution of methyl 7-bromo-5,6-
dimethoxy-1H-indole-2-carboxylate (15 mg, 0.049 mmol) in dry THF (0.4 mL) at -78 °C under 
N2 was added 2.5 mM n-BuLi (0.24 mmol, 5 eq.) dropwise. The reaction mixture was stirred at 
room temperature for 2 hours and dimethylformamide (17.5 mg, 0.24 mmol) was added at 0 °C. 
Mixture was stirred at room temperature for 5 hours. Ice pieces were added to the reaction 
mixture followed by 1N HCl (~1 mL) and extracted with ethyl acetate (3x5 mL). The combined 
organic layer was dried over sodium sulfate and solvent was evaporated under reduced pressure. 
The crude product was purified with silica gel flash chromatography (20:80 EtOAc:Hex). Yield-
6 mg, 38%. 1H NMR (500 MHz, CDCl3) δ 10.54 (s, 1H), 10.02 (s, 1H, N-H), 7.40 (s, 1H), 6.18 
(d, 1H, 2.0 Hz), 4.02 (s, 3H), 3.93 (s, 3H), 1.31-1.18 (m, 9H) ppm. 
Conjugation (Failed) 
 
To a 7 mL scintillation vial were added methyl 4-formyl-5,6-dimethoxy-1H-indole-2-carboxylate  
(4 mg, 0.015 mmol), ethyl 4-methoxybenzo[d]thiazole-6-carboxylate (2.5 mg, 0.01 mmol), tert-
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butyl hydroperoxide (70% aq., 0.03 mmol), potassium iodide (0.001 mmol, 10 mol%) and water 
(0.3 mL). Mixture was heated at 100 °C for 24 hours. Starting material was not consumed as 
monitored by TLC and crude NMR. Acetonitrile (0.2 mL) was added and mixture was stirred at 
85 °C for 18 hours.  
Methyl 5,6-dimethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-
carboxylate   
 
To a mixture of methyl 4-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (70 mg, 0.224 mmol), 
tetrakis(triphenylphosphine)palladium(0) (13 mg, 0.0112 mmol, 0.05 eq.), potassium acetate (66 
mg, 0.672 mmol, 3 eq.), and bis(pinacolato)diboron (74 mg, 0.291 mmol, 1.3 eq.) evacuated and 
purged with N2 was added dry-dioxane (0.4 mL) under N2. The mixture was stirred at 100 
oC for 






The crude mixture from the borylation reaction was stirred in water:acetonitrile (1:1, 5 mL) for 
24 hours. Solvent was evaporated and the crude product was purified with prep-reverse phase 
HPLC. After purification prep fractions containing product were analyzed using NMR and 
analytical HPLC. 38 mg, 61%.  1H NMR (500 MHz, C3D6O) δ 10.66 (s, 1H), 7.71 (s, 1H), 7.51 
(s, 2H), 7.21 (s, 2H), 3.92 (s, 3H), 3.89 (s, 3H), 3.86 (s, 3H) ppm. 13C NMR (125 MHz, C3D6O) 
δ 162.79, 152.67, 135.71, 127.20, 125.37, 112.66, 108.97, 103.73, 98.47, 61.97, 56.05, 51.72 
ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 280.0992 Da, found 280.0986 Da. 
Methyl 5,6-dimethoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-
carboxylate 
 (Reaction conditions are listed in Table 4-1)   
General procedure: To a mixture of methyl 3-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (20 
mg, 0.064 mmol), Pd(0) catalyst (13 mg, 0.0112 mmol, 0.05 eq.), base (1.7- 3 eq.), and 
bis(pinacolato)diboron (19.5 mg, 0.077 mmol, 1.2 eq.) evacuated and purged with N2 was added 
dry-dioxane or THF (0.3 mL) under N2. Mixture was stirred at (a temp. between room 








carboxylate   
 
To a mixture of methyl 7-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (12 mg, 0.038 mmol), 
tetrakis(triphenylphosphine)palladium (0) (2.2 mg, 0.0019 mmol, 0.05 eq.), potassium acetate 
(11 mg, 0.114 mmol, 3 eq.), and bis(pinacolato)diboron (13 mg, 0.05 mmol, 1.3 eq.) evacuated 
and purged with N2 was added dry-dioxane (0.2 mL) under N2. The mixture was stirred at 100 
oC 
for 36 hours. Reaction was monitored by HPLC. The catalyst was filtered, and the crude was 
used for hydrolysis. 
(5,6-dimethoxy-2-(methoxycarbonyl)-1H-indol-7-yl)boronic acid 
 
The crude mixture from the borylation reaction was stirred in water:acetonitrile (1:1, 5 mL) for 
24 hours. Solvent was evaporated and the crude product was purified with prep-reverse phase 
HPLC. After purification prep fractions containing product were analyzed using NMR and 
analytical HPLC. 8 mg, 77%. 1H NMR (500 MHz, C3D6O) δ 10.09 (s, 1H), 7.79 (s, 1H), 7.40 
(s, 1H), 7.09 (s, 3H), 3.98 (s, 3H), 3.91 (s, 3H), 3.89 (s, 3H) ppm.  13C NMR (125 MHz, C3D6O) 
δ 162.43, 156.46, 149.16, 132.60, 129.42, 127.79, 124.04, 108.72, 108.17, 62.01, 56.38, 52.00 






To a 7 mL vial were added XPhosPdG2(4 mol%), (5,6-dimethoxy-2-(methoxycarbonyl)-1H-
indol-4-yl) boronic acid (0.021 mmol), ethyl 2-bromo-4-methoxybenzo[d]thiazole-6-carboxylate 
(0.0216 mmol, 1.03 eq.). The vial was evacuated and purged with N2 followed by addition of 
1,4-dioxane (0.35 mL) and 0.5 M potassium phosphate tribasic (3 eq.). The reaction mixture was 
heated at 75 ℃ for 5 hrs. The reaction mixture was quenched with water (4 mL) and extracted 
with ethyl acetate (5x4 mL), dried with sodium sulfate and solvent was evaporated under 
reduced pressure. The crude product was purified with silica gel flash chromatography (50:50 
EtOAc:Hex). 9 mg, 96%. 1H NMR (500 MHz, CDCl3) δ 9.10 (s, 1H, N-H), 8.43 (d, 1H, J=2.0 
Hz), 8.29 (d, 1H, J=1.5 Hz), 7.59 (d, 1H, J=1.5 Hz), 7.04 (s, 1H), 4.43 (q, 2H), 4.17 (s, 3H), 
3.99 (s, 3H), 3.98 (s, 3H), 3.95 (s, 3H), 1.43 (t, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 
166.52, 164.23, 162.45, 153.23, 152.37, 145.89, 145.52, 137.08, 133.95, 128.10, 127.28, 119.63, 
119.17, 115.72, 112.14, 107.34, 97.32, 61.28, 60.96, 56.41, 56.22, 51.92, 14.42 ppm. HRMS 








To a 7 mL vial were added XPhosPdG2(4 mol%), (5,6-dimethoxy-2-(methoxycarbonyl)-1H-
indol-4-yl) boronic acid (0.021 mmol), 2-(2-bromo-4-methoxybenzo[d]thiazol-6-yl)acetonitrile 
(0.0216 mmol, 1.03 eq.). The vial was evacuated and purged with N2 followed by addition of 
1,4-dioxane (0.35 mL) and 0.5 M potassium phosphate tribasic (3 eq.). The reaction mixture was 
heated at 75 oC for 6 hrs. The reaction mixture was quenched with water (4 mL) and extracted 
with ethyl acetate (5x4 mL), dried with sodium sulfate and solvent was evaporated under 
reduced pressure. The crude product was purified with silica gel flash chromatography (50:50 
EtOAc:Hex). 8 mg, 88%. 1H NMR (500 MHz, CDCl3) δ 8.85 (s, 1H, N-H), 8.41 (d, 1H, J=2.0 
Hz), 7.52 (d, 1H, J=1.5 Hz), 7.02 (s, 1H), 6.85 (d, 1H, J=1.5 Hz), 4.16 (s, 3H), 4.00 (s, 3H), 3.99 
(s, 3H), 3.96 (s, 3H), 3.91 (s, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ 152.44, 142.72, 128.99, 
128.97, 128.77, 128.40, 127.86, 127.19, 126.02, 119.73, 112.53, 112.10, 106.82, 96.90, 61.00, 
56.47, 56.20, 51.90, 24.11 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 438.1124 Da, 










To a 7 mL vial were added XPhosPdG2(4 mol%), (5,6-dimethoxy-2-(methoxycarbonyl)-1H-
indol-7-yl) boronic acid (0.015 mmol), 2-(2-bromo-4-methoxybenzo[d]thiazol-6-yl) acetonitrile 
(0.0155 mmol, 1.03 eq.). The vial was evacuated and purged with N2 followed by addition of 
1,4-dioxane (0.35 mL) and 0.5 M potassium phosphate tribasic (3 eq.). The reaction mixture was 
heated at 75 ℃ for 6 hrs. The reaction mixture was quenched with water (4 mL) and extracted 
with ethyl acetate (5x4 mL), dried with sodium sulfate and solvent was evaporated under 
reduced pressure. The crude product was purified with silica gel flash chromatography (50:50 
EtOAc:Hex). 5 mg, 70%. 1H NMR (500 MHz, CDCl3) δ 8.83 (s, 1H, N-H), 8.43 (d, 1H, J=2.0 
Hz), 7.49 (d, 1H, J=1.5 Hz), 7.06 (s, 1H), 6.90 (d, 1H, J=1.5 Hz), 4.11 (s, 3H), 3.99 (s, 3H), 3.98 
(s, 3H), 3.94 (s, 3H), 3.92 (s, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ 153.16, 143.50, 129.79, 
129.42, 128.27, 128.05, 126.89, 127.19, 126.51, 118.93, 112.95, 112.50, 107.20, 96.90, 61.49, 
56.92, 56.65, 52.15, 24.60 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 438.1124 Da, 





5 SYNTHESIS, STRUCTURE AND PHOTOPHYSICAL PROPERTIES OF METAL 
DICYANIDE DONORS COORDINATED TO AZA[5]HELIZENE VIOLOGEN 
ACCEPTORS 
5.1 Introduction  
This chapter describes our collaborative work with HHP group (UMaine) on synthesis and study 
of 2D network of gold-heli viologen as published in Dalton Transactions.199 Viologens are redox 
active, strong electron accepting diquaternary salts of 4, 4’-bipyridine with the ability to form ion-
pair charge transfer complexes (IPCT) with donors such as dicyanoaurate. Charge transfer 
properties of IPCT can be applied in photochromic and electrochromic devices.200–203 The 
photoreduction properties of viologens have been known for several years with applications as 
herbicides, photocleaving agents, and electronic devices. However, the photophysical and 
photochemical properties of viologens are mostly unexplored.141 Phenylviologens such as 1,1’-
bis-(2,4-dinitrophenyl)-4,4’-bipyridinium (DNP2+) have shown desirable optical and electronic 
properties due to extended π conjugation.150,204 The π–π stacking interactions of phenyl viologens 
are being explored in chemistry and biology due to its effect on the photophysical properties of 2D 
and 3D networks.205 In conjunction, dicyanoaurate(I) complexes are also of interest as they form 
one of the most stable two coordinate complexes, with reports of high stability constants as well 
as potential applications in semiconductor materials and photonic devices.147,148 Dicyanoaurate(I) 
has also unique geometric and charge-transfer properties as the d10 Au(I) metal center favors 
aurophilic interactions and aggregation of [Au(CN)2
−]n
−, which allow tuning of the optical 
properties.149,150 Due to their strong electron accepting potential, viologens are luminescence 
quenchers of triplet metal-to-ligand charge transfer (MLCT) luminescence in complexes 




Figure 5-1 Previously studied DNP viologen and target Gold-heli viologen (5-13). 
In previous studies by HHP group at University of Maine, low energy phosphorescence was 
observed from a 3D network consisting of DNP2+ coupled with dicyanoaurate(I) dimers (Figure 
5-1).150 These results were surprising given that DNP2+ is non-luminescent in its free state. The 
observed luminescence in this complex revealed unique photophysical properties that were 
attributed to an IPCT transition arising from the heavy atom effect due to gold-viologen orbital 
overlap.150,206 It would be interesting to study the photochemical interaction of other methylated 
phenyl viologens which possess extended π conjugation and are luminescent in the free state with 
dicyanoaurate(I).  
5,10-dimethyl-5,10-diaza[5] helicene bis-tetrafluoroborate viologen was synthesized a few years 
ago and the synthetic route has recently been optimized.141,206 In addition, it is one of the few 
viologens known which has chirality due to the helical aromatic heterocycle.141,207 It was shown 
that this compound has energy holding abilities and is a good electron transfer contender due to its 
Ve being greater than Vh (electronic coupling for electron and hole respectively).208 The 
conductivity spectra and refractive index of this viologen highlighted its ability of high intra/inter 
molecular charge transfer within the crystal and ability to yield significant outputs with low input.  
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In this work, we extend the previous work of HHP group on methyl viologen (MV2+) systems by 
synthesizing 5,10-dimethyl-5,10-diaza[5]helicene (heli-viologen2+) and coupling it with two 
molecules of [Au(CN)2]
− to form complex 8 as shown in Figure 5-1. Synthesis and characterization 
of the N,N-dimethylaza[5]helicene dicyanoaurate (Au and Ag salts) complex was done using 
nuclear magnetic resonance (NMR). The crystal structure of Au heli-viologen was determined by 
single crystal X-ray diffraction. Optical properties of this complex were studied using temperature 
variable photoluminescence, diffuse reflectance spectroscopy (DRS), and Stern–Volmer analysis. 
Density Functional Theory (DFT) calculations were performed to assist with interpretation of the 
experimental data. 
5.2 Results and Discussion 
5.2.1 Synthesis 
 
Scheme 5-1 Retrosynthetic scheme for viologen synthesis. 
In order to access the Gold and silver heli-viologens, the key intermediate was quinolyl-E-stilbene, 
which can be cyclized to form the aza-helicene structure. As shown in Scheme 5-1, aza-helicene 
can be methylated to get MV2+ species of the desired viologen, which can be coupled with gold or 
silver anionic species to get the desired metal-heli viologens. The key intermediate, quinolyl-E-
stilbene was initially synthesized from stepwise wittig route, and the method was improved by 




Scheme 5-2 Step-wise Wittig route to access quinolyl-E-stilbene (5-5). 
As shown in Scheme 5-2, stilbene intermediate (5-5) was synthesized in four steps from quinoline-
3-carbaldehyde (5-1) via Wittig reaction.13 5-1 was reduced with sodium borohydride to yield 
primary alcohol of quinoline followed by chlorination using thionyl chloride to access 5-3. In order 
to perform Wittig reaction, Wittig salt (5-4) was synthesized from 5-3. Wittig reaction of 5-4 with 
aldehyde 5-1 resulted in formation of the new C-C bond resulting in quinolyl-E-stilbene (5-5). 
Overall yield of this four-step route was ~20% due to poor yields at Wittig salt synthesis and Wittig 
reaction steps. One of the major reasons for product loss was due to difficulty in silica gel 
purification of product 5-5 due to presence of triphenylphosphine oxide. To improve the yield and 
efficiency of stilbene (5-5) synthesis, Pd catalyzed Stille coupling was explored. To perform Stille 
coupling, bis-tributylstannyl ethylene linker (5-8) was required, which was synthesized from 




Table 5-1 Catalyst optimization for Stille coupling. 
































Reaction condition optimizations were done in order to improve the yield of 5-5. Table 5-1 shows 
the reaction conditions and catalyst optimization reactions for Stille coupling. Reaction conditions 
shown above with Pd2(dba)3 as Pd(0) catalyst and X-phos as the ligand were the optimized 
condition resulting in 57% of the desired product. Later, Pd(II) catalyzed Hiyama–Heck cross-
coupling was used with triethoxyvinylsilane to get better scalability and higher yield (91%) as 
shown by Clennan and coworkers in 2016.141 
 
Figure 5-2 Photocyclization mechanism of 5-5. 
Following the synthesis of Stilbene intermediate (5-5), photocyclization was done to synthesize, 
5,10-Diaza[5]helicene (5-9). As described by Woodward-Hoffman rules of cyclization, 4n+2 
cyclization of 5-5 is conrotatory and as a result is photochemically allowed.209 Figure 5-2 
described the mechanism of photocyclization to synthesize 5-9. Several photocyclization 




Figure 5-3 UV-Vis absorption spectrum of 5-5 
Table 5-2 Light source optimization for photocyclization of 5-5 






Incandescent Lamp 600 48-52  90% 65% 
Halogen Flood lamp 5000 55-60 86% 63% 
Photo reactor (350 nm) 24000 4-6  100% 73% 
 
Table 5-2 shows different light sources used to optimize photocyclization reaction yields. 
Photocyclization generates desired product 5-9 and a side product 5-10. As shown in Table 5-2, 
incandescent lamp and halogen flood lamp gave good conversion and yield of the desired 
product, however the reaction times were longer, and reproducibility was inconsistent due to low 
amount of UV emitted by these light sources. Photocyclization in a photoreactor (350 nm), 
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which was equipped with a magnetic stir plate, and cooling fan to minimize the heating resulted 
in 100% conversion and 71% yield of the desired product in 4 to 6 hours.  
 
Scheme 5-3 Gold-heli viologen (5-13) synthesis. 
Subsequently, Methylation of 5-9 with trimethyloxonium tetrafluoroborate under nitrogen 
produced the BF4 salt of heli[5]viologen (5-11) which was purified with preparative HPLC. In 
order to couple the heli viologen with gold or silver dicyanide, the reaction needed to be done in 
aqueous solution. Due to the limited solubility of 5-11 in aqueous solvents, the tetrafluoroborate 
counterion was exchanged for chloride counterions using DOWEX ion-exchange resin. The 
chloride heli-viologen (5-12) showed high solubility in aqueous solvents and was further reacted 
with potassium dicyanoaurate to produce gold-coupled viologen, 5-13 in powder form. The 
powder was dried and used for luminescence experiments. Three crystallization methods were 
attempted in order to get single crystals for X-ray crystallography: Slow evaporation, liquid-liquid 
diffusion, and vapor diffusion method. Among which vapor diffusion using the solvent 




Figure 5-4 Single crystal synthesis via vapor-diffusion method. 
The crystallization conditions via a vapor diffusion method for Au heli-viologen (5-13) were 
optimized and methanol: n-hexane and ethanol: cyclohexane were used as solvent : anti-solvent to 
get single crystals for X-ray diffraction analysis.210  
5.2.2 Single crystal X-ray diffraction 
The solid state structure of Au heli-viologen crystallized in the centrosymmetric monoclinic space 
group C2/c and contained one viologen dication and two [Au(CN)2]
- anions on general positions 
as the elements of the asymmetric unit (Figure 5-5). When looking into the bc-plane of the unit 
cell, one of the [Au(CN)2]
- anions lies perpendicular to this plane (and parallel to the a-axis) at a 
distance of 3.3773(6) Å between the Au(I) atom of the dicyanoaurate anion and the centroid of the 
aromatic ring sitting at the turn of the right-handed helical viologen. Typically, dicyanoaurate 
anions are linear with N–Au–N angles approaching 180°; however within the structure of Au heli-
viologen, the [Au(CN)2]
- anion lying above the turn of the helicate deviates from linearity, showing 
an N–Au–N angle of 174.0(3)°.211 Such a deviation from linearity can be rationalized upon the 
application of symmetry to the asymmetric unit. After applying crystallographic symmetry, this 
dicyanoaurate anion dimerizes with itself and supports the formation of a bond between the 
monovalent gold atoms at a distance of 3.3098(11) Å, a value on par with those published in a 




Figure 5-5 View along the a-axis of Au heli-viologen crystal. The dotted lines show dimer 
interactions among adjacent [Au(CN)2]
- anions. 
As a direct consequence of the binding of the neighboring, symmetry-equivalent [Au(CN)2]
- 
anions to one another, their dimerization imparts some structural rigidity as evidenced by the 
smaller size of the thermal parameters of the dimer’s constituent gold, carbon and nitrogen atoms. 
Projections of the asymmetric unit along the b-axis (Figure 5-5) demonstrated strong one-
dimensional overlap between the dimerized [Au(CN)2]
- anions and the nearly-planar region of the 
viologen dications parallel to that axis. Such an orientation of these moieties relative to one another 
within the solid-state structure may provide evidence for the onset of interesting spectroscopic 
properties. Despite the potential for the dicyanoaurate anion located above the turn of the helical 
viologen in concert with its propensity to dimerize upon the application of crystallographic 
symmetry to generate interesting spectroscopic features, the second [Au(CN)2]
- anion in the 
asymmetric unit does not dimerize upon the application of crystallographic symmetry. Unlike the 
anion in the asymmetric unit which does dimerize, the second anion has much more linear 
geometry as evidenced by its N–Au–N angle of 176.5(5)°. Thermal parameters for the second 
dicyanoaurate anion also demonstrate more thermal motion as evidenced by the larger anisotropic 
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displacement ellipsoids for its constituent gold, carbon and nitrogen atoms. Between the anion and 
the helical viologen, the closest contact occurred between the centroid of the phenyl at the turn in 
the helix and N4 from the terminal nitrile at a distance of 3.351(19) Å. This distance suggests the 
onset of a potential dipole–dipole interaction given the positioning of the electron-rich nitrile 
relative to the electron deficient phenyl ring of the dication.31 Also, given the less intimate 
molecular orbital overlap between this latter dicyanoaurate and the planar surface of the viologen, 
suggests that unlike the former [Au(CN)2]
-, the latter is more spectroscopically innocent. As a 
consequence, Au heli-viologen can be described as a 2D network consisting of a series of 
noninteracting stacked [Au(CN)2]2
2-/ heli-viologen2+ slabs. 
 Analysis of the bond distances within the different [Au(CN)2]
- anions as a function of their being 
free or dimerized in the solid state also revealed subtle differences. Within the dicyanoaurate anion 
that dimerizes, the bond distances between the nitriles and the Au(I) were measured at distances 
of 2.007(16) and 2.011(15) Å while those in the free anion were measured at 1.98(2) and 1.94(2) 
Å respectively. The nitrile distances from the different anions also revealed differences as those 
from the dimerized anion were measured at 1.09(2) and 1.132(19) Å while their analogues from 
the free [Au(CN)2]
- revealed distances of 1.12(3) and 1.17(3) Å between the constituent carbon 
and nitrogen atoms. Such a difference can be hypothesized on the basis of dimerization between 
the neighboring dicaynoaurate anions upon the application of symmetry. Electron density is 
donated from the nitrile into the corresponding Au–C bond, resulting in a shortening of the former 
and a lengthening of the latter. This build-up of electron density on the monovalent Au atom, in 
concert with the nearby positioning of a symmetry-related anion, supports bond formation between 
the gold atoms. Relevant bond distances within the free dicyanoaurate anion are similar to those 
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reported in the literature as no intramolecular donation of electron density to support Au–Au bond 
formation occurs.211 
5.2.3 Infrared spectroscopy 
 
Figure 5-6 Infrared spectrum of Au heli viologen (5-13). 
Au heli-viologen (5-13) is a coordination polymer, where a dominant vibrational feature is the 
cyanide stretch. The νs(CN) of the gold(I) dicyanide anions are observed at 2140 cm
-1, 2152 cm-1, 
2160 cm-1, and 2165 cm-1, indicating that the CN ligands are slightly inequivalent throughout the 
crystal motif. This split is in agreement with the structural data which shows the presence of 
monomer [Au(CN)2]
- and dimer [Au(CN)2]2
2- units. For oligomer units of metal cyanides, the 
νs(CN) vibrational mode moves to lower energies as the oligomer size increases due to the 
increased electron density of the CN π* LUMO.213 In keeping with this, we have assigned the 
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bands at 2140 cm-1 and 2152 cm-1 to the νs(CN) vibration modes of the dimers and the 2160 cm
-1 
and 2165 cm-1 bands to the vibrational modes of the monomer subunits. 
5.2.4 Photophysical studies 
To investigate the absorption of Au heli-viologen, we have performed diffuse reflectance 
measurements of solid microcrystalline samples of both Au heli-viologen (5-13) and MV2+ at 298 
K (Figure 5-7). Solid samples of gold coordinated MV2+ are yellow in color and absorb strongly 
in the UV. 
 
Figure 5-7 Solid state DRS absorption spectrum of solid samples of Au heli-viologen and MV2+ 
at 298 K converted via Kubelka-Munk. 
As seen in the spectra, the absorption falls off sharply around 475 nm with an optical absorption 
edge of 2.39 eV. This edge is slightly more variable for the gold free heli-viologen2+ which slowly 
tappers off through the visible range and is identical to previous reports of MV2+ which are 
assigned to a π → π* state.141 Introduction of [Au(CN)2]
- results in few changes in the DRS spectra 
in comparison to heli-viologen2+.  





















Figure 5-8 Luminescence spectra of Au heli-viologen between 10 K and 298 K. Excitation 
(dashed) and emission (solid). 
The appearance of higher energy bands at 268 nm not observed in the gold free heli-viologen2+ are 
assigned to a metal to ligand charge transfer (MLCT) localized to the [Au(CN)2]
-/[Au(CN)2]2
2- 
subunits consistent with reports elsewhere.214 The majority of the band remains a π → π* state of 
the heli-viologen2+. 
As an aromatic cation, heli-viologen2+ is well equipped to accept electrons from the electron rich 
gold(I) dicyanide anions as reported for other viologen like molecules. To probe this temperature 
variable photoluminescence measurements of microcrystalline samples of Au heli-viologen 
between 298 K and 10 K were performed. The spectra are shown in Figure 5-8 and are overlaid to 
demonstrate the change in peak shape and relative intensity with respect to temperature. We 
observe that the excitation spectrum of Au heli-viologen (5-13) consists of two bands: one high 
energy band at 375 nm, and one low energy band at 470 nm. A shift in the relative intensity towards 
the high energy band is observed upon temperature change. No significant shift in the position of 
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either excitation band is observed at lower temperatures. At room temperature, compound 5-13 in 
microcrystalline form shows one broad triplet emission band at 580 nm (τ298 K = 1.01 μs, τ78 K = 
1.12 μs). At lower temperatures the relative emission intensity increases and a second, lower-
energy band appears at 608 nm. This band first appears at 129 K and does not shift during cooling. 
Time-dependent measurements show much shorter lifetime of this band (τ78 K = 130 ns) in 
comparison to that of the band at 580 nm.  
 
Figure 5-9 Energy diagram of emission pathways for Au heli-viologen. At higher temperatures 
the heli-viologen2+ emission by T1→S0 is favored along with quenching of [Au(CN)2]
-2 via the 
excited S1 to heli-viologen
2+ S1. At low temperatures (<129 K) electron transfer is absent resulting 
in [Au(CN)2]
-2 S1→S0 emission. S0, ground state; S1, first excited state; T1, first triplet state; NR, 
nonradiative decay; ET, electron transfer 
Based on previous reports of heli-viologen2+ the data reported here, the 580 nm band is assigned 
to a triplet π → π* localized to heli-viologen2+. The emission band observed at 608 nm is a new 




wavelength of this band are too long for cation S1→S0 emission. Instead, these values better fit 
expected values for [Au(CN)2]
- emission. We have observed similar behavior in Au(CN)2
-/DNP2+ 
structures where low temperature emission is dominated by [Au(CN)2]
- bands but quenched at 298 
K.150 The absence of [Au(CN)2]
- emission above 129 K indicates quenching by heli-viologen2+ at 
high temperatures. It is attributed to an oxidative electron transfer in the excited state at higher 
temperatures between [Au(CN)2]
- and heli-viologen2+ (Figure 5-9). 
5.2.5 Electron transfer analysis 
An analysis of this system was performed via Stern–Volmer and a Rehm–Weller to support the 
proposed electron transfer. First, a Stern–Volmer analysis was performed in order to examine the 
nature of heli-viologen2+ quenching of [Au(CN)2]
-, specifically to determine if the observed 
quenching is due to electron transfer or resonance.215 First, the ground state absorption spectra of 
the components were compared to the combined mixture.  
 
Figure 5-10 Absorption spectra of potassium dicyanoaurate, heli[5]viologen, and Au heli-
viologen in methanol (5 x 10-4 M). 
Figure 5-10 shows that the absorption spectrum of a mixture of heli-viologen2+ and potassium 





















absorption band in the mixed spectrum indicates that no ground state electronic interaction occurs 
between the two species. From this observation, we conclude that no static quenching occurs in 
this system. While our previous experiment indicates no ground-state quenching, the possibility of 
quenching in the excited-state was further investigated. The effect of heli-viologen2+ as a dynamic 
quencher of [Au(CN)2]
- photoluminescence was investigated by measuring the photoluminescence 
of a series of heli-viologen2+/dicyanoaurate solutions. Luminescence intensity associated with 
[Au(CN)2]
- was observed to decrease as the concentration of heli-viologen2+ was increased. Since 
we observe photoluminescence quenching upon addition of heli-viologen2+, this data can be fit to 
the Stern–Volmer equation to further analyze the photophysical kinetics of the system.  
 
Figure 5-11 Stern-Volmer plot for aqueous Au heli-viologen. 
Figure 5-11 shows the Stern–Volmer plot constructed for this experiment. From this plot a KSV 
value can be determined (KSV = 5170 M
-1). The data show that quenching is observed for this 
system. This indicates that there is a significant interaction between gold dicyanoaurate species 
and heli-viologen2+ during the photophysical excitation and relaxation process. This observation 












provides further support for our assignment of the emission band observed at 608 nm as a 
[Au(CN)2]
- →heli-viologen2+ electron transfer. 
The Rehm–Weller equation35 can be used to support the proposed electron transfer by determining 
whether the process is thermodynamically favorable. 
 
In the Rehm–Weller equation shown above, ΔGET is the free energy change associated with the 
electron transfer process, Ered and Eox are the reduction potential of the viologen heli-viologen
2+ 
acceptor and oxidation potential of the [Au(CN)2]2
2- donor respectively. Es represents the energy 
of the singlet state energy at 78 K (average of the lowest energy excitation band and highest energy 
emission band), and eo
2/εa is taken as the attraction that the ion pair experiences.
206,216 We have 
calculated the Eox (1.74 eV) via DFT by taking the difference in energy between an optimized 
structure of [Au(CN)2]2
2- and [Au(CN)2]
-. For the Au heli-viologen, ΔGET is therefore calculated 
as: ((1.74 + 0.22)-2.32-0.15) = -0.51 eV, indicating the electron transfer is spontaneous. This 
calculated free energy change supports an electron transfer process as a feasible explanation for 
the observed quenching system. 
5.2.6 Ag-Heli Viologen (5-14) 
Chloride-heli viologen (5-12) was coupled with potassium dicyanoargentate in order to synthesize 
silver-heli[5] viologen (5-14). Several attempts were made to synthesize and recover 5-14, which 
were semi-successful as the powder did not precipitate out of solution as easily. When precipitation 
was induced by solvent evaporation, inorganic salts precipitated out along with the desired metal 
organic complex and isolation of 5-14 could not be confirmed. As shown in Figure 5-12, potassium 
dicyanoargentate showed that νs(CN) vibration mode is observed at 2136 cm
-1. Synthesized and 




similar to Au-heli viologen. In addition low energy vibrational modes of aza-helicine system are 
observed below 1600 cm-1. 
 
Figure 5-12 Infrared spectra of KAg(CN)2 (upper) and potential Ag-Heli viologen (lower) 
However, this product could not be confirmed with 1H NMR, 13C NMR or MS. Single crystal 
synthesis was attempted on precipitated powder using vapor-diffusion methods but these attempts 
were unsuccessful. Synthesis and photophysical properties of Ag-heli viologen need to be studied 
in a future to compare the 2D structure of Ag-heli viologen to the synthesized Au-heli viologen. 
5.3 Conclusion and Future direction 
Au-heli viologen (5-13) was synthesized from 4-bromoquinoline via Pd catalyzed Stille 
coupling/ Pd catalyzed Hiyama-Heck coupling, photocyclization, methylation and metal 
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coupling reactions with overall yield of 22%. Single crystals of Au-heli viologen (5-13) were 
accessed via vapor-diffusion, and characterized by single crystal X-ray diffraction. The 2D 
network was found to consist of [Au(CN)2]
− dimers and monomers trapped within heli-
viologen2+ units. Photophysical studies show that at 298 K this complex emits at 580 nm via a 
triplet π → π* transition localized to the heli-viologen2+. Cooling to low temperatures results in a 
new emission band at 608 nm. Lifetime measurements and DFT calculations indicate that this 
new band is the appearance of [Au(CN)2]2
2− emission. The lack of this emission at temperatures 
higher than 129 K indicates that quenching occur from heli-viologen2+. Stern–Volmer and 
Rehm–Weller analysis of this transition supports our assignment by revealing that quenching of 
[Au(CN)2]2
2−by heli-viologen2+ involves the transfer of an electron between ion pairs. Synthesis 
of Ag-heli viologen was attempted but crystallization and structure confirmation were 
unsuccessful. In a future study 2D/3D networks of Ag-heli viologen involving better electron 
donors such as dicyanoargentate would provide insight into the electron-transfer phenomenon 
investigated here. 
5.4 Experimental 
5.4.1 General Information 
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly 
without further purification. All products were purified with silica-gel flash 
chromatography or preparative HPLC. HPLC was performed on a Gilson analytical to 
semi-preparative system using Kinetex 5 µm EVO C18 100Å 4.6 x 150 mm for analytical 
and Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for preparative purpose. Products were 
characterized by 1H and 13C NMR and mass spectrometry. NMR characterization results 
and J values were compared with published results. 1H and 13C NMR spectra were recorded 
on Agilent/Varian 400 MHz and 101 MHz NMR spectrometer respectively. Mass spectra 
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were recorded using a Synapt G2 Q-TOF ESI mass spectrometer at the Mass Spectrometry 
lab at the University of Illinois Urbana Champagne.  
5.4.2 Synthesis of (E)-1,2-di(quinoline-3-yl)ethene (5-5) 
5.4.2.1 Step-wise Wittig route 
Quinolin-3-ylmethanol (5-2) 
 
In a 7 mL scintillation vial, 3-quinolinecarboxaldehyde (150 mg, 0.95 mmol) was dissolved 
in ethanol (2 mL) followed by addition of sodium borohydride (50 mg, 1.32 mmol, 1.4 eq.). 
Mixture was stirred at rt for 2 hrs. The mixture was diluted with diethy ether (5 mL) and 
washed with water (2 x 5 mL). The aqueous phase was extracted with diethyl ether (2 x 5 
mL) and combined organic phases were dried with sodium sulfate (Na2SO4) and 
concentrated. 132 mg, 87% yield. 1H NMR (400 MHz, CDCl3) δ 8.74 (d, 1H, J=2.0 Hz), 
8.06 (s, 1H), 8.00 (d, 1H, J=8.8 Hz), 7.70 (d, 1H, J=8.0 Hz), 7.62 (m,1H), 7.48 (m, 1H), 
4.83 (s, 2H) ppm. Spectral data matched with those in literature.207 
3-chloromethylquinoline (5-3) 
 
In a 7 mL scintillation vial quinolin-3-ylmethanol (130 mg, 0.82 mmol) in dry methylene 
chloride (5 mL) under N2 at 0 °C was added thionyl chloride (1.1 mL, 16.3 mmol, ~20 eq.) 
was added dropwise. The mixture was warmed up to rt and stirred for 1 hr. The mixture 
was concentrated to dryness under vacuum to give 3-chloromethylquinoline. 140 mg, 96% 
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yield. 1H NMR (400 MHz, CDCl3) δ 9.42 (s, 1H), 9.33 (s, 1H), 8.38 (d, 1H, J=8.4 Hz), 
8.33 (d, 1H, J=8.8 Hz), 8.20 (m,1H), 8.01 (m, 1H), 5.12 (s, 2H) ppm. Spectral data matched 
with those in literature.207 
Triphenyl(quinolin-3-ylmethyl)phosphonium chloride (5-4) 
 
In a 20 mL scintillation vial, 3-chloromethylquinoline (135 mg, 0.76 mmol) was dissolved 
in toluene (7 mL) followed by addition of triphenylphosphine (200 mg, 0.76 mmol). 
Reaction mixture was refluxed at 110 °C for 6 hrs. Solid was filtered, washed with toluene 
and dried to get wittig salt. 187 mg, 56%. 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H, J=2.0 
Hz), 8.04 (s, 1H), 7.80 (d, 1H, J=8.4 Hz), 7.69 (m, 8H,), 7.66 (d,1H), 7.55 (m, 7H), 7.51 
(m, 1H), 7.37 (m, 1H), 5.60 (d, 2H, JH-P=14.8 Hz ) ppm. Spectral data matched with those 
in literature.207 
Wittig reaction (synthesis of (E)-1,2-di(quinoline-3-yl)ethane) (5-5) 
  
 In a 7 mL scintillation vial, to a solution of triphenyl(quinolin-3-ylmethyl)phosphonium 
chloride (117 mg, 0.25 mmol) and 3-quinolinecarbaldehyde (40 mg, 0.25 mmol) in 
methanol (4 mL) was added sodium methoxide (0.3 mL, 0.3 mmol, 1M in MeOH) 
dropwise. Mixture was refluxed at 65 °C for 4 hrs. After cooling the mixture, water (20 
mL) was added the mixture was extracted with methylene chloride (4 x 20 mL). Due to 
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significant presence of triphenylphosphine oxide, the product was purified with silica gel 
flash chromatography (60:40 EtOAc:Hexane). 31 mg, 43%  
5.4.2.2 Stille coupling to synthesize 5-5 
Bis-1,2-tributylstannyl ethylene synthesis (5-9) 
 
Tributylstannyl acetylene (328 mg, 1 mmol) & tributylstannyl hydride (291 mg, 1 mmol) 
were added to a vial with AIBN (3.3 mg, 0.02 mmol). The mixture was heated and stirred 
at 100 oC for 6 hrs. Water was added to the reaction mixture and the product was extracted 
with four aliquots of methylene chloride and dried over Na2SO4. The solvent was 
evaporated under reduced pressure yielding 5-9. This product was used in the following 
step without further purification. 549 mg, 90%. 1H NMR (400 MHz, CDCl3) δ 6.89 (s, 
2H), 1.46-1.64 (m, 12H), 1.25-1.44 (m, 12H), 0.80-0.98 (m, 30H) ppm. Spectral data 
matched with those in literature.217 
(E)-1,2-di(quinoline-3-yl)ethane(5-5) 
 
3-Bromoquinoline (131 mg,0.63 mmol) and  bis-1,2-tributylstannyl ethylene (194 mg, 0.32 
mmol) were added to a vial purged with N2. Pd2(dba)3 catalyst (5 mol%) & X-phos (0.1 
eq.) were added to the reaction vial, followed by addition of dry toluene (4 mL) under N2. 
The reaction mixture was heated at 110 oC. The solvent was evaporated under reduced 
pressure and the crude product was purified with flash chromatography using 70%:30% 
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ethyl acetate:hexane mixture with 1% triethylamine to get (E)-1,2-Di(quinoline-3-
yl)ethane. 51 mg, 57%. Same procedure was followed for other catalysts and ligands (Table 
5-1) during optimizations with catalyst amounts varying from 5-10 mol% and ligand (0.1-
0.2 eq.). 
5.4.2.3 Hiyama-Heck Coupling 
 
A mixture of triethoxyvinylsilane (0.43 g, 2.25 mmol) and sodium hydroxide (0.5 M, 18 
mL) was added to a 40 mL pressure vial, followed by addition of 3-bromoquinoline (1) 
(0.75 g, 3.60 mmol) & palladium acetate (0.5 mol%). The reaction vial was sealed with a 
heat resistant teflon resistant screw cap and the mixture was stirred at 140 oC for 6 hrs. 
After cooling, the green precipitate was filtered and washed with 10:1 ethyl 
acetate:chloroform. The solvent was evaporated under vacuum. 460 mg, 91%. 1H NMR 
(400 MHz, CDCl3) δ 9.19 (d, 2H, J=2.1 Hz), 8.25 (d, 2H, J=2.1 Hz), 8.11 (d, 2H, J=8.4 
Hz), 7.86 (d, 2H, J=8.0 Hz), 7.72 (ddd, 2H, J=8.3,7.0,0.9 Hz), 7.58 (ddd, 2H, J=8.1, 6.7, 
0.9 Hz), 7.47 (s, 2H) ppm. 13C NMR (101 MHz, DMSO-d6) δ 175.40, 
151.16,149.62,145.85, 137.60, 130.34, 130.07, 128.96, 127.61, 116.79 ppm. HRMS (TOF 
MS ES+) m/z calculated for C20H15N2 ([M+H]
+) 283.1235 Da, found 283.1231Da. 
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5.4.3 Photocyclization to synthesize 5,10-diaza[5]helicene (5-9) 
 
(E)-1,2-di(quinoline-3-yl)ethane (0.6 g, 2.1 mmol) was dissolved in ethyl acetate (500 mL) 
in a round bottom flask. A condenser was attached to the top and the setup was mounted 
inside an RPR-100 photoreactor on a stir-plate.  
 
The mixture was stirred and irradiated at 350 nm for 7 hrs.  The crude product was purified 
with silica-gel chromatography using 70%:30% ethyl acetate:hexane. 430 mg, 73%. 1H 
NMR (400 MHz, CDCl3) δ 9.46 (s, 2H), 8.65 (dd, 2H, J=8.4, 1.2 Hz), 8.29 (dd, 2H, J=8.3, 
1.3 Hz), 8.14 (s, 2H), 7.76 (ddd, 2H, J=8.3, 7.0, 1.3 Hz), 7.44 (ddd, 2H, J=8.4, 7.0, 1.3 Hz) 
ppm. 13C NMR (101 MHz, CDCl3) δ 152.53, 145.88, 129.71, 129.48, 129.43, 128.17, 
127.32, 127.26, 125.61, 124.38 ppm. HRMS (TOF MS ES+) m/z calculated for C20H13N2 
([M+H]+) 281.1079 Da, found 281.1070 Da. Benzo-[b]-1,8-diaza[4]-helicene (6) was 
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recovered as a side-product. Yield: 110 mg, 19%. 1H NMR (400 MHz, CDCl3) δ 11.37 (d, 
1H), 9.37 (s, 1H), 8.75 (s, 1H), 8.49 (d, 2H, J=8.7 Hz), 8.30 (d, 2H, J=8.1 Hz), 8.09-7.98 
(m, 2H), 7.93-7.83 (m, 4H), 7.67 (dd, 1H, J=7.96, 6.92 Hz) ppm. 
5.4.4 Synthesis of dimethylaza[5]helicene  
Dimethylaza[5]helicene bis-tetrafluoroborate (5-11) 
 
To trimethyl oxonium tetrafluoroborate (Meerwein’s salt, 0.356 g, 2.39 mmol) in a 40 mL 
scintillation vial was added anhydrous methylene chloride (100 mL) under N2. 5,10-
diaza[5]helicene (5-9) (0.223 g, 0.80 mmol) in anhydrous methylene chloride (20 mL) was 
then added to the vial under N2. The vial was stirred under N2 for 24 hrs. Methylene chloride 
was removed under vacuum. The dried yellow solid was triturated with warm 90% ethanol. 
The crude (5-11) was further purified with preparative HPLC using 5% to 15% acetonitrile 
in 10 minutes. Yield: 233 mg (60%). 1H NMR (400 MHz, CD3CN) δ 10.04 (d, 2H, J=2.2 
Hz), 8.72 (d, 2H, J=8.5 Hz), 8.67 (d, 2H, J=1.5 Hz), 8.57 (d, 2H, J=8.5 Hz), 8.24 (ddd, 2H, 
J=8.7, 7.4, 1.3 Hz), 7.88 (ddd, 2H, J=8.3, 7.3, 1.0 Hz), 4.82 (s, 6H) ppm. 13C NMR (101 
MHz, CD3CN) δ 154.82, 136.93, 135.12, 133.74, 131.78, 131.06, 129.86, 129.32, 127.33, 
120.34, 47.60 ppm. HRMS (TOF MS ES+) m/z calculated for C20H15N2 ([M]
+2) 155.0735 





Dimethylaza[5]helicene dichlorate (5-12) 
 
DOWEX 1×8 200-400 mesh ion-exchange resin (Acros) (11.25 g) was loaded onto a 
column and washed with methanol followed by equilibration with 50% aqueous ethanol. 
Compound 5-11 (225 mg, 0.46 mmol) dissolved in acetonitrile (0.5 mL) was loaded into 
the column. The column was washed with 50% aqueous ethanol. The fractions were 
concentrated and reloaded on the column and collected two more times. Combined 
fractions were concentrated under reduced pressure to yield the product (5-12). Yield: 167 
mg (95%). 1H NMR (400 MHz, CD3OD) δ 10.54 (d, 2H, J=2.2 Hz), 8.86 (d, 2H, J=8.4 
Hz), 8.82 (d, 2H, J=1.2 Hz), 8.75 (d, 2H, J=8.7 Hz), 8.28 (ddd, 2H, J=8.6, 7.3, 1.3 Hz), 
7.92 (ddd, 2H, J=8.2, 7.3, 1.0 Hz), 4.99 (s, 6H) ppm. 13C NMR (101 MHz, CD3OD) δ 
155.89, 137.21, 135.33, 133.99, 132.12, 130.97, 130.46, 129.73, 127.63, 120.59, 47.12 
ppm. HRMS (TOF MS ES+) m/z calculated for C20H15N2 ([M]




5.4.5 Synthesis of Au heli-viologen(5-13) 
 
To a solution of N,N-Dimethylaza[5]helicene dichloride (5-12) (40 mg, 0.104 mmol) in 
water (30 mL), potassium dicyanoaurate (60 mg,0.21 mmol) in water was added while 
stirring. The precipitate was filtered after 10-12 hours and solvent was slowly evaporated 
to complete the precipitation of N,N-Dimethylaza[5]helicene dicyanoaurate (5-13). Yellow 
solid was dried under reduced pressure and used for crystallization. Yield- 49 mg (58%). 
Crystallization. Au-heli viologen (Complex 5-13) (10 mg) was dissolved in ethanol (0.2 
mL) in a 2 mL scintillation vial. This vial was covered with porous aluminum foil and 
placed in a 20 mL scintillation vial containing cyclohexane (2 mL). This closed system was 
kept inside the fume hood for 8 to 9 days. Small crystals formed through slow vapor 
diffusion. Results were reproduced with methanol as a solvent and n-hexane as anti-
solvent.210 
1H NMR (400 MHz, CD3OD) δ 10.49 (d, 2H, J=2.2 Hz), 8.89 (d, 2H, J=8.8 Hz), 8.80 (d, 
2H, J=2.1 Hz), 8.75 (d, 2H, J=9.0 Hz), 8.29 (ddd, 2H, J=8.6, 7.5, 1.1 Hz), 7.95 (ddd, 2H, 
J=8.6, 7.5, 1.1 Hz), 4.97 (s, 6H) ppm. 13C NMR (101 MHz, D2O) δ 153.67, 135.70, 134.10, 
133.08, 130.69, 129.96, 129.93, 128.96, 128.51, 126.43, 119.03 ppm. 
5.4.6 Crystallography 
A small yellow block-like crystal of Au heliviologen having dimensions 0.057 × 0.063 × 0.092 
mm3 was secured to a Mitegen cryomount using Paratone oil. Single crystal reflection data were 
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collected on a Rigaku Oxford Diffraction (ROD) Synergy-S X-ray diffractometer equipped with a 
HyPix-6000HE hybrid photon counting (HPC) detector. The data were collected at 100 K using 
Mo Kα1 radiation from a data collection strategy calculated using CrysAlisPro which was also 
responsible for unit cell determination, initial indexing, data collection, frame integration, Lorentz-
polarization corrections and final cell parameter calculations.218 A numerical absorption correction 
via face indexing was performed using the SCALE3 ABSPACK algorithm integrated into 
CrysAlisPro.17. The crystal structure was solved via intrinsic phasing using ShelXT and refined 
using olex2. refine within the Olex2 graphical user interface.219–221 The structural model’s space 
group was unambiguously verified by PLATON.21 
Structural refinement of the reflection data for 8 resulted in the identification of electron density 
peaks associated with a highly disordered interstitial CH2Cl2 molecule that could not be 
satisfactorily modeled. This minor impurity may have been trapped during screening of solvents 
for crystallization. The data were treated using the SQUEEZE routine in PLATON, then refined 
on F2 to acceptable levels.222 The final structural refinement included anisotropic temperature 
factors on all nonhydrogen atoms and hydrogen atoms were attached via the riding model at 
calculated positions using appropriate HFIX commands. The crystallographic and refinement data 
for Au heli-viologen is listed in Table 1. Crystallographic data for this paper has been deposited 
with the Cambridge Crystallographic Data Centre with the CCDC number 1558366.  
5.4.7 Spectroscopy studies  
Steady-state photoluminescence scans were collected between 298 K and 10 K. Spectra were taken 
with a Model Quantamaster-1046 photoluminescence spectrophotometer from Photon Technology 
International using a 75 W xenon arc lamp combined with two excitation monochromators and 
one emission monochromator. A photomultiplier tube at 800 V was used as the emission detector. 
The solid samples were mounted on a copper plate using non-emitting copper-dust high vacuum 
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grease. All scans were collected under vacuum with a Janis ST-100 optical cryostat. Infrared 
spectra were collected on solid samples at 298 K using a PerkinElmer FT-IR Spectrum Two 
equipped with a Universal Attenuated Total Reflectance (UATR) accessory and a LiTaO3 MIR 
detector. Diffuse reflectance spectra were collected on solid samples at 298 K. The light source 
was a Mikropack DH-2000 deuterium and halogen light source coupled with an Ocean Optics 
USB4000 detector. Scattered light was collected with a fiber optic cable. Spectra was referenced 
with polytetrafluoroethylene. Data was processed using SpectraSuite 1.4.2_09. 
5.4.8 Stern–Volmer quenching experiments  
For quenching experiments, heli-viologen2+ was used as the quencher. After determining proper 
quencher concentration ranges, the quenching experiment performed using the [Au(CN)2]
- sample 
solutions. A stock solution of 5 x 10-4 M K[Au(CN)2]2 was first prepared, and then 1 mL stock  
solution was distributed among all quenching vials. The quencher solution was then added to the 
quenching vials in increments of 50 μL. The contents of each vial were then transferred to cuvettes 
and the emission spectrum of each sample was measured separately. Emission scans were 
conducted on a Jobin Yvon Systems Fluorolog 3 Spectrofluorometer. The excitation 
monochromator was referenced to a secondary detector, and the emission monochromator was 
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NMR SPECTRA FOR CHAPTER 2 
 
Figure A 1 1H NMR spectrum of 2-1 
 




Figure A 3 1H NMR of 2-2 
 




Figure A 5 1H NMR of 2-3 
 




Figure A 7 1H NMR of 2-18 
 




Figure A 9 1H NMR of 2-19 
 




Figure A 11 1H NMR of 2-4 
 




Figure A 13 1H NMR of 2-22 
 






Figure A 15 1H NMR of 2-23 
 




Figure A 17 1H NMR of 2-5 
 




Figure A 19 1H NMR of 2-6 
 





Figure A 21 1H NMR of 2-7 
 




Figure A 23 1H NMR of 2-8 
 





Figure A 25 1H NMR of 2-20 
 




Figure A 27 1H NMR of 2-21 
 




Figure A 29 1H NMR of 2-9 
 




Figure A 31 1H NMR of 2-10 
 




Figure A 33 1H NMR of 2-11 
 






Figure A 35 1H NMR of 2-12 
 





Figure A 37 1H NMR of 2-24 
 
 







Figure A 39 1H NMR of 2-25 
 





Figure A 41 1H NMR of 2-14 
 





Figure A 43 1H NMR of 2-15 
 





Figure A 45 1H NMR of 2-17 
 




Figure A 47 1H NMR of 2-16 
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Figure B 1 1H NMR of 3-5 
 




Figure B 3 1H NMR of 3-6 
 





Figure B 5 1H NMR of 3-7 
 




Figure B 7 1H NMR of 3-8 
 






Figure B 9 1H NMR of 3-9 
 







Figure B 11 1H NMR of 3-10 
 





Figure B 13 1H NMR of 3-11 
 





Figure B 15 1H NMR of 3-12
 




Figure B 17 1H NMR of 3-13 
 





Figure B 19 1H NMR of 3-14 
 




Figure B 21 1H NMR of 3-17 
 




Figure B 23 1H NMR of 3-18 
 





Figure B 25 1H NMR of 3-19 
 





Figure B 27 1H NMR of 3-20 
 







Figure B 29 1H NMR of 3-21 
 






Figure B 31 1H NMR of 3-22 
 





Figure B 33 1H NMR of 3-23 
 




Figure B 35 1H NMR of 3-24 
 




Figure B 37 1H NMR of 3-26 
 





Figure B 39 1H NMR of 3-27 
 






Figure B 41 1H NMR of 3-29 
 




Figure B 43 1H NMR of 3-30 
 
 




Figure B 45 1H NMR of 3-31 
 
 






Figure B 47 1H NMR of 3-33 
 
 






Figure B 49 1H NMR of 3-32
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Figure C 1 1H NMR of 4-1
 





Figure C 3 1H NMR of 4-6 
 




Figure C 5 1H NMR of 4-9
 




Figure C 7  1H NMR of 4-4 
 









Figure C 10 2D (1H-13C) HSQC of 4-4 
 




Figure C 12 1H NMR of 4-10 
 





























Figure C 17 1H NMR of 4-11 
 
 




A. HPLC CHROMATOGRAM OF CHAPTER-4 
 
 





















B. PHOTOPHYSICAL DATA FOR CHAPTER-4 
 
Figure E 1 UV/Vis spectra of 5,6-DMIC (2-3), Benzothiazole (3-10), and mixed melanoid (4-4) 
 
Figure E 2 Luminescence spectra of mixed melanoid (4-4) 







































Figure E 3 UV/Vis spectrum of mixed melanoid (4-11) 
 
Figure E 4 Luminescence spectra mixed melanoid (4-11) 
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Figure F 5 1H NMR of 5-5 
 




Figure F 7 1H NMR of 5-9 
 




Figure F 9 1H NMR of 5-11 
 




Figure F 11 1H NMR of 5-12 
 
 




Figure F 13 1H NMR of 5-13 
 
 




C. IR SPECTRA FOR CHAPTER 5 
 
 












D. BOND LENGTHS AND BOND ANGLES OF AU-HELI VIOLOGEN 
 
Au(1)-C(1) 2.0107(1) C(9)-C(10) 1.4369(1) 
Au(1)-C(2) 2.0068(1) C(10)-C(11) 1.4131(1) 
Au(2)-C(4) 1.9837(1) C(10)-C(19) 1.3644(1) 
Au(2)-C(3) 1.9433(1) C(13)-C(18) 1.4101(1) 
N(1)-C(1) 1.1318(1) C(13)-C(14) 1.4156(1) 
N(2)-C(2) 1.0913(1) C(14)-C(15) 1.3473(1) 
N(3)-C(3) 1.1708(1) C(15)-C(16) 1.3870(1) 
N(4)-C(4) 1.1198(1) C(16)-C(17) 1.3998(1) 
N(5)-C(5) 1.4637(1) C(17)-C(18) 1.3923(1) 
N(5)-C(6) 1.2860(1) C(18)-C(19) 1.4561(1) 
N(5)-C(26) 1.4028(1) C(19)-C(20) 1.4407(1) 
N(6)-C(11) 1.3096(1) C(20)-C(21) 1.4663(1) 
N(6)-C(12) 1.4724(1) C(21)-C(26) 1.4320(1) 
N(6)-C(13) 1.4031(1) C(21)-C(22) 1.4159(1) 
C(6)-C(7) 1.4320(1) C(22)-C(23) 1.3267(1) 
C(7)-C(8) 1.4136(1) C(23)-C(24) 1.4234(1) 
C(7)-C(20) 1.4379(1) C(24)- (C25) 1.3774(1) 
C(8)-C(9) 1.3398(1) C(25)-C(26) 1.3754(1) 




C(1)-Au(1)-C(2) 176.62(1) N(6)-C(13)-C(14) 120.77(1) 
C(3)-Au(2)-C(4) 177.67(1) C(13)-C(14)-C(15) 120.78(1) 
Au(1)-C(1)-N(1) 177.15(1) C(14)-C(15)-C(16) 121.68(1) 
Au(1)-C(2)-N(2) 175.42(1) C(15)-C(16)-C(17) 117.87(1) 
Au(2)-C(3)-N(3) 175.29(1) C(16)-C(17)-C(18) 122.24(1) 
Au(2)-C(4)-N(4) 176.96(1) C(13)-C(18)-C(17) 117.82(1) 
C(11)-N(6)-C(13) 119.08(1) C(13)-C(18)-C(19) 118.40(1) 
C(12)-N(6)-C(13) 119.16(1) C(17)-C(18)-C(19) 118.40(1) 
C(11)-N(6)-C(12) 121.62(1) C(10)-C(19)-C(20) 116.99(1) 
C(5)-N(5)-C(26) 118.65(1) C(10)-C(19)-C(18) 116.94(1) 
C(6)-N(5)-C(26) 122.98(1) C(18)-C(19)-C(20) 125.97(1) 
C(5)-N(5)-C(6) 117.87(1) C(7)-C(20)-C(21) 116.80(1) 
N(5)-C(6)-C(7) 123.13(1) C(19)-C(20)-C(21) 126.22(1) 
C(6)-C(7)-C(8) 120.84(1) C(7)-C(20)-C(19) 116.64(1) 
C(8)-C(7)-C(20) 121.99(1) C(20)-C(21)-C(26) 119.32(1) 
C(6)-C(7)-C(20) 117.14(1) C(22)-C(21)-C(26) 116.97(1) 
C(7)-C(8)-C(9) 119.55(1) C(20)-C(21)-C(22) 122.64(1) 
C(8)-C(9)-C(10) 118.18(1) C(21)-C(22)-C(23) 121.43(1) 
C(9)-C(10)-C(19) 124.38(1) C(22)-C(23)-C(24) 120.64(1) 
C(11)-C(10)-C(19) 120.09(1) C(23)-C(24)-C(25) 119.77(1) 
C(9)-C(10)-C(11) 115.47(1) C(24)-C(25)-C(26) 119.63(1) 
N(6)-C(11)-C(10) 122.91(1) N(5)-C(26)-C(21) 117.72(1) 
N(6)-C(13)-C(18) 120.16(1) C(21)-C(26)-C(25) 120.78(1) 
C(14)-C(13)-C(18) 118.99(1) N(5)-C(26)-C(25) 121.41(1) 





E. COMPUTATIONAL MODELLING 
All geometry parameters were determined using Gaussian ‘16 software (Gaussian Inc.) with the 
University of Maine Advanced Computing Group.23 All ground state and excited state 
calculations were performed using density functional theory (DFT) and time-dependent density 
functional theory (TD-DFT) calculations using the M06 metahybrid functional24,25 with the CEP-
31G(d) basis set employed for all atoms.26,27 XRD structures were used as initial structural input. 
From the structural data we have developed a neutral model that is composed of two heli-
viologen2+ units bridged by a dimer [Au(CN)2
2- and capped with terminal [Au(CN)2] monomer 
units. This model contains all subunits present within the crystal structure. Isodensity 
representations of molecular orbitals were generated using GaussView 5.0 software (Gaussian 
Inc.). MOs were generated and visualized using the Avogadro 1.2.0 software program.28 
DFT calculations were performed to interpret the photophysical changes and emission spectra of 
Au heli-viologen upon excitation. A neutral model of gold(I) dicyanide coordinated to heli-
viologen2+, shown in Fig. 9, was developed containing both [Au(CN)2]
- and [Au(CN)2]2
2- subunits. 
Calculated ground state geometry parameters, Table S3 (ESI†), are in good agreement with 
experimental values with short Au⋯Au distances supportive of aurophilic interactions.   
 
Figure I 1 DFT M06/CEP-31G(d) calculated ground state of [Au(CN)2]
-/[Au(CN)2]2
-2 coordinated 
heli-viologen2+. Close Au⋯Au distance (3.435 Å) shown 
263 
 
Calculations at the [Au(CN)2]2
2- center accurately predict a short Au⋯Au distance of 3.435 Å 
compared to an experimental value of 3.310 Å. The close contact distance between the CN- anion 
and the N+ cation of the phenyl (3.155 Å) is slightly shorter than the experimental value of 3.216 
Å. We attribute this shortened distance to the lack of surrounding [Au(CN)2]
- ions normally 
present. The loss of surrounding anions causes our model to overly rely on the central electron rich 
[Au(CN)2]2
2- dimer to balance the cationic viologen ion. TD-DFT calculated UV-vis spectra, Fig. 
S14 (ESI†), show agreement of our model with the experimental UV-Vis results with both having 
strong absorption bands at energies higher than 500 nm. An excited state at 399 nm is predicted 
with a strong oscillator strength of 0.0132. This excited state energy aligns with our experimental 
luminescence excitation value of 400 nm. The highest contributing molecular orbital transition 




Figure I 2 TD-DFT M06/CEP-31G(d) energy diagram calculated for Au heli-viologen at 399 nm 
excitation for top 3 transitions. Transition percent contributions are noted. 
TD-DFT calculations predict that two general types of electron transitions occur upon excitation 
at 399 nm. The first centers on the electron donating MOs (HOMO-9, and HOMO-11) which are 
primarily composed of the heli-viologen2+ π* with minor contribution from the neighboring 
[Au(CN)2]
- anion. The electron accepting MO (LUMO) is composed of the heli-viologen2+ π* and 
clearly represents a π → π* transition. In the second case, the electron donating MO (HOMO) is 
exclusively composed of the dimerized [Au(CN)2]2
2- subunit with no contribution from the 
neighboring heli-viologen2+ cations. This molecular orbital calculated transition is clearly an 
electronic transfer and demonstrates the emissive quenching of [Au(CN)2]
- by the viologen in the 





 Distance (Å) / Angle (o) 
 Experimental* Calculated* 
Au...Au 3.310 3.327 
NAu(CN)2
...Naza[5]helicene 3.216 3.088 
Au-C 2.010 2.029 
C-Au-C 176.6 166.8 
N-C-Au 177.1 169.6 
*Average distances 
Figure I 3 TD-DFT M06/CEP-31G(d) energy diagram calculated for Au heli-viologen at 399 






F. UV-VIS, DFT AND MO FOR CHAPTER 5 
 


































7 428 nm 0.0078 
8 425 nm 0.0067 
9 423 nm 0.0014 
10 421 nm 0.0000 
11 421 nm 0.0069 
12 420 nm 0.0027 
13 406 nm 0.0004 
14 404 nm 0.0009 
15 401 nm 0.0028 
16 399 nm 0.0132 
17 392 nm 0.0011 
18 390 nm 0.0083 





















Figure J 2 Isodensity representations of MO transitions of excited state at 399 nm for Au heli-
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